Structure-function analysis of CXXC finger protein 1 by Tate, Courtney Marie
  
 
 
 
STRUCTURE-FUNCTION ANALYSIS OF 
CXXC FINGER PROTEIN 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Courtney Marie Tate 
 
 
 
 
 
 
Submitted to the faculty of the University Graduate School  
in partial fulfillment of the requirements 
 for the degree 
 Doctor of Philosophy 
 in the Department of Biochemistry and Molecular Biology, 
Indiana University 
 
 
April 2009 
 ii 
Accepted by the Faculty of Indiana University, in partial  
fulfillment of the requirements for the degree of Doctor of Philosophy. 
 
 
 
 
 
 
 
 
 
__________________________ 
David G. Skanik, Ph.D.-Chair 
 
 
 
 
 
 
 
 
__________________________ 
Robert M. Bigsby, Ph.D. 
 
 
 
 
Doctoral Committee 
 
 
__________________________ 
Joseph R. Dynlacht, Ph.D. 
 
 
 
February 19, 2009 
 
 
 
__________________________ 
Ronald C. Wek, Ph.D. 
 
 iii 
Acknowledgements 
 
First, I would like to thank my advisor, Dr. David Skalnik, for his mentorship 
throughout my graduate career.  He has been an outstanding advisor, and I appreciate 
his time, patience, and the guidance he has given me for my thesis project.  I also 
appreciate his advice and suggestions he has given for my future career. 
I would like to express my gratitude to the members of my committee: Dr. 
Joseph Dynlacht, Dr. Ronald Wek, and Dr. Robert Bigsby.  I am grateful to all for their 
time, guidance, and suggestions concerning my research project.  I would also like to 
thank Dr. Melissa L. Fishel for her help and collaboration with the DNA damage aspect 
of my project.  I am grateful to the NIH for three years of fellowship support for an 
Infectious Disease Training Grant through Dr. Janice Blum.  I would like to thank Dr. 
Janice Blum for her interest in my project and for alerting me to conferences and 
workshops to enhance my graduate studies.  I would also like to thank Dr. Kristin Chun 
for her advice with my projects and with improving my presentations.  I am grateful to 
the Deparment of Education for support my first year of graduate studies through a 
GAANN (Graduate Assistance in Areas of National Need) fellowship. 
I also need to acknowledge the past and present members of the Skalnik Lab, the 
environment was an enjoyable place to carry out my research, and the interactions, both 
scientific and personal, were crucial for my success at Indiana University.  For this, I 
am grateful to Dr. Jeong-Heon Lee, Dr. Suzanne Young, Dr. Jill Butler, Erika Dobrota, 
Dr. Raji Muthukrishnan, and Patricia Pick-Franke.  I would like to thank the lab 
members for their friendship, support, advice, and help. 
 iv 
Finally, I need to sincerely thank my family for their love, support, and 
encouragement.  I appreciate my parents, Jerry and Sherree, for ingraining a solid 
foundation of hard work and dedication in me.  My parents have provided me with 
everything I have ever needed to be where I am today and have always been there for 
me.  Also, I want to thank my parents for believing in me and encouraging me to pursue 
my dreams.  I am grateful to know that I can always count on my family for help, and 
comforted to know that I will always have their love and support.  I would particularly 
like to thank my grandparents (Mary and Ralph), my brothers (Ryan and Dustin), and 
my aunts (Teta Jeannie and Teta Karen) for their love, support, and interest in my 
project.  I am grateful to Giancarlo for his love, support, colorful suggestions to explain 
the unexpected results of some of my experiments, and patience with me while carrying 
out my thesis research and writing.  I would also like to thank the rest of my family, 
Giancarlo’s family, and my friends for their support and encouraging me to relax, have 
fun, and enjoy life.  I am indebted to my family for their support and indispensable role 
in my achievements, for this, I dedicate this work to them.    
 v 
Abstract 
Courtney Marie Tate 
STRUCTURE-FUNCTION ANALYSIS OF CXXC FINGER PROTEIN 1 
This dissertation describes structure-function studies of CXXC finger protein 1 
(Cfp1), encoded by the CXXC1 gene, in order to determine the functional significance 
of Cfp1 protein domains and properties.  Cfp1 is an important regulator of chromatin 
structure and is essential for mammalian development.  Murine embryonic stem (ES) 
cells lacking Cfp1 (CXXC1-/-) are viable but demonstrate a variety of defects, including 
hypersensitivity to DNA damaging agents, reduced plating efficiency and growth, 
decreased global and gene-specific cytosine methylation, failure to achieve in vitro 
differentiation, aberrant histone methylation, and subnuclear mis-localization of 
Setd1A, the catalytic component of a histone H3K4 methyltransferase complex, and tri-
methylated histone H3K4 (H3K4me3) with regions of heterochromatin.  Expression of 
wild-type Cfp1 in CXXC1-/- ES cells rescues the observed defects, thereby providing a 
convenient method to assess structure-function relationships of Cfp1.  Cfp1 cDNA 
expression constructs were stably transfected into CXXC1-/- ES cells to evaluate the 
ability of various Cfp1 fragments and mutations to rescue the CXXC1-/- ES cell 
phenotype.   
These experiments revealed that expression of either the amino half of Cfp1 
(amino acids 1-367) or the carboxyl half of Cfp1 (amino acids 361-656) is sufficient to 
rescue the hypersensitivity to DNA damaging agents, plating efficiency, cytosine and 
histone methylation, and differentiation defects.  These results reveal that Cfp1 contains 
redundant functional domains for appropriate regulation of cytosine methylation, 
 vi 
histone methylation, and in vitro differentiation.  Additional studies revealed that a 
point mutation (C169A) that abolishes DNA-binding activity of Cfp1 ablates the rescue 
activity of the 1-367 fragment, and a point mutation (C375A) that abolishes the 
interaction of Cfp1 with the Setd1A and Setd1B histone H3K4 methyltransferase 
complexes ablates the rescue activity of the 361-656 Cfp1 fragment.  In addition, 
introduction of both point mutations (C169A and C375A) ablates the rescue activity of 
the full-length Cfp1 protein.  These results indicate that retention of either DNA-
binding or Setd1 association of Cfp1 is required to rescue hypersensitivity to DNA 
damaging agents, plating efficiency, cytosine and histone methylation, and in vitro 
differentiation.  In contrast, confocal immunofluorescence analysis revealed that full-
length Cfp1 is required to restrict Setd1A and histone H3K4me3 to euchromatic 
regions. 
 
David G. Skalnik, Ph.D. - Chair 
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Focus of Dissertation 
  
The first portion of this dissertation is a determination of the importance of Cfp1 
protein domains and properties in mediating Cfp1 function in ES cell growth, colony 
forming ability, cytosine methylation, and differentiation.  This was achieved by 
expressing various Cfp1 mutations in CXXC1-/- ES cells and assaying for rescue of the 
defects observed in the absence of Cfp1.  Colony forming assay was used to analyze 
plating efficiency, cell growth curves were used to calculate cell population doubling 
time, and apoptosis was analyzed by TUNEL assay in CXXC1-/- ES cells expressing 
Cfp1 mutations.  Global cytosine methylation was analyzed by methyl acceptance 
assay, Southern blot was used to analyze gene-specific cytosine methylation at IAP 
repetitive elements, and Western blot was used to analyze Dnmt1 protein expression 
levels in CXXC1-/- ES cells expressing Cfp1 mutations.  The ability of CXXC1-/- ES cells 
expressing Cfp1 mutations to achieve in vitro differentiation was analyzed by 
morphology, alkaline phosphatase activity, and RT-PCR (reverse transcriptase-
polymerase chain reaction) to assess induction of lineage and developmental markers. 
The second portion of this dissertation focuses on the functional properties of 
Cfp1 required to rescue the histone methylation defects observed in CXXC1-/- ES cells.  
Western blot analysis was used to determine Setd1A protein expression and global 
levels of H3K9me2 and H3K4me3 in CXXC1-/- ES cells expressing Cfp1 mutations.  
Confocal immunofluorescence was carried out to determine subnuclear localization of 
Setd1A and H3K4Me3 in CXXC1-/- ES cells expressing Cfp1 mutations. 
The third portion of this dissertation focuses on gaining insight into the role that 
chromatin structure plays in DNA damage sensitivity.  Analysis of cell sensitivity to a 
 xxv 
variety of DNA-damaging agents was determined in the absence of Cfp1 by clonogenic 
survival assays.  DNA damage accumulation was analyzed by accumulation of H2AX-γ 
by Western blot analysis and platinum incorporation onto DNA by atomic absorption 
spectroscopy.  In addition, Western blot analysis was used to analyze Ape1 protein 
expression, and Ape1 AP endonuclease activity was measured in CXXC1-/- ES cells.  
This work demonstrated a novel finding that Cfp1 may play a role in the DNA repair 
process.       
The goal of this dissertation is to gain insight into the molecular mechanism of 
how cytosine methylation and histone methylation are regulated in mammals.  A current 
focus in the field of epigenetic regulation is to understand how epigenetic machinery is 
regulated and targeted within the genome.  Describing the mechanism by which Cfp1 
functional properties are required for appropriate regulation of chromatin structure and 
targeting the Setd1A histone H3K4 methyltransferase complex contributes to the 
understanding of epigenetic regulation.  In addition, insight into the role that chromatin 
structure plays in DNA-damaging agent and chemotherapeutic agent effectiveness may 
lead to more effective combinations of chemotherapy in cancer patients.     
 1 
Introduction 
 
I.  Chromatin Structure and Epigenetics 
In eukaryotic cells, the genetic information encoded by DNA is packaged with 
core histone proteins and other chromosomal proteins into chromatin.  The basic 
repeating unit of chromatin, the nucleosome, includes two copies of each of the four 
core histones, H2A, H2B, H3, and H4 wrapped by approximately one hundred forty-
seven base pairs (bp) of genomic DNA.  Each nucleosome is linked to the next by small 
(~50 bp) segments of linker DNA (Quina 2006).  Additional proteins, including histone 
H1, help further package the nucleosomes (Zhang 2001).  Several additional folding 
mechanisms contribute to the 10,000-fold compaction that is necessary to fit DNA into 
the cell nucleus (Loden 2005).  Nucleosomes are packed and stacked into more compact 
structures.  The chromatin fibre can form loops that allow distant chromosomal regions 
to interact, and particular regions of the genome may be tethered to scaffolding 
structures in the nucleus (Loden 2005).  Each level of chromatin organization plays 
important roles in the regulation of gene expression.   
Epigenetics is defined as heritable patterns of gene expression that occur without 
a change in the nucleotide sequence of the DNA.  Epigenetic modifications include 
cytosine methylation and distinct combinations of covalent modifications of histone 
protein tails, also referred to as the “histone code”.  Covalent modifications of histone 
proteins include methylation, acetylation, ubiquitination, SUMOylation, ADP-
ribosylation and phosphorylation, all of which influence chromatin structure and 
regulation of gene expression (Shilatifard 2006; Peterson 2004; Roth 2001; Martin 
 2 
2005).  The histone code hypothesis predicts that distinct modifications occurring on a 
specific histone protein tail can be read by other chromatin-associated proteins, thereby 
serving as a platform to recruit specific nuclear factors.  In addition, distinct types of 
higher order chromatin are largely dependent on the local concentration and 
combination of differentially modified nucleosomes leading to the creation of an 
epigenetic code (Jenuwein 2001; Turner 2000; Strahl 2000).   
Chromatin can be broadly divided into euchromatin, which is permissive for 
transcription, and heterochromatin, which is repressive (Rassmussen 2003).  Originally, 
the two forms of chromatin were distinguished cytologically by how darkly they stained 
the former is lighter, while the latter stains darkly, indicating tighter packing (Frenster 
1974).  Heterochromatin is usually localized to the periphery of the nucleus and is 
found in parts of chromosomes with little or no genes (Frenster 1974).  Heterochromatin 
is a condensed 30 nm fiber structure characterized by dense DNA methylation, 
hypoacetylated histones, and histone H3 methylated on lysine 9 (H3K9me).  In contrast, 
transcriptionally active euchromatin is in a more loosely-packaged beads-on-a-string 
structure characterized by hypomethylated DNA, acetylated core histones, and histone 
H3 methylated on lysine 4 (H3K4me) (Weintraub 1976) (Fig. 1).  Heterochromatin 
appears to have much more molecular complexity than euchromatin.  Most euchromatin 
consists of standard nucleosomes, but heterochromatin often contains modified 
nucleosomes in which histone variants substitute for the standard core histones 
(Milutinovic 2003).  Histone variants have functional roles in transcriptional regulation, 
DNA repair, and establishment of heterochromatin (Bernstein 2006).  Histone variants 
and conventional histone proteins differ in amino acid composition that leads to 
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FIGURE 1.  Chromatin classification. 
The schematic represents general characteristics of euchromatin and 
heterochromatin.  Transcriptionally active regions of the genome are packaged less 
densely as euchromatin and are more accessible to transcription factors.  Euchromatin is 
generally characterized by hypomethylated DNA and hyperacetylated histone proteins.  
In contrast, transcriptionally inactive regions of the genome are densely packaged into 
heterochromatin that is inaccessible to transcription factors and is characterized by 
hypermethylated DNA and hypoacetylated histone proteins.   
 
 
 
 
EUCHROMATIN
HETEROCHROMATIN
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structural differences or differences in post-translational modifications that affect 
nucleosome dynamics (Bernstein 2006).  DNA and histone octamers need to be 
physically separated and rejoined after DNA replication (Hsieh 2005).  Embeded in the 
process is the random mixing of old and newly synthesized histones that need to be 
reassembled into histone octamers and wrapped by each of the daughter chromosomes.  
The expression of histone genes is tightly regulated in S phase to meet the demand of 
packaging newly replicated DNA.  However, other situations occur outside of S phase, 
such as the repair of DNA damage, where limited supply of histone proteins might 
endanger the integrity of the chromosome.  Therefore, copies of variant histone genes 
are constitutively expressed at low levels throughout the cell cycle and serve as 
replacements for standard histones (Hsieh 2005).   
In addition to histones, chromatin contains a large number of other proteins.   
Among them are elements of the transcription machinery, heterochromatin protein 1 
(HP1), and proteins that belong to the high mobility group (HMG), polycomb group 
(PcG), and trithorax group (trxG) (Roloff 2005).  HMG proteins are a family of nuclear 
proteins that bind to nucleosomes, destabilize higher order structures of the chromatin 
fiber, and enhance activation of transcription and replication from chromatin templates 
(Bustin 2001).  PcG proteins play a significant role in establishing and maintaining 
transcriptional repression in heterochromatic regions during development.  In contrast, 
trxG group proteins are involved in transcriptional activation at euchromatic regions.  
One main activity of the trxG group proteins is to activate transcription by inducing 
trimethylation of lysine 4 of histone H3 (H3K4me3) at specific regulatory sites in their 
target chromatin.  
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II.  Cytosine Methylation 
DNA methylation involves the addition of a methyl group to the carbon 5-
position of the cytosine ring in the context of CpG dinucleotides and is primarily 
correlated with gene repression (Singal 1999; Paulsen 2001).  The methylation pattern 
of genomic DNA is characterized by the presence of methylated cytosines on the bulk 
of the DNA while unmethylated cytosines are mainly located within particular regions 
in euchromatin termed CpG islands.  CpG islands are generally found in promoter 
regions of active genes and within housekeeping genes because these regions tend to be 
unmethylated (Caiafa 2005).  Methylated cytosines are not randomly distributed but 
form a tissue- and cell-specific pattern (Hermann 2004).  CpG dinucleotides are 
distributed at a lower frequency than expected throughout the mammalian genome, 
presumably due to the propensity of 5-methylcytosine to undergo a spontaneous 
deamination reaction to form thymine.  Spontaneous hydrolytic deamination of 
unmethylated cytosine generates uracil, which is readily recognized as an inappropriate 
nucleotide within the DNA and is repaired by uracil-glycosylase mediated DNA repair 
(Lindahl 1993).  G-T and G-U mispairs that remain uncorrected can alter both coding 
and regulatory sequences and are frequently observed in aging and cancer (Hendrich 
1999).  The methyl-CpG binding protein/thymine glycosylase Mbd4 protein is involved 
in interpreting the CpG methylation mark, modifying chromatin, and repressing 
transcription (Bassal 2005).  Mbd4 corrects G-U mismatches and also coordinates the 
repair of other DNA mismatches, although less efficiently than uracil repair (Bellacosa 
2001).   
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Cytosine methylation plays essential roles in mammalian development, 
gametogenesis, genome stability, X chromosome inactivation, and genomic imprinting 
(Bestor 2000, Li 2002).  The majority of genomic cytosine methylation serves to 
transcriptionally silence transposons and retroviruses that have accumulated in the 
mammalian genome (Bestor 2000).  The silencing of endogenous retroviral and 
parasitic sequences by DNA methylation prevents propagation of these elements that 
may inappropriately integrate throughout the genome and disrupt normal gene function 
(Bird 2002).  Genomic hypomethylation has multiple consequences, including 
chromosomal instability, aberrant activation of endogenous retroviral elements and 
oncogenes, and loss of genomic imprinting (Wilson 2007).  In addition, genomic 
hypomethylation of centromeric repeat sequences can lead to chromosomal breakage 
and rearrangements (Turleau 1989).   
DNA methylation patterns are reprogrammed during mouse embryogenesis by 
genome-wide demethylation and de novo methylation (Okano 2002).  During early 
development, a dramatic reduction in methylation levels occurs in the preimplantation 
embryo.  This is followed by a wave of de novo methylation involving most CpG 
dinucleotides, but leaving the CpG islands unmethylated at the time of implantation 
(Singal 1999).  After implantation, most of the genomic DNA is methylated, whereas 
tissue-specific genes undergo demethylation during histogenesis (Singal 1999).  
Genomic imprinting plays a critical role in embryogenesis and development.  
Imprinting leads to preferential expression of one of the two parental alleles in a parent-
of-origin-specific manner.  Imprinted genes are characterized by methylation patterns 
specific to each of the paternal alleles (Paulsen 2001).  Imprinted regions show 
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remarkable differences in histone acetylation between the two alleles, suggesting a role 
for both DNA methylation and histone modifications in genomic imprinting.  Genome-
wide reprogramming of DNA methylation also occurs during gametogenesis and plays a 
critical role in establishing the parental-specific methylation marks in imprinted genes 
(Okano 2002).   
Epigenetic modifications also play a critical role in X chromosome inactivation.  
Female mammals inactivate one of two X chromosomes during early embryogenesis in 
order to make X-linked gene dosages equivalent to males.  The X chromosome contains 
a region known as the X-inactivation center, which encodes Xist (X-inactivation specific 
transcript), an RNA molecule that coats the X chromosome in cis and triggers its 
silencing (Plath 2002).  A histone H3K9 methylation hot spot upstream of the Xist locus 
serves to initiate the cooperative spreading of Xist RNA and H3K9 methylation across 
the entire inactive X.  Shortly after Xist coating, characteristic patterns of histone 
modifications, such as hypoacetylation of H3 and H4, di-methylation of H3K9, tri-
methylation of H3K27, and lack of methylation of H3K4 occur.  Then, the inactive X 
becomes heavily methylated at CpG dinucleotides.  These chromatin modifications in 
combination with polycomb group proteins all contribute to and ensure the maintenance 
of X inactivation by maintaining a heterochromatic configuration (Csankoszki 2001).    
One mechanism by which DNA methylation leads to transcriptional repression 
is by interfering with the binding of transcription factors to the DNA (Hendrich 1998).  
Several transcription factors, including Ap-2, c-Myc/Myn, Creb, E2F, and NF-κB, 
recognize sequences that contain CpG dinucleotides, and binding to each has been 
shown to be inhibited by methylation (Singal 1999).  Methylation of the promoter of the 
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neurofibromatosis gene, NF1, interferes with Creb and Sp1 transcription factor binding.  
In addition, methylation of the promoter region of the mismatch repair gene MLH1 
interferes with CREB-binding protein (Cbp), a histone acetyltransferase (HAT), binding 
and inhibits gene expression (Loden 2005).  Methylation might also result in structural 
effects on nucleosomes themselves or effects on nucleosome positioning, nucleosome 
stability, or assembly of higher order chromatin structure (Wade 2001).   
 
III.  DNA Methyltransferase Enzymes   
Cytosine methylation is catalyzed by DNA methyltransferase (Dnmt) enzymes 
in the context of CpG dinucleotides (Singal 1999).  Dnmt enzymes catalyze the transfer 
of a methyl group from S-adenosyl L-methionine (SAM) to the carbon 5-position of the 
pyrimidine ring of a cytosine base (Ferguson-Smith 2001).  There are three families of 
DNMTs in mammals that exhibit non-redundant functional roles: DNMT1, DNMT2, 
and DNMT3.  The Dnmts are not sequence specific and molecular mechanisms 
regarding their genomic targeting remain unclear.  The DNMT1 family contains a 
single member (Dnmt1), but there are many splice variants of the DNMT1 gene.  
Tissue-specific alternative splicing produces several forms of Dnmt1, which may result 
in enzymes designed to carry out distinct roles in DNA methylation metabolism 
(Robertson 2002).  Dnmt1 is considered the major maintenance DNA methyltransferase 
due to its preference for hemimethylated substrates relative to unmethylated DNA 
(Bestor 2000).  Consequently, Dnmt1 is the primary enzyme responsible for copying 
methylation patterns from the parental to daughter DNA strand following semi-
conservative DNA replication (Bestor 2000; Okano 2002).  Consistent with this idea, 
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Dnmt1 localizes at replication foci in S phase and interacts with the replication 
processivity factor Pcna (Okano 2002).  Dnmt1 transcript levels increase during the 
transition from late G1 phase to early S phase in apparent preparation for the S phase 
synthesis of DNA.  In addition, Dnmt1 protein level and activity are highest in the S 
phase and lowest in the G1 phase (Milutinovic 2003).  Although, Dnmt1 is primarily 
responsible for maintenance methylation, it also possesses de novo methylation activity 
toward an unmethylated substrate (Fatemi 2002).   
Genomic DNA methylation plays an important role in development, disease, and 
genomic stability.  Mice lacking DNMT1 die during early embryogenesis (E9.5-11) and 
exhibit a 70% reduction in global cytosine methylation, loss of monoallelic expression 
of imprinted genes, and increased cell death (Li 1992).  DNA hypomethylation caused 
by Dnmt1 deficiency in DNMT1-/-  murine embryonic stem (ES) cells was correlated 
with higher recombination frequency, chromosomal deletion (Chen 1998; Eden 2003), 
and was associated with higher frequency of microsatellite instability (MSI) (Wang 
2004).  DNMT1 mutation produces a lethal differentiation phenotype in which 
homozygous mutant ES cells grow normally with severely hypomethylated genomes, 
abnormal imprinting, and derepression of endogenous retroviruses, but undergo cell 
autonomous apoptosis when induced to differentiate (Bestor 2000).  In addition, 
overexpression of Dnmt1 also results in embryonic lethality with global 
hypermethylation and loss of imprinting (Biniszkiewicz 2002).  Inactivation of Dnmt1 
in murine embryonic fibroblasts (MEFs) and human colorectal carcinoma cells 
(HCT116) results in a genome-wide loss of DNA methylation resulting in genomic 
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instability and eventually cell death by apoptosis, indicating an important role for 
Dnmt1 in cell viability (Li 1992; Lei 1996; Jackson-Grusby 2001; Robert 2003).   
The DNMT2 family also contains a single member (Dnmt2), and this protein 
contains the functional motifs required to carry out cytosine methylation and is capable 
of binding DNA (Dong 2002).  Dnmt2 mRNA is ubiquitously expressed at low levels, 
but the biological function of Dnmt2 was not directly apparent.   DNMT2-/- mice are 
viable, exhibit normal levels of cytosine methylation, and appear normal (Okano 1998).  
Functional activity of Dnmt2 toward DNA was demonstrated upon overexpression of 
Dnmt2 but the level of activity was very low (Tang 2003).  Dnmt2 was identified as an 
RNA methyltransferase that localizes in the cytoplasm (Goll 2006).  In addition, the 
RNA methyltransferase function of Dnmt2 is required for appropriate development of 
the liver, brain, and retina in Danio rerio (Rai 2007).   
The DNMT3 family contains the Dnmt3a and Dnmt3b proteins that are 
responsible for the establishment of de novo methylation patterns during early 
embryonic development (Yokochi 2002).  Dnmt3a and Dnmt3b enzymes are highly 
expressed during early developmental stages and prefer unmethylated DNA more than 
hemimethylated DNA as a substrate (Bestor 2000).  Dnmt3a and Dnmt3b also play a 
role in maintaining DNA methylation patterns in ES cells (Chen 2003).  In addition, 
there is a third member of the Dnmt3 family, Dnmt3-like (Dnmt3L) that shares 
homology with Dnmt3a and Dnmt3b but lacks catalytic activity (Aapola 2000).  
Dnmt3L co-localizes with Dnmt3a and Dnmt3b and stimulates DNA methylation by 
accelerating Dnmt3a binding to DNA and increasing the affinity of Dnmt3a for the 
coenzyme SAM (Chedin 2002).    
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DNMT3a knockout mice are viable and appear normal at birth, but become 
runted and die around 4 weeks of age (Okano 2002).  DNMT3b knockout mice are 
embryonic lethal before E9.5 and exhibit multiple developmental defects and growth 
impairment (Okano 2002).  DNMT3a-/- and DNMT3b-/- ES cells exhibit methylation 
defects in imprinted genes and minor satellite genes, and a 45% reduction in global 
cytosine methylation that continues to decline with passaging along with inability to 
differentiate (Jackson 2004).  Mutations in Dnmt3b are observed in immunodeficiency, 
centromere instability, and facial anomalies (ICF) syndrome, a genetic disorder which is 
characterized by loss of pericentromeric repeat methylation and is associated with 
chromosomal instability and loss of B-cell function (Jackson-Grusby 2001).  Patients 
with ICF syndrome exhibit normal Dnmt3a expression and function, which 
demonstrates non-redundant functions between Dnmt3a and Dnmt3b.  Dnmt3L is not 
required for murine development, but DNMT3L-/- male mice are sterile and exhibit 
imprinting defects during spermatogenesis, while female mice exhibit loss of imprinting 
and aberrant expression of maternally imprinted genes (Hata 2002).  DNA 
hypomethylation results in an increased rate of rearrangements and gene loss by mitotic 
recombination (Chen 1998).  This observation is consistent with other studies showing 
an increase in chromosome 1 pericentromeric rearrangements in DNMT3b-/- ES cells, 
and in cells treated with the Dnmt inhibitor 5-aza-2’-deoxycytidine (Ji 1997).         
Multiple mechanisms ensure the integrity of the genome in response to DNA 
damage and it is likely that mechanisms also exist to protect cells from epigenomic 
stress (Milutinovic 2003).  The association of Dnmt1 with DNA replication may ensure 
concordant replication of DNA and its methylation pattern.  Knockdown of Dnmt1 
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using antisense oligonucleotides causes inhibition of cell growth due to an intra-S phase 
arrest of DNA synthesis and induces expression of many stress response genes.  This 
slow down of DNA synthesis during S phase may protect the DNA from a global loss of 
methylation (Milutinovic 2003).  Intra-S phase arrest was not caused by 5-aza-2’-
deoxycytidine, which causes extensive loss of DNA methylation, suggesting that the 
arrest is a direct or indirect result of a reduction in Dnmt1 protein level (Milutinovic 
2003).  In addition, cells from post-gastrulation and differentiating cultures of DNMT1-
mutant embryos show stochastic apoptotic cell death, and DNMT1 deficient primary 
MEFs undergo p53-dependent apoptosis and global induction of gene expression 
(Jackson-Grusby 2001).  In addition, several genes known to be involved in apoptosis 
were deregulated in DNMT1-deficient cells (Jackson-Grusby 2001).          
Targeting of Dnmts to particular genomic regions might occur through protein-
protein interactions.  Dnmts can be recruited to particular genomic loci through their 
association with specific transcription factors, methylated histone binding proteins such 
as HP1, or co-repressors (Ding 2002).  DNA methylation plays an important role in 
regulating genome function which necessitates tight regulation of Dnmt1 protein levels.  
Transcription of Dnmt1 is regulated by the Ras signaling pathway in cancer cells, and 
post-transcriptional regulation of Dnmt1 has been proposed to be responsible for 
regulation of Dnmt1 mRNA levels during the growth state of cells (Slack 1999).  
Dnmt1 protein stability is also tightly regulated.  Dnmt1 interacts with the 
transcriptional repressor protein Dmap1 (DNA methyltransferase 1 associated protein) 
which interacts with the tumor suppressor Tsg101 (McCabe 2005).  It is possible that 
Dnmt1 degradation is regulated through an interaction involving Dnmt1, Dmap1, and 
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Tsg101 (Ding 2002).  Tsg101 controls p53 protein levels by interacting with Mdm2, a 
negative regulator of p53 tumor suppressor, and inhibiting Mdm2 ubiquitination and 
degradation (Ding 2002).  Tsg101 could regulate the level of Dmap1 by a similar 
mechanism and indirectly regulate Dmap1-controlled degradation of Dnmt1.  Also, 
Dnmt1 is a direct transcriptional target of the retinoblastoma tumor suppressor 
(Rb)/E2F pathway (McCabe 2005).  Rb is required for proper cell cycle regulation of 
Dnmt1 transcription, which may be crucial for maintenance of normal DNA 
methylation patterns.  In the absence of Rb, cells exhibit increased transcription of the 
Dnmt1 gene leading to accumulation of Dnmt1 protein.  Increased levels of Dnmt1 
were correlated with aberrant DNA hyper-methylation-mediated transcriptional 
silencing (McCabe 2005). 
If DNA methylation patterns act as biological signals in post development cells, 
cytosine methylation patterns must be reversible (Szyf 2005).  It appears that DNA 
methylation is a late event in gene silencing, and one of the first epigenetic marks to be 
removed upon activation (Arney 2004).  It is possible to reverse DNA methylation in 
replicating cells by passive demethylation, by blocking Dnmt1 during DNA synthesis.  
Demethylation in post-mitotic cells could be achieved by an active process of 
converting methylated cytosine to cytosine by repair or by breakage of the carbon-
carbon bond that links the pyrimidine to its methyl group.  There is evidence supporting 
passive and active demethylation.  The 5-methylcytosine base could be removed by a 
glycosylase or through nucleotide excision and then be replaced by an unmethylated 
cytosine.  Many groups have reported 5-methylcytosine-DNA glycosylase activity 
carried out by thymine DNA glycosylase and also by Mbd4 (Bird 2002).  Evidence 
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supporting active demethylation includes the fact that genes that are highly methylated 
in sperm are rapidly demethylated in the zygote only hours after fertilization, before the 
first round of DNA replication commences (Oswald 2000).  Also, the interleukin 2 (Il2) 
gene is silent in naive murine T lymphocytes, but is expressed when T cells become 
activated (Bird 2003).  Demethylation is a key step in activation of Il2, and the 
demethylation occurs much too fast to be passive (Bird 2003).  In addition, the 
demethylation of methylated DNA injected into zebrafish embryos occurs in a 
replication-independent manner (Collas, 1998).  Recently, active DNA demethylation in 
zebrafish was shown to involve the coupling of a 5-methylcytosine deaminase (Aid), 
the mismatch-specific thymine glycosylase (Mbd4), and a non-enzymatic factor 
(Gadd45) (Rai 2008).      
 
IV.  Methyl CpG Binding Proteins 
The functional properties of methylated DNA result, in part, from the action of a 
family of proteins that bind selectively to methylated CpG dinucleotides (Bird 1999).  
In mammals, this family of proteins is characterized by the presence of a common 
sequence motif termed the methyl-CpG-binding domain (MBD) (Jorgensen 2004).  
Binding of methyl CpG binding proteins physically obstructs the basal transcription 
machinery (Hattori 2004).  Mbd1 is a member of the subfamily of MBD proteins that 
bind methylated CpG motifs, which in mammals includes Mecp2 (Nan 1998), Mbd2 
(Hendrich 1998), the DNA repair protein Mbd4 (Jorgensen 2004), and Kaiso 
(Prokhortchouk 2001).  Unlike Mbd1, Mbd2, Mbd4, and Mecp2, that bind DNA 
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through conserved MBD domains, DNA-binding by Kaiso is mediated through a zinc 
finger motif that requires two symmetrically methylated CpGs (Prokhorchouk 2001).   
Consistent with the silencing effect of DNA methylation, most of the proteins 
that bind methylated DNA are involved in transcriptional repression.  Mbd1 has 
intrinsic repression ability through a transcriptional repression domain (TRD) whereas 
Mbd2 and Mecp2 recruit HDAC enzymes and the co-repressor Sin3 through their 
transcriptional repression domains (Fujita 1999).  Mbd1 interacts with the histone H3K9 
methyltransferase Suv39h1 and histone deacetylases HDAC1 and HDAC2 (Fujita 
2003).  Mecp2 also associates with histone H3K9 methylation and facilitates H3K9 
methylation of the imprinted gene, H19 (Fuks 2003).  Mecp2 is also a component of the 
SWI/SNF chromatin remodeling complex (Harikrishnan 2005).  Mbd3 is a component 
of the Mi2/NuRD histone methyltransferase complex but cannot bind DNA (Tatematsu 
2000).  Mbd3 interacts with Mbd2 which can bind methylated DNA, which may 
contribute to the function of the Mi-2/NuRD complex (Tatematsu 2000).  Mbd4 (also 
called Med1, for methyl-CpG binding endonuclease) binds methylated DNA but does 
not function in transcriptional repression and is the only MBD family member not 
associated with HDAC activity.  Mbd4 functions as a DNA repair protein that removes 
thymine/uracil-guanine mismatches after cytosine deamination (Hendrich 1999).  Kaiso 
is a member of the N-CoR HDAC complex (Yoon 2003).  Kaiso binds p120 catenin that 
interacts with the cell adhesion molecule E-cadherin and has been proposed to regulate 
p120 catenin/E-cadherin signaling to the nucleus and regulate gene expression (Yoon 
2003).       
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V.  Heterochromatin 
Inactive genes widely outnumber actively transcribed genes, suggesting that 
repression of unnecessary genes may be a basic rule of transcriptional control.  
Heterochromatin is defined as chromosome regions that remain highly condensed 
throughout the cell cycle, whereas euchromatin is decondensed during interphase 
(Hsieh 2005).  Heterochromatin is often associated with telomeres and pericentric 
regions of chromosomes, and is rich in repetitive sequences and low in gene density.  
The condensed feature of heterochromatin is reflected in its regularly packaged 
nucleosomal arrays and resistance to nuclease digestion.  Transcriptionally inactive 
heterochromatin can be categorized as facultative heterochromatin or constitutive 
heterochromatin.  Facultative heterochromatin corresponds to regions of silenced 
euchromatin, such as the inactive X chromosome in females.  Facultative 
heterochromatin exists in different locations within euchromatic regions and may be 
transcriptionally silenced in one tissue type, cell lineage, or developmental stage while 
active in others (Hsieh 2005).  In contrast, constitutive heterochromatin refers to 
condensed and permanently inactive chromosomal regions associated with centromeres 
and telomeres and consists primarily of repetitive DNA elements.  Heterochromatin 
formation is a complex process requiring the activity of histone-modifying enzymes, 
chromatin-remodeling proteins, Dnmts, and RNA-directed silencing complexes.    
RNA interference (RNAi) is believed to have evolved as a defense mechanism 
against parasitic DNA elements.  In addition to its role in targeted destruction of 
mRNAs, the RNAi pathway is involved in initiating heterochromatin formation and 
silencing repeat sequences (Cam 2005).  At the silent mating-type interval of S. pombe, 
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the RNAi machinery cooperates with cenH, a DNA element homologous to centromeric 
repeats, to initiate heterochromatin formation (Hall 2002).  The transcripts derived from 
cenH are processed by the RNAi machinery, and resulting RNA intermediates directly 
recruit HDAC and histone H3K9 methyltransferases to the mat locus.  The initial 
recruitment is proposed to nucleate heterochromatin by creating H3K9 methylated 
binding sites for Swi6, an ortholog of HP1.  Swi6 can then serve as a platform for the 
recruitment of histone-modifying activities that create additional Swi6 binding sites on 
adjacent nucleosomes, enabling spreading to occur in a stepwise manner (Hall 2002).  
Similarly, in mammals, HP1 binding to methylated H3K9 results in the assembly of a 
repressive protein complex.  Propagation of a repressive chromatin state occurs by HP1-
mediated recruitment of Suv39h1 H3K9 methyltransferase resulting in histone 
methylation of neighboring nucleosomes (Verschure 2005).  These processes form a 
self-propagating loop of events which results in the spreading of the heterochromatin 
state.   
 
VI. Histone Modifications 
Each core histone is composed of a structured, three-helix domain called the 
histone fold and two unstructured tails (Zhang 2001).  Many covalent modifications of 
histones take place on the histone N-terminal tails that extend from the nucleosome core 
and can lead to altered DNA and protein binding of histones.  Each histone tail can be 
modified on several residues by different mechanisms, and the histone protein tails are 
subject to a variety of covalent modifications, including acetylation, phosphorylation, 
methylation, ubiquitination, SUMOylation, and ADP-ribosylation (Fig. 2).  Covalent 
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modifications of histone proteins can lead to changes in their electrostatic charge and 
create binding sites for proteins (Iizuka 2003).  Certain modifications correlate with 
transcriptionally active or inactive chromatin sites and an open or compact chromatin 
structure, respectively (Jenuwein 2001; Iizuka 2003).  These modifications mark 
chromatin states and can be specifically recognized by other proteins.  They are referred 
to as the “histone code” (Strahl 2000).  In general, acetylation of lysine (K) residues and 
methylation of arginine (R) residues of histone H3 and H4 are related to transcriptional 
activation (Lachner 2003).  Lysine residues can be mono- di-, or trimethylated and the 
functional relevance of these modifications depends on their amino acid position.  For 
example, di- and trimethylated K4 of histone H3 is found at transcribed genes (Santos-
Rosa 2002), whereas di- and trimethylated H3K9 is present at transcriptionally inactive 
chromatin sites (Boggs 2002; Peters 2001; Noma 2001).   
The acetylation status of histones is determined by histone acetyltransferases 
(HATs) and histone deacetylases (HDACs).  HATs are categorized into three principal 
groups: GNAT, MYST, and p300/CBP.  HATs tend to be components of multi-protein 
complexes and are recruited to specific promoters via DNA bound transcription factors 
(Gibbons 2005).  The prime targets of the HATs in chromatin are the N-terminal tails of 
the core histones H2A, H2B, H3, and H4 (Kalkhoven 2002).  Acetylation of histone 
tails results in neutralization of the positively charged lysines, thereby influencing the 
interaction of histone tails with DNA, RNA, and proteins.  In addition, some HATs can 
acetylate nonhistone proteins, including sequence-specific transcription factors and the 
basal transcription factors TFIIE and TFIIF (Kalkhoven 2002).  
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FIGURE 2.  Sites of covalent modifications in histone N-termini.  
The core histone protein tails, H2A, H2B, H3, and H4 can be modified on a 
variety of amino acid residues.  Histone H3K4 methylation is associated with 
transcriptional activation, whereas histone H3K9 and H3K27 methylation are typically 
associated with transcriptional repression.  Some of the post-translational modifications 
include methylation (Me), acetylation (Ac), and phosphorylation (P).  The amino acid 
position within the primary sequence is denoted below the amino acid residue.  Figure 
was modified from www.cns.pdx.edu/ActiveInactiveChromatin2. 
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 Acetylation of lysine residues within histone proteins is reversible with 
deacetylation being catalyzed by HDACs.  Transcriptional repression can be mediated 
through recruitment of HDACs, components of multi-subunit complexes, whose histone 
deacetylase activity results in nucleosome remodeling, or changes in histone-DNA 
interaction within nucleosomes (Fuks 2000).  In addition to their roles in transcriptional 
regulation, HATs and HDACs are also involved in DNA replication, DNA repair, 
maintaining the silenced heterochromatic states at the mating-type loci and sub-
telomeric regions, and preventing the spread of silenced chromatin to neighboring 
euchromatic regions (Hsieh 2005).   
 
VII.  Histone Methylation 
Histone methylation occurs on both arginines and lysines, such as arginine 17 
and lysine 9 of histone H3 that mark opposite transcription states (Lee 2005).  The 
lysine ε-amino groups of histones can be mono-, di-, or tri-methylated and, depending 
on the specific residue modified, this methylation is associated with the formation of 
repressive heterochromatin, with transcriptional activation and elongation by RNA 
polymerase II (RNAP II), or with the transcriptional silencing of euchromatin genes.  
Histone methylation is carried out by a family of histone methyltransferases, many of 
which are characterized by a SET [Su(var)3-9, Enhancer of Zeste, Trithorax] domain 
(Dillon 2005).  Histone methylation has been found on a range of lysine residues in 
various histones: K4, K9, K27, K36, and K79 in histone H3, K20 in histone H4, K59 in 
the globular domain of histone H4, and K26 of histone H2B (Dillon 2005).  Several 
proteins responsible for the methylation of specific residues have been characterized, 
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and all but one of these contains a SET domain.  The exception is the DOT1 family, 
members of which methylate K79 in the globular region of histone H3 and which are 
structurally not related to SET-domain proteins (Dillon 2005).  SET-domain-containing 
proteins methylate a few proteins in addition to histones.  The function of SET-domain 
proteins is to transfer a methyl group from S-adenosyl-L-methionine to the amino group 
of a lysine residue on the histone or other protein, leaving a methylated lysine residue 
and the cofactor by product S-adenosyl-L-homocysteine.   
Yeast express only a single histone H3K4 methyltransferase, referred to as Set1, 
which associates with a complex known as COMPASS (Complex Proteins Associated 
with Set1) (Miller 2001).  In contrast, mammalian cells contain numerous histone 
methyltransferases that exhibit specificity for H3K4, including Setd1A, Setd1B, Mll1, 
Mll2, Mll3, Mll4, Smyd1, Smyd2, Smyd3, and Set7/9 (Lee 2005; Lee 2007; Glaser 
2006; Dillon 2005).  Five mammalian H3K9-specific histone methyltransferases 
(HMTs) have been identified, among which Suv39h1 and Suv39h2 mainly function in 
heterochromatic regions, whereas G9a, Eset/Setdb1, and Eu-HMTase 1, mainly 
function in euchromatin (Aagaard 1999; Tachibana 2002; Schultz 2002; Yang 2002).  
Eset/Setdb1 represses transcription in a HMT activity-independent manner, through its 
interaction with HDAC1 and HDAC2 (Yang 2003).    
Unlike many other histone modifications, methylation, which is uncharged, does 
not alter the overall charge of the positive lysine residue and therefore is not thought to 
directly alter interactions between histone molecules and DNA.  Instead, histone 
methylation is recognized by a growing list of effector proteins (Zhang 2006).  In yeast 
and humans, histone H3K4 acts, in part, to recruit chromat
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histone-modifying activities.  In yeast, H3K4 methylation recruits both the Isw1 and 
Chd1 ATPases (Pray-Grant 2005).  In humans, H3K4 methylation recruits Chd1 and the 
ISWI-related remodeling factor Nurf (Flanagan 2005).  H3K4 tri-methylation also 
recruits the ING family of PHD finger-containing proteins, including ING2, which is a 
gene repressor protein that is associated with HDAC activity (Shi 2006).  In addition to 
the recruitment of effector proteins, H3K4 methylation in humans also promotes 
hSet1/Mll1/Mll2 association to chromatin through a feed-forward mechanism whereby 
H3K4 trimethylation by these complexes allows their Wdr5 component, a WD40 
repeat-containing protein, to bind this histone modification and foster further H3K4 
methylation (Wysocka 2006).   
The precise function of histone H3K4 methylation is not known, but it has been 
hypothesized to facilitate transcription by serving as a mark to recruit necessary 
transcription machinery components, or alternatively to protect euchromatic regions 
from the repressive effects of neighboring silent chromatin complexes (Noma 2001; Litt 
2001).  It is possible that H3K4 methylation either facilitates histone acetylation or it 
protects transcriptionally active regions from the effects of repressive chromatin 
remodeling activities such as HDACs, or both (Noma 2002).  Histone H3K4 
methylation facilitates subsequent acetylation of the histone tail by acetyltransferases in 
vivo (Wang 2001).  Methylation of H3K4 interferes with interactions between the 
NuRD histone deacetylase and H3 tail, as well as precludes H3K9 methylation by 
Suv39h1 (Nishioka 2002; Zegerman 2002).  
Epigenetic marks comprise a complex and inter-related collection of 
modifications at adjacent residues.  Mass spectrometric analysis of the cellular pool of 
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histones indicates that the H3K4me mark is associated with histone H3 molecules 
containing high levels of acetylation (Nightingale 2007).  In addition, co-localization of 
acetylation and H3K4me has been observed.  Both the precise lysine residue modified 
and the degree of methylation have differential effects on transcriptional regulation, 
suggesting that a combination of both parameters defines the epigenetic mark and its 
functional role (Nightingale 2007).  The patterns of histone modifications present in a 
nucleosome can be read by binding molecules which results in transcriptional 
activation, transcriptional repression, or DNA repair.  Post-translational histone 
modifications can also create specific docking sites for regulatory proteins.  For 
example, heterochromatin protein 1 (HP1), which binds to methylated histone H3K9, is 
a key interaction in heterochromatin that is facilitated by Suv39h1 and Suv39h2 histone 
methyltransferases (Plath 2002).   
Suggested mechanisms of histone demethylation include demethylation by 
histone-demethylases, cleavage of methylated tails, and replacement/degradation of 
methylated histones (Jenuwein 2001).  Lsd1 (lysine-specific histone demethylase 1) is a 
histone H3K4 and H3K9 demethylase (Shi 2004).  Lsd1 associates with HDAC1 and 
HDAC2 and is part of co-repressor complexes (Forneris 2005).  Lsd1 specifically 
demethylates histone H3K4 via an oxidation reaction that generates formaldehyde.  
RNAi inhibition of Lsd1 causes an increase in H3K4 methylation and derepression of 
target genes (Verschure 2005).  Members of the Jumonji C (JmjC) domain-containing 
family of histone demethylases (JHDMs) are able to demethylate mono-, di-, and tri-
methylated forms of histone H3K9 (Klose 2006).  This reveals dynamic regulation of 
histone methylation by both histone methylases and demethylases.   
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VIII.  Histone Methylation and RNA Polymerase II 
The C-terminal domain (CTD) of RNA polymerase II’s (RNAP II) largest 
subunit is essential for transcription, for organization of transcription foci within the 
nucleus, and for pre-mRNA processing (Palancade 2003).  The CTD consists of 
multiple repeats of a seven amino acid motif.  Five of the seven amino acids in the 
consensus motif are phosphate acceptors, and phosphorylation is a major post-
translational modification of the CTD in vivo (Bensaude 1999).  CTD phosphorylation 
plays a major role in the transcriptional process (Dahmus 1996; Riedl 2000; 
Oelgeschlager 2002).  Upon preinitiation complex assembly, TFIIH phosphorylates 
serine 5 of the CTD at or near the promoter (Komarnitsky 2000), thereby marking the 
transition between initiation and elongation.  At a later stage, elongating RNAP II is 
phosphorylated at serine 2 of the CTD by Ctk1, with the level of serine 2 
phosphorylation increasing toward the 3’ end of the gene (Komarnitsky 2000; Cho 
2001).  Subsequently, serine 5 of the CTD is de-phosporylated and the Set2 H3K39 
methyltransferase is recruited to the elongation complex through direct binding to the 
CTD phosphorylated by Ctk1 on serines at position 2.  Therefore, specific CTD 
phosphorylation patterns determine and coordinate the interactions with protein partners 
such as transcription factors, histone-modifying complexes or mRNA-processing 
enzymes (Palancade 2003).   
In yeast and mammals, Set1 and Setd1A, respectively, localize to the 5’ ends of 
actively expressed genes and interact with RNAP II CTD phosphorylated at serine 5 
(Ser5-P CTD), a mark associated with transcription initiation (Palancade 2003; Ng 
2003; Lee 2008).  It has been proposed that Set1 is released from RNAP II after the loss 
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of Ser5 phosphorylation and that the binding of Set1 to Ser5 phophorylated RNAP II 
restricts H3K4 tri-methylation to the 5’ end of genes (Ng 2003).  Tri-methylated H3K4 
peaks at the beginning of the transcribed portions of genes, dimethylated H3K4 is most 
enriched in the middle of genes, and monomethylated H3K4 is found predominantly at 
the end of genes (Dehe 2006).  Histone H3K4 methylation occurs throughout the 
genome, but it appears slightly higher at the coding regions of active genes (Bernstein 
2002).      
Set1 histone methyltransferase is not recruited to gene-regulatory sequences but 
rather is targeted to active mRNA coding regions (Ng 2003).  Targeted H3K4 tri-
methylation constitutes a molecular memory within the mRNA coding region for recent 
transcriptional activity (Ng 2003).  Yeast cells have evolved a robust and highly specific 
memory mechanism for recent transcriptional activity (Ng 2003).  Set1 targeting is 
robust, highly specific (restricted to a limited domain of active RNAP II genes), 
dynamic (Set1 association and dissociation occurs within 1-2 min), and generates a 
specific diagnostic molecular signal (H3K4 tri-methylation) that is relatively stable and 
not easily reversed (Ng 2003).  This memory mechanism might be important for 
maintaining an active transcriptional state, for genes that are rapidly switched on and off 
by environmental changes, an inhibitory mark to prevent recently active genes from 
becoming silenced, or for some other mRNA-related process (e.g., splicing, 
polyadenylation, or nuclear export) or for some other chromatin-dependent process 
(DNA repair, recombination, mitosis, or meiosis) (Ng 2003).   
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IX.  ATP-dependent Chromatin Remodeling 
Several processes (transcription, DNA replication, mitosis, chromosomal 
recombination, and DNA repair) require a transient abolishment of histone-DNA 
binding in order to provide access of other proteins to DNA.  Changes in (modulation 
of) histone-DNA interactions in nucleosomes are termed chromatin remodeling (Lusser 
2003), and are brought about by ATP-hydrolyzing enzymes which are commonly part 
of multi-protein complexes.  Chromatin remodeling represents a change of nucleosome 
position and conformation, leading to chromatin assembly and disassembly.   
There are three classes of chromatin-remodeling protein complexes, 
SWI/SNF/Brm, ISWI, and Mi-2/NuRD, which contain different catalytic ATPase 
subunits and associated proteins.  SWI/SNF complexes are required for obtaining a 
transcriptionally active or repressed chromatin state (Hsieh 2005).  SNF2 family 
members appear to act as helicases.  They utilize the energy derived from ATP 
hydrolysis to disrupt histone-DNA interactions and allow for the physical movement, or 
sliding, of nucleosomes on the DNA.  Therefore, they can reorganize the chromatin 
structure of a region to one more permissive for transcription factor binding and 
transcriptional activation, or to one with more regularly spaced, tightly packed 
nucleosomes characteristic of transcriptionally inactive heterochromatin (Wolffe 1996).  
The SWI2/SNF2 sub-family changes the winding of DNA around the histone core, 
making DNA more accessible to nuclease and restriction enzyme digestion and function 
mainly in transcription activation or repression.  In contrast, ISWI members relocate 
nucleosomes by sliding the histone octamers along the DNA template and play 
additional roles in maintaining stable higher-order chromatin structure and chromatin 
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assembly (Hsieh 2005).  The Mi-2/NuRD (nucleosome remodeling and deacetylase) 
complex is unique in that it couples histone deacetylation and chromatin remodeling to 
primarily regulate transcriptional repression.  The Mi-2/NuRD complex stimulates 
deacetylase activity of HDAC1 and HDAC2 and contains several other proteins, 
including Mbd2 or Mbd3 (Wade 2001).  Mutations in remodeling factors have been 
shown to affect both histone modifications and DNA methylation and have also been 
implicated in carcinogenesis (Gibbons 2005).     
 
X.  Epigenetic Cross-talk 
Many studies have revealed complex and interconnected relationships between 
cytosine methylation and histone modifications.  DNA methylation and histone 
deacetylation cooperate to repress transcription through the action of MBD factors, 
which are either components of, or recruit, HDAC complexes to methylated DNA in 
order to remodel chromatin (Fuks 2000).  Mbd1 is involved in histone deacetylation and 
Mbd2 is part of the MeCP1 protein complex that acts as a methylation-dependent 
transcriptional repressor.  Mbd2-Mbd3 heterodimers recruit the Mi-2-NuRD complex, 
which possesses HDAC and chromatin remodeling activities (Guezennec 2006).  Also, 
Mecp2 can recruit HDAC1 via the bridging protein Sin3 (Fujito 2003).  Dnmts can 
interact with HDAC complexes either directly or indirectly through several pathways 
(Paulsen 2001).  The Dnmt1 N-terminal non-catalytic domain binds to HDACs and can 
repress gene transcription through HDAC activity (Fuks 2000), and Dnmt1 interacts 
with the histone modifying protein Suv39h1 and heterochromatin binding protein HP1 
(Fuks 2003).  Dnmt1 can also form complexes with the corepressor Dmap1 and 
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HDACs, with Mbd2, Mbd3, and Mecp2, or with Rb, E2F transcription factor 1 (E2F1), 
and HDAC1 to repress transcription (Robertson 2000).  Dnmt3a and Dnmt3b also 
associate with HDAC1 through their PHD (plant homeodomain)-like motif (Aapola 
2002; Fuks 2001).  The SET domain containing protein Ezh2 interacts with Dnmts, and 
Ezh2 is required for DNA methylation of Ezh2-target promoters (Vire 2006).  Loss of 
the histone H3K4 methyltransferase Mll1 SET domain is sufficient to induce histone 
and DNA methylation defects at the promoter of several HOX genes in mutant mice and 
down-regulate HOX gene expression (Terranova 2006).   
Knockout of DNMT1 in a human colorectal cancer cell line (HCT116) results in 
a global change in chromatin structure; an increase in H3K9 acetylation and a decrease 
in H3K9 methylation (Szyf 2005).  Overexpression of Dnmt3a in D. melanogaster 
results in developmental defects due to irregular chromosome condensation and 
elevated rates of histone H3K9 methylation that could be rescued by mutant alleles of 
the histone H3K9 methyltransferase gene Suv39h1 (Weissmann 2003).  The Suv39h1 
H3K9 histone methyltransferase was shown to be required for recruiting Dnmt3b-
dependent methylation to pericentromeric repeats (Gopalakrishnan 2008).  Mammalian 
Dnmt3a localizes with HP1, which binds to methylated histones (Bachman 2001).  
Murine ES cells lacking SUV39H1/2 display altered DNA methylation profiles at 
pericentromeric satellite repeats (Lehnertz 2003).  There are also indications for a direct 
relationship between DNA methylation and H3K9 methylation.  Loss of H3K9 
methylation in Neurospora crassa results in loss of DNA methylation (Tamaru 2001).  
In addition, the lysine demethylase, Lsd1, is required for maintenance of global DNA 
methylation by demethylating and stabilizing Dnmt1 protein (Wang 2009).    
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 Studies of a SNF2 family of remodeling proteins, ATRX (α-
thalassaemia/mental retardation syndrome, X linked) and Lsh (lymphoid specific 
helicase), have revealed that proteins with chromatin remodeling and DNA-helicase 
activities can also modulate DNA methylation in mammalian cells (Li 2002).  In the 
human disorder, X-linked α-thalassaemia, mutations occur in the putative SNF2-like 
ATPase ATRX, resulting in decreases in methylation at rDNA repeats (Gibbons 2000).  
Lsh is required for methylation of select imprinted loci and silencing of IAP 
retrotransposons (De La Fuente 2006).  Lsh recruits Dnmt1, Dnmt3b, and HDACs to 
establish a transcriptionally repressive chromatin structure independent of the 
enzymatic activities of the Dnmts (Myant 2008).  In Arabidopsis, the DDM1 gene 
(decrease in DNA methylation 1), which encodes an SNF2-like protein, is required for 
maintaining DNA methylation.  In addition, mutations in DDM1 result in a reduction of 
histone H3K9 methylation and an increase of histone H3K4 methylation in 
heterochromatin (Li 2002). 
 
XI.  Epigenetics and Disease 
Normal cytosine methylation patterns are frequently disrupted in tumor cells 
with global hypomethylation accompanying region-specific hypermethylation 
(Robertson 2000).  Increased expression of Dnmts is also a feature of cancer cells and 
has been linked to the deregulation of tumor suppressor genes, oncogenes, and 
imprinted genes (Park 2005).  Altered cytosine methylation patterns, both hypo- and 
hypermethylation, may result in inappropriate gene expression or gene silencing.  In 
cancer, abnormal methylation at the transcription start site can lead to the silencing of 
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tumor suppressor genes, such as p16, VHL, and Rb (Paulsen 2001).  Aberrant 
methylation of the APC gene is observed in digestive tract neoplasms, and methylation 
of the E-cadherin gene is implicated in breast and other tumor types (Momparler 2003).  
Promoter methylation of the mismatch repair gene MLH1 contributes to colorectal 
adenocarcinomas with microsatellite instability (Gibbons 2005).  A common alteration 
in tumor cell lines and primary tumors is the loss of heterozygosity at chromosome 
9p21, which contains the cell cycle regulatory genes p16 and p15 (Singal 1999).  
Among most solid tumors, a CpG island in the 5’ region of the CDKN2A (p16) gene is 
frequently methylated.  In addition, methylation-mediated inactivation of the INK4B 
(p15) gene occurs predominantly in hematopoietic neoplasms (Singal 1999).  Aberrant 
methylation of genes involved in DNA repair, including MGMT and BRCA1 also 
contribute to carcinogenesis (Wu 2005).  
Similar to Dnmt enzymes, methyl CpG-binding proteins also demonstrate the 
importance of appropriate cytosine methylation in genome integrity.  Mutations in 
MECP2 result in the X-linked, neurological disorder Rett syndrome, which causes 
autism, dementia, ataxia, and loss of purposeful hand use (Amir 1999).  Mice lacking 
MECP2 develop symptoms associated with Rett syndrome around 6 weeks of age (Guy 
2001).  In addition, mice lacking MBD1 have neurological defects (Zhao 2003).  Mice 
lacking MBD4 have increased cytosine to thymine transitions and are more susceptible 
to tumorigenesis (Millar 2002).  The MBD4 gene is often mutated in microsatellite-
instability tumors, which results in frame-shifts and the production of truncated Mbd4 
protein (Nan 2001).      
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Perturbations in activity of histone modifiying enzymes, including histone 
methyltransferases may also be implicated in cancer.  Overexpression of histone 
methyltransferases may lead to mis-regulated expression of normally silenced 
oncogenes and lead to carcinogenesis.  Mice null for the histone H3K9 
methyltransferase SUV39H1 exhibit an increased incidence of B cell lymphoma 
(Gibbons 2005).  Prdm2, another histone H3K9 methyltransferase, appears to have 
tumor suppressor activity (Gibbons 2005).  In addition, the Ezh2 histone H3K9 
methyltransferase is involved in metastatic prostate and breast cancer (Varambally 
2002).  The mixed lineage leukemia (MLL1) gene encodes a histone H3K4 
methyltransferase, human trithorax (Hrx, Mll1, or All), that functions to maintain 
embryonic Homeobox gene expression (Yokoyama 2004).  Mutations of MLL1 result in 
the development of hematological malignancies, and MLL1 is frequently the target of 
chromosomal translocations involved in acute lymphoid and myeloid leukemias 
(Ziemin-van der Poel 1991; Djabali 1992; Tkachuk1992; Gu 1992).  Smyd3 expression 
is upregulated in colorectal and hepatocellular carcinomas, and its histone H3K4 
methyltransferase activity activates oncogenes and other genes associated with the cell 
cycle (Hamamoto 2004).   
HATs have also been shown to be linked to oncogenesis.  Rubenstein-Taybi 
syndrome (RTS) is a developmental disorder associated with mutations in Cbp which 
inactivate the protein’s HAT activity, and patients with this syndrome exhibit an 
increased risk of developing malignant tumors (Gibbons 2005, Yang 2004).  Missense 
or truncating mutations of Cbp and p300 HATs are seen in cases of colorectal and 
gastric tumors and biallelic mutations have been identified in cancers of epithelial origin 
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(Yang 2004). Therefore, Cbp and p300 are considered tumor suppressors.  The HATs, 
Cbp, p300, Moz, and Morf are also involved in fusion proteins that arise from 
chromosomal translocations associated with leukemia.  Moz and Morf interact with 
Runx1 (AML1), the most frequent target of leukemia-associated chromosomal 
translocations (Gibbons 2005).  The MOZ gene is also involved in translocations 
associated with therapy-related myelodysplastic syndrome.  Recruitment of HDACs to 
tumor-suppressor genes via oncogenic DNA-binding factors may also contribute to 
tumorigenesis (Yang 2004).   
A number of human genetic diseases are associated with imprinting defects, 
resulting in gene expression from the wrong parental allele which causes diseases 
including Beckwith-Wiedemann syndrome (BWS), Prader-Willi syndrome, and 
Angelman syndrome (Falls 1999).  Normally, the imprinted insulin-like growth factor 2 
gene (IGF2) is maternally expressed and the paternal allele is silenced.  However, in 
BWS, the IGF2 gene exhibits biallelic expression as a result of loss of imprinting on the 
paternal allele (Paulsen 2001).  Prader-Willi and Angelman syndromes are caused by 
chromosomal deletion of the paternal or maternal chromosome 15, respectively which 
results in absence of the UBE3A gene, which endodes an ubiquitin ligase (Paulsen 
2001).  Common characteristics of these diseases include abnormal growth and mental 
development, and predispose children to tumor formation (Tycko 2002).  Direct genetic 
evidence linking tumorigenesis and aberrant imprinting is seen in Wilms’ tumor.  The 
majority (~70%) of Wilms’ tumors have biallelic expression of the imprinted gene 
IGF2.  Also, M6P/IGF2R and p57KIP2 are imprinted genes implicated in tumor 
suppression.  Epigenetic silencing of p57KIP2, a cyclin-dependent kinase inhibitor, has 
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been reported in some tumors and BWS patients.  M6P/IGF2R plays a role in 
intracellular sorting of lysosomal enzymes and degradation of IGF2.  Mutations of 
M6P/IGF2R have been reported in hepatocellular carcinomas, breast tumors, gastric 
tumors, gliomas, and endometrial tumors (Falls 1999).  Imprinted genes can be involved 
in carcinogenesis when loss of heterozygosity or uniparental disomy occurs at an 
imprinted region that results in the deletion of the only functional copy of a tumor 
suppressor gene.  Alternatively, mutational inactivation of an imprinting center might 
result in the aberrant expression of imprinted oncogenes and/or tumor suppressor genes 
present in an imprinted chromosomal region (Falls 1999).    
 
XII.  Chromatin Structure and DNA Repair 
The eukaryotic cell acquires more than 10,000 DNA lesions per day.  
Endogenous and environmental agents can cause DNA damage in cells (Lindahl 1993; 
Atamna 2000).  DNA damage is a cell stress and injury that has been implicated in the 
pathogenesis of many neurologic disorders, including amyotrophic lateral sclerosis, 
Alzheimer disease, Down syndrome, Parkinson disease, cerebral ischemia, and head 
trauma (Lindahl 1993).  DNA damage is defined as any modification of DNA that 
changes its coding properties or normal function in transcription or replication.  DNA 
lesions can occur in many different forms, including apurinic/apyrimidinic (AP) sites, 
adducts, single-strand breaks (SSBs), double-strand breaks (DSBs), DNA-protein cross-
links, and insertion/deletion mismatches (Rao 1993).  Apurinic/apyrimidinic sites are 
common lesions in DNA and are formed either spontaneously or as intermediates 
during the course of the normal repair of oxidized, deaminated, or alkylated bases 
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(Lindahl 1993).  AP sites are one of the major types of damage generated by reactive 
oxygen species (ROS).  Hydroxyl radical attack on the deoxyribose moiety can cause 
the release of free bases from DNA (Atamna 2000).  AP sites can be mutagenic or they 
can cause cell death (Lindahl 1993; Atamna 2000).  In SSB formation, there is loss of a 
purine or pyrimidine base and the deoxyribose is cut in the phosphodiester backbone of 
one strand of the double helix.  DSBs are one of the most severe types of DNA damage 
because the genome potentially loses its continuity if the damage is not repaired 
(Costelloe 2006).  DNA-protein cross-links interfere with DNA replication and 
transcription and can be caused by cytostatic drugs used in chemotherapy such as 
cisplatin.  Abasic sites impede DNA synthesis by replicative DNA polymerases, and 
blockage of DNA replication is an apparent source of cytotoxicity (Loeb 1986).   
Failure to repair DNA lesions can lead to mutations, genomic instability, or cell 
death (Ataian 2006).  Various types of DNA damage can be caused by ionizing 
radiation (IR) and a variety of laboratory and chemotherapeutic agents.  Modified bases 
are usually repaired by excision repair pathways.  Nucleotide excision repair (NER) 
removes bulky modifications of bases induced by ultraviolet (UV) or aromatic 
compounds; base excision repair (BER) removes alkylated or oxidatively modified 
bases; and mismatch repair (MMR) replaces misincorporated nucleotides (Widlak 
2006).  DNA DSBs are repaired by two major pathways.  Homologous recombination 
(HR) takes advantage of sequence homology from an undamaged sister chromatid or 
homologous chromosome to repair the lesion with high fidelity, and non-homologous 
end-joining (NHEJ) involves processing and ligation of broken ends (Wurtele 2006).  In 
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addition, DNA damage checkpoints delay cell cycle progression, providing more time 
for repair of lesions before DNA replication and chromosome segregation.   
The efficiency of DNA repair is affected by chromatin structure, nucleosome 
accessibility/disruption, and transcriptional activity (Thoma 1999; Orphanides 2000).  
The repair of DNA damage is complicated by the fact that genomic DNA is packaged 
with histone and non-histone proteins into chromatin, a highly condensed structure that 
hinders DNA accessibility and its subsequent repair.  Mitochondrial DNA sustains 
higher steady-state damage compared with nuclear DNA, which is in part caused by the 
lack of chromatin protection afforded by histones (Szczesny 2003).  In addition, BER is 
not as efficient on mononucleosome substrates compared to naked DNA (Nilsen 2002; 
Beard 2003; Menoni 2007), and transcriptionally active chromatin is more efficiently 
repaired after ultraviolet and IR exposure (Chiu 1982; Mellon 1986).  Consequently, 
chromatin structural changes are required to increase the accessibility of repair proteins 
to sites of DNA damage (Widlak 2006).  In order to bring about changes in chromatin 
structure, repair of DNA lesions occurs with the assistance of ATP-dependent 
chromatin-remodeling enzymes and histone-modifying enzymes, which allow access of 
the necessary repair factors to the lesion (Ataian 2006).   
Histone modifications play a major role during DNA repair by marking the 
lesion, recruiting components of the repair machineries, and facilitating their action 
(Escargueil 2008).  Histone ubiqutination, methylation, phosphorylation, acetylation, 
deacetylation, ATP-dependent remodeling, and histone variants have all been 
implicated in the response to DSBs (Lydall 2005).  Manipulation of chromatin structure 
is required for many aspects of the DNA damage response and, accordingly, genetic 
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studies have revealed that mutants of histone modifying enzymes and chromatin 
remodeling proteins often show sensitivity to genotoxic agents (Costelloe 2006).  
Sensitivity to genotoxic agents that create DSBs is conferred by single mutations in at 
least five distinct ATP-dependent nucleosome remodeling complexes, including INO80 
(van Attikum 2004), SWR1 (Downs 2004; Mizuguchi 2004), RSC (Chai 2005), 
SWI/SNF (Chai 2005), and the homologous recombination protein Rad54 (Wolner 
2005).  NuA4, a HAT, acetylates histones H4 and H2A in yeast and plays an important 
role in DNA repair, because mutation of its key subunits, or the four acetylatable lysine 
residues of H4, causes hypersensitivity to DSB-inducing agents (Downs 2004).  Human 
cells expressing a mutant form of the Tip60 HAT, that lacks acetyltransferase activity, 
accumulate DSBs following exposure to IR (Ikura 2000).  In human cells, lack of the 
enzyme disruptor of telomeric silencing-1 (Dot1l), that methylates H3K79, abolishes 
the recruitment of p53 binding protein (53bp1), a transcriptional coactivator of the 
tumor suppressor p53, to DSB repair foci (Qin 2002).  Cells defective in H3K79 
methylation are sensitive to IR (Wysocki 2005).  Histone modifications, such at 
phosphorylation of H2AX (H2AX-γ), serve to mark the positions of DNA damage and 
provide novel landing platforms for repair machineries and direct the recruitment of 
ATP-dependent chromatin remodeling complexes required for DNA repair (Ataian 
2006).   
Chromatin surrounding a DSB is modified for direct recruitment of DNA 
damage response proteins, with recruitment often being mediated by specific covalent 
histone modifications, and modification of compacted chromatin structure to facilitate 
DNA repair (Costelloe 2006).  The phosphorylation of H2AX is believed to be required 
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for the concentration and stabilization of DNA repair proteins to the damaged chromatin 
(Escargueil 2008), recruitment of both HATs and chromatin remodelers (Costelloe 
2006), and facilitating a checkpoint that prevents cell division as a consequence of DNA 
damage (Bassal 2005).  Phosphorylation of H2AX is catalyzed by DNA damage 
checkpoint protein kinases: ATM (ataxia-telangiectasia-mutated protein kinase), ATR 
(ATM/Rad3 related kinase), and DNA-PK (DNA-dependent protein kinase) in human 
cells.  These kinases are recruited to DSBs through their association with partner 
proteins that recognize DNA lesions either directly or indirectly (Wurtele 2006).  The 
kinases function to prevent cell division, and trigger initiation of the repair pathways 
(Bassal 2005).  The catalytic subunit of the phosphatase, known as PP2A, is recruited to 
DSBs in an H2AX-dependent manner and dephosphorylates H2AX-γ in human cells.  
PP2A also controls the phosphorylation of a number of DNA damage response proteins 
(Wurtele 2006).  It is possible that the covalent modifications, phosphorylation, 
methylation, and acetylation may act together to form a DNA damage response-specific 
histone code, similar to that proposed for transcriptional regulation (Costelloe 2006; 
Jenuwein 2001).  Phosphorylation of H2AX plays a role in both non-homologous end-
joining (NHEJ) and homologous recombination (HR) repair pathways.  However, the 
choice of the repair pathway might depend on or induce additional post-translational 
modifications affecting other histone proteins necessary to complete the entire DNA 
repair process (Escargueil 2008).  Even in the absence of DSBs, histone modifications 
occur.  Following UV exposure, histone acetylation takes place and is believed to 
facilitate the NER process by promoting chromatin accessibility to the repair factors 
(Escargueil 2008).   
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Several reports support an association between DNA damage, recombination, 
and DNA methylation.  Dnmt1 and Pcna, an auxiliary factor in DNA replication and 
repair, form a complex in vitro (Chuang 1997), Dnmt1 is recruited to DNA repair sites 
(Mortusewicz 2005), mouse cells lacking DNMT1 are genetically unstable (Chen 1998; 
Okano 1999), and global inhibition of methylation leads to genome instability in human 
cell lines (Xu 1999).  Pcna coordinates events in replication, DNA repair, and cell cycle 
control through multiple protein-protein interactions.  DNA methylation is coordinated 
with replication by a physical association of Dnmt1 with Pcna (Chuang 1997; Knox 
2000).  The specific targeting of nucleosome assembly to newly synthesized DNA is 
achieved by the direct interaction of the histone chaperone, chromatin assembly factor 
(Caf-1) with Pcna (Shibahara 1999).  Upon UV damage, Caf-1 is recruited to the lesion, 
and Pcna locates to the same sites (Green 2003), suggesting that local recruitment of 
Caf-1 participates directly in chromatin rearrangements at the site of damage (Bassal 
2005).  Pcna also interacts with HDACs suggesting pathway cross-talk between the 
different cellular functions of DNA repair and epigenetic modification (Fuks 2000; 
Robertson 2000; Rountree 2000).   
 
XIII.  DNA Base Excision Repair 
The BER pathway predominantly recognizes and removes oxidative and 
alkylation damage caused by endogenous and exogenous agents, including ROS-
induced damage and spontaneous base loss (Christmann 2003; Coates 2005; Fleck 
2004; Zharkov 2008).  Both radiation and alkylating agents induce baseless sites via 
DNA glycosylase-mediated excision of oxidized and alkylated purines and pyrimidines 
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(Demple 1994; Krokan 2000).  In addition, radiation-induced oxidative free radicals can 
induce abasic sites by direct attack on deoxyribose (Demple 1994).  BER requires the 
coordinated activity of a number of enzymes.  BER is initiated with excision of the 
damaged base by one of the DNA glycosylases which catalyze hydrolysis of the N-
glycosidic bond of the damaged deoxynucleoside.  The damaged nucleotide is then 
converted into an AP site, which is a substrate for AP endonucleases.  Ape1 is a 
multifunctional protein that has AP endonuclease activity which hydrolyzes the 
phosphodiester bond immediately 5’ to the AP site.  The hanging 5’-abasic dNMP can 
be excised via β-elimination by deoxyribosephosphate hydrolyase activity (provided 
predominantly by DNA β-polymerase, Xrcc1, or δ/ε-polymerase with Pcna), the correct 
nucleotide is inserted by DNA β-polymerase (β-pol), and a DNA ligase (DNA ligases I 
and III, Xrcc1) completes the process by ligation of the single-stranded nick in the DNA 
(Zharkov 2008).  X-ray cross-complementing protein (Xrcc1), a protein with no known 
enzymatic activity, functions as both a scaffold protein and modulator of BER via 
functional and physical interaction with Ape1, bridging the incision and nick-sealing 
steps of BER (Vidal 2001).  In addition, Xrcc1 interacts with DNA ligase III and DNA 
β-polymerase to play a role to re-generate an intact DNA strand (Kulkari 2008). 
Unrepaired AP sites may threaten genomic stability by serving as blocks to 
DNA replication, by stalling RNA polymerase II during transcription, or by promoting 
topoisomerase II-mediated double strand breaks (Raffoul 2004).  BER is the main 
pathway responsible for repairing AP sites in DNA.  BER is thought to require highly 
intimate, yet transient protein-protein interactions among BER enzymes to ensure 
proper damage repair, with Ape1 being at the center of activity (Wilson 2000).  Ape1 
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also interacts with β-pol, recruiting it to the incised AP site and enhancing its rate-
limiting deoxyribosephosphate hydrolyase activity (Bennet 1997).  β-pol removes the 
deoxyribosephosphate residue after AP endonuclease cleaves DNA at AP sites and 
inserts a new nucleotide in the resulting gap, the deoxyribosephosphate hydrolyase 
activity of  β-pol is the rate-determining step in BER (Raffoul 2004).   
Mutations in many DNA repair proteins are implicated in disease.  APE1 
variants have been identified in the human population, and variants in DNA repair 
genes have been associated with increased risk of cancer (Hadi 2000; Mohrenweiser 
2003).  MUTYH-associated polyposis (MAP) is characterized by multiple colorectal 
adenomas and carcinomas and is associated with biallelic germline mutations of the 
human MUTYH glycosylase that functions in the BER of oxidative DNA damage by 
excising adenines misincorporated opposite 8-oxo-7,8-dihydroguanine (8-oxo-G) 
(Cheadle 2007).  In addition to Mutyh, several mammalian glycosylases are involved in 
BER, including Nth1, Ogg1, Ung, and Aag.  Murine homozygous mutants for the 
glycosylases NTH1, OGG1, UNG, AAG, and MUTYH are viable, and the mice show no 
overt abnormalities (Engelward 1997; Klungland 1999; Ocampo 2002; Takao 2002).  
However, after a long latency, UNG-/- and MUTYH-/- mice developed B-cell lymphomas 
and intestinal tumors, respectively (Nilsen 2003; Sakamoto 2007).  This suggests 
functional redundancy of certain BER glycosylases.  In contrast to glycosylases, 
targeted inactivation of enzymes that act downstream of the glycosylases in BER result 
in peri-natal lethality.  Homozygous mutants for APE1 (Ludwig 1998), LIGI (Petrini 
1995), LIGIII (Puebla-Osorio 2006), XRCC1 (Tebbs 1999), or Flap endonuclease 1 
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(FEN1) (Kucherlapati 2002) die during embryonic development, whereas homozygous 
mutants for POLβ die immediately after birth (Gu 1994; Sugo 2000).   
 
XIV.  Apurinic/Apyrimidinic Endonuclease (Ape1/Ref-1) 
Ape1/Ref-1 (also called Ape1, Hap1 or Apex; AP endonuclease, redox factor 1) 
is a multi- functional enzyme containing apurinic/apyrimidinic (AP) endonuclease 
activity in BER, reduction/oxidation (redox) activation of transcription factors, and 
controls the intracellular redox state by inhibiting reactive oxygen species (ROS) 
production (Tell 2009).  Ape1 also possesses 3’ to 5’ exonuclease, 3’ phosphatase, 3’ 
phosphodiesterase, and RNase H activities (Evans 2000).  Ape1 is the major AP 
endonuclease activity in human cells responsible for recognition and incision of non-
coding AP sites in DNA arising as a consequence of spontaneous, chemical, or DNA 
glycosylase-mediated hydrolysis of the Ν-glycosyl bond initiated by the BER pathway 
(Raffoul 2004; Demple 1994).   
Ape1/Ref-1 modulates DNA-binding activity of several transcription factors 
including Nf-kB, Egr-1, p53, AP-1, CREB, HIF-α, and members of the Pax family 
(Merluzzi 2004; Xanthoudakis 1992; Huang 1993).  The redox and DNA repair 
activities of Ape1/Ref-1 are encoded by distinct regions of the protein that can function 
independently of one another (Xanthoudakis 1994).  Inactivation of one APE1 allele is 
sufficient to mediate increased spontaneous mutagenesis in germ line and somatic tissue 
DNA (Huamani 2005).  In addition, inactivation of the major AP endonuclease in yeast, 
APN1, results in increased spontaneous mutagenesis (Ramotar 1991).  Ape1 is a DNA 
repair enzyme capable of recognizing and initiating repair of AP lesions, functions as a 
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strong p53 activator, and stimulates DNA binding of multiple transcription factors.  
Therefore, Ape1 may provide molecular cross-talk among DNA repair, transcription, 
and apoptosis pathways, all of which are involved in maintaining genomic integrity 
(Huamani 2005).    
The tumor suppressor, p53, is involved in the cellular response to stress, p53 
activation is Ape1-dependent (Meira 1997; Gaiddon 1999), and p53 may regulate BER 
activity (Zhou 2001).  Because Ape1 is known to promote the activation of p53 in a 
redox-dependent and independent manner, it is likely that the decrease in BER of 
APE1+/- mice may be due to a decrease in the activation of p53 (Raffoul 2004).  Down-
regulation of Ape1 by antisense RNA has been shown to dramatically reduce p53 
activation (Gaiddon 1999).  Reduced Ape1 redox activity may render a cell/tissue more 
susceptible to environmental stress by altering cellular responses such as BER (Raffoul 
2004).  The kinetics of cancer induction in XPC-/- mice that are heterozygous 
additionally for both p53 and Ape1 is indistinguishable from that in XPC-/- animals 
heterozygous for just p53, suggesting that the enhanced predisposition to skin cancer in 
XPC-/-APE1+/- animals results from loss of p53 activity, which in turn is dependent on 
normal Ape1/Ref-1 activity (Meira 2001).   
 
XV.  CXXC Finger Protein 1 (Cfp1) 
CXXC finger protein 1 (Cfp1), encoded by the CXXC1 gene, is an important 
regulator of chromatin structure that intersects with both cytosine methylation and 
histone modifications.  Cfp1 is ubiquitously expressed, specifically binds unmethylated 
CpG motifs, and functions as a transcriptional activator (Lee 2001; Voo 2000).  Cfp1 
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physically interacts with Dnmt1 (Butler 2008) and partially co-localizes with Dnmt1 
(J.S. Butler unpublished data).  Cfp1 is also a component of the Setd1A and Setd1B 
histone H3K4 methyltransferase complexes, which also contain Rbbp5, Wdr5, Ash2, 
and Wdr82 (Lee 2005; Lee 2007).    
Homologues of Cfp1 have been identified in Drosophila melanogaster, 
Caenorhabditis elegans, Saccharomyces cerevisiae, Schizosaccharomyces pombe, 
Xenopus laevis, Danio rerio, and Mus musculus.  Cfp1 contains many conserved 
domains, including two cysteine-rich plant homeodomains (PHD), a cysteine-rich 
CXXC domain, a basic domain, an acidic domain, a coiled-coil domain, and a cysteine-
rich Set1 interaction domain (SID) (Fig. 3).  In general, the PHD finger is thought to be 
involved in chromatin-mediated transcriptional control, and PHD finger proteins are 
associated with chromatin remodeling complexes or contribute to histone acetylation 
(Halbach 2000).  There are several hundred PHD finger-containing proteins in humans 
(Bienz 2006).  PHD fingers are very diverse in sequence, suggesting that the molecular 
function related to chromatin is also diverse (Ragvin 2004).  Since many PHD finger-
containing proteins reside in large multiprotein complexes, PHD domains were 
speculated to be involved in protein-protein interactions (Aasland 1995).  It was also 
suggested that PHD fingers may be DNA or RNA binding domains, or involved in the 
recognition of differentially modified histone tails (Aasland 1995; Ragvin 2005).  
Indeed, recent studies have shown that PHD fingers associate with chromatin.  The 
PHD domain of Spp1, the S. cerevisiae homologue of Cfp1, binds H3K4me2/3 (di- and 
tri-methylation) (Shi 2007).  The ING (inhibitor of growth) protein family includes a  
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FIGURE 3.  Cfp1 protein domains. 
A schematic representation of the conserved domains within human Cfp1 
protein are depicted.  The numbers below the diagram indicate the position of amino 
acids within the primary sequence.  Plant homeodomain (PHD), Set1 interaction 
domain (SID).  
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Human     ----------------------------------MEGDGSDPEPPDAGEDSKSENGENAP 26 
Mouse     ----------------------------------MEGDGSDLEPPDAGDDSKSENGENAP 26 
D.rerio   ----------------------------------MDSEMSDMDQT-PGLDNSMEKGENAP 25 
Fly       MTDKRKYKKTVSFTRCTAIIFLTTKEVSKQKEEIRREIAREFDLPERKSKIATILKQEDQ 60 
C.ele.    ------------------------------------------------------------  0 
S.cer     --------------------------------------MSLPQWCPPHSTLKRNPTTGED 22 
                 
Human    IYCICRKPDINCFMIGCDNCNEWFHGDCIRITEKMAKAIREWYCRECREKDPKLEIRYRH  86 
Mouse    IYCICRKPDINCFMIGCDNCNEWFHGDCIRITEKMAKAIREWYCRECREKDPKLEIRYRH  86 
D.rerio  LYCICRKSDINCFMIGCDNCNEWFHGHCINVTEKMAKAIREWYCQQCRARDPSLSIRYR-  84 
Fly      AYCICRSSDCSRFMIGCDGCEEWYHGDCIGITEKEAKHIKQYYCRRCKKENPELQTIFRL 120 
C.ele.   ------------------------------------------------------------   0 
S.cer    VYCICKRPDYGELMVGCDGCDDWFHFTCLHIPEQFKDLVFSFYCPYCQAG----------  72 
                                        
 
 
Human    KKSRERDGNERDSSEPRDEGGGRKRPVPDPNLQRRAGSGTGVGAMLARGSASPHKSSPQP 146 
Mouse    KKCRERDGSERAGSEPRDEGGGRKRPASDPELQRRAGSGTGVGAMLARGSASPHKSSPQP 146 
D.rerio  KKNRDKD------VEP--ERVEKRSSTPEYKIDKRRGS---------------------- 114 
Fly      VATERAAASNAASTSLNAPGVGPSGAAPAAAPVASATTS--------------------- 159 
C.ele.   ------------------------------------------------------------   0 
S.cer.   ------------------------------------------------------------  72 
                                                                             
Human   LVATPSQHHQQQQQQ----IKRSARMCGECEACRRTEDCGHCDFCRDMKKFGGPNKIRQKC 202 
Mouse   LVATPSQHHHQQQQQQQQQIKRSARMCGECEACRRTEDCGHCDFCRDMKKFGGPNKIRQKC 206 
D.rerio ------------------KVKRSARMCGECEPCTRTEDCGHCDFCKDMKKFGGPNKIRQKC 156 
Fly     QQAPPPTTAAAKRKNSSAREPKMGKRCGTCEGCRR-PNCNQCDACRVRVGH------KPRC 212 
C.ele.  -----------------------------------------------MKRIVEHVG-----   9 
S.cer.  -------------------------------------------------------------  72 
                                                                            
                      
 
Human   RLRQCQLRARESYKYFPSSLSPVTPSESLPRPRRPLPTQQQPQPSQKLGRIREDEGAVA 262 
Mouse   RLRQCQLRARESYKYFPSSLSPVTPSEALPRPRRPPPTQQQPQQSQKLGRIREDEGTVL 266 
D.rerio RLRQCVVRAR------------------------------------KMLRVRDEE---- 176 
Fly     IFRTCVVQAA------------------------------------------------- 223 
C.ele.  -----------------------------------------------------------   9 
S.cer.  -----------------------------------------------------------  72 
 
 
 
Human   SSTVKEPPEATATPEPLSDEDLPLDPDLYQDFCAGAFDDNGLPWMSDTEESPFLDPALRK 322 
Mouse   SSVVKEPPEATATPEPLSDEDLALDPDLYQDFCAGAFDDHGLPWMSDAEESPFLDPALRK 326 
D.rerio FSLRERKDNIMHRDRRYSDDYDENDMDLYEHY-----KDRNASWGSEDDDGQLYSPVPRK 231 
Fly     ------------------------------------------------------TVLKES 229 
C.ele.  -------------------------------------------------------RVEME  14 
S.cer.  ------------------------------------------------------ITGKNK  78 
                                                                            
                                          
 
Human   RAVKVKHVKRREKKSEKKKEERYKRHRQKQKHKDKWKHPERADAKDPASLPQCLGPGCVR 382 
Mouse   RAVKVKHVKRREKKSEKKKEERYKRHRQKQKHKDKWKHPERADAKDPASLPQCLGPGCVR 386 
D.rerio KAIKVKHVKRRDKKFDKKKESR--RHKQKQKHRDRLRHSDRTDGRHGGDTQQCLGPNCIE 289 
Fly     QATQAGPSRKREKAAPKS---------RNVQVGPRAASPEIFLNPELQGIRQCYGPNCCS 280 
C.ele.  KLVICGNVSQRK------------------DYIMRKAEPDKHP-------RQCLNPNCIY  49 
S.cer.  DAIINGEGSLPKTLWK----------------------------------RKCRISDCYK 104 
                            
            
 
 
Human   RAVKVKHVKRREKKSEKKKEERYKRHRQKQKHKDKWKHPERADAKDPASLPQCLGPGCVR 382 
Mouse   RAVKVKHVKRREKKSEKKKEERYKRHRQKQKHKDKWKHPERADAKDPASLPQCLGPGCVR 386 
D.rerio KAIKVKHVKRRDKKFDKKKESR--RHKQKQKHRDRLRHSDRTDGRHGGDTQQCLGPNCIE 289 
Fly     QATQAGPSRKREKAAPKS---------RNVQVGPRAASPEIFLNPELQGIRQCYGPNCCS 280 
C.ele.  KLVICGNVSQRK------------------DYIMRKAEPDKHP-------RQCLNPNCIY  49 
S.cer.  DAIINGEGSLPKTLWK----------------------------------RKCRISDCYK 104 
                            
PHD1 domain 
CXXC domain 
Acidic domain 
Basic domain 
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Human   PAQPSSKYCSDDCGMKLAANRIYEILPQRIQQWQQS-PCIAEEHGKKLLERIRREQQSAR 441 
Mouse   AAQPGSKYCSDDCGMKLAANRIYEILPQRIQQWQQS-PCIAEEHGKKLLERIRREQQSAR 445 
D.rerio PARPNSKYCSEDCGMKLAANRIYEVLPQRIQQWQQS-PCIAEEQGKKQLERIRREQQAAR 348 
Fly     HARPQSKYCSDKCGFNLATKRIFQVLPQRLQEWNLT-PSRAAEETRKHLDNIRHKQSLVR 339 
C.ele.  ESRIDSKYCSDECGKELARMRLTEILPNRCKQYFFEGPSGGPRSLEDEIKPKRAKINREV 109 
S.cer.  PCLQDSKYCSEEHGREFVNDIWSRLKTDEDRAVVKK--MVEQTGHIDKFKKFGQLDFIDN 162 
 
 
Human   TRLQEMERRFHELEAIILRAKQQAVREDEESNEGDSDDTDLQIFCVSCGHP-INPRVALR 500 
Mouse   TRLQEMERRFHELEAIILRAKQQAVREDEENNENDSDDTDLQIFCVSCGHP-INPRVALR 504 
D.rerio MRLAEMERRFHELEGIIAKAKQQLVLQDEDVNETDSEDTDLQIFCVSCSHP-VNPKVALR 407 
Fly     FALAELEKRSEELNMVVERAKRSSIDTLGSQDTADMED-EQSMYCITCGHE-IHSRTAIK 397 
C.ele.  QKLTESEKNMMAFLNKLVEFIKTQLKLQP-LGTEERYDDNLYEGCIVCGLPDIPLLKYTK 168 
S.cer.  NIVVKTDDEKEIFDQIVVRDMTLKTLEDDLQEVQEISLPLFKKKLELLEVYLGWLDNVYT 222 
                                                                   
 
Human   HMERCYAKYESQTSFGSMYPTRIEGATRLFCDVYNPQSKTYCKRLQVLCPEHSRDPKVPA 560 
Mouse   HMERCYAKYESQTSFGSMYPTRIEGATRLFCDVYNPQSKTYCKRLQVLCPEHSRDPKVPA 564 
D.rerio HMERCYAKYESQTSFGSIFPTRIEGATRLFCDVYNPQSKTYCKRLQVLCPEHSRDPKVTS 467 
Fly     HMEKCFNKYESQASFGSIFKTRMEGNN-MFCDFYNPASKTYCKRLRVLCPEHSKDPKVND 456 
C.ele.  HIELCWARSEKAISFG----APEKNNDMFYCEKYDSRTNSFCKRLKSLCPEHRKLGDEQH 224 
S.cer.  EMRKLDDDAASHVECG-----KEDSKGTKRKKKKNSSRSRARKNICGYCSTYERIPCSVE 277 
             
                                            
Human   DEVCGCP------------LVRDVFELTGDF----CRLPKRQCNRHYCWEKLRRAEVDLE 604 
Mouse   DEVCGCP------------LVRDVFELTGDF----CRLPKRQCNRHYCWEKLRRAEVDLE 608 
D.rerio DEVCGCP------------LVRNVFDPTGDY----CRVSKRKCNKHYCWEKLRRAEVDLE 511 
Fly     TDVCGSP------------LVNNVFNPTGEF----CRAPKKNCFKHYAWEKIRRAEIDLE 500 
C.ele.  LKVCGYPKKWEDGMIETAKTVSELIEMEDPFGEEGCRTKKDACHKHHKWIPSLRGTIELE 284 
S.cer.  EFVRDFG-------------SNEEATKIHEV------CTKWKCNRHLDWVSTN------- 311 
                   
          Human   RVRVWYKLDELFEQERNVRTAMTNRAGLLALMLHQTIQHDPLTTDLRSSADR-------- 656 
Mouse   RVRVWYKLDELFEQERNVRTAMTNRAGLLALMLHQTIQHDPLTTDLRSSADR-------- 660 
D.rerio RVRVWYKLDELFEQERNVRTAMTNRAGLLALMLHQTIQHDPLTTDLRSSKDR-------- 563 
Fly     RVRQWLKMDDLMEQERVMRQQLTSRANLLGLMLHSTYNHEVMDELVRKQQEHLVEFEKQR 560 
C.ele.  QACLFQKMYELCHEMHKLNAHAEWTTNALSIMMHKQPNIIDSEQMSLFNKSQSTSSSASA 344 
S.cer.  QEQYLQQIDSLESMQERLQHLIQARKKQLNIQYYEEILRRGL------------------ 353 
                 
FIGURE 4. Cfp1 protein alignment between species.   
A multi-species alignment of Cfp1 proteins from human (H. sapiens), mouse 
(M. musculus), D. rerio (zebrafish), fly (D. melanogaster), C. ele. (C. elegans), and S. 
cer. (S. cerevisiae) was performed using the ClustalW program (EMBL-EBI).  
Conserved protein domains are underlined and denoted; plant homeodomain (PHD), 
Set1 interaction domain (SID).  
at their carboxyl termini (Martin 2006).   
 
 
Coiled-coil domain 
SID domain 
PHD2 domain 
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group of homologous nuclear proteins that share a highly conserved PHD finger 
domain.  The PHD finger of the tumor suppressor ING2 directly associates with histone 
H3K4Me3 (Pena 2006). Cfp1 also contains a cysteine-rich CXXC domain that is 
required and sufficient for DNA-binding (Voo 2000; Lee 2001).  There are many 
proteins that can bind to methylated CpG motifs, including Mecp2, Mbd1, Mbd2, 
Mbd4, and Kaiso, and these proteins function as transcriptional repressors (Baylin 
2000).  In contrast, Cfp1 is unique in that it binds to unmethylated CpG motifs (Lee 
2001) and acts as a transcriptional activator (Voo 2000).  CXXC domains are also found 
in Dnmt1 (Bestor 1994), Mbd1, a transcriptional repressor (Cross 1997); the histone 
H3K4 methyltransferases Mll1 (also known as Hrx or All) (Gu 1992; Tkachuk 1992; 
Domer 1993) and Mll2 (FitzGerald 1999); and leukemia associated protein, Lcx (Ono 
2002).  LCX is involved in chromosomal translocations with MLL1 implicated in solid 
tumors and leukemia (Gu 1992).  Zinc finger domains are nucleic acid-binding protein 
structures.  The CXXC-type zinc finger contains eight conserved cysteine residues that 
bind zinc and is characterized by a CX2CX2CX5CX2CX2C type motif.  The CXXC 
domains of MLL, Dnmt1, and Mbd1 function to repress transcription, and the CXXC 
domain of Mll is essential for its oncogenic activity.  Mbd1 has three zinc-coordinating 
CXXC domains, and several different human splice variants (Jorgensen 2004).  The 
Mbd1 protein has two distinct DNA-binding domains, the methyl binding domain 
requiring methylated CpG motifs and the third copy of the CXXC domain (contained in 
some isoforms of Mbd1) that can bind unmethylated CpG motifs (Jorgensen 2004).  
Interestingly, the CXXC domain of Cfp1 is not conserved in S. cerevisiae, S. pombe, 
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and C. elegans, organisms that lack cytosine methylation, suggesting that the CXXC 
domain plays a function in cytosine methylation (Voo 2000).   
Cfp1 also contains acidic and basic domains along with a coiled-coil domain.  
Acidic regions in proteins have been shown to act as activation domains in various 
transcription factors including Gal4, Gcn4, and Vp16 (Fujino 2000).  The acidic region 
of Cfp1 was shown to be important for transcriptional transactivation activity (Fujino 
2000).  However, the acidic domain of Cfp1 is not conserved in D. rerio (zebrafish).  
The acidic region is rich in aspartic acid and glutamic acid residues and also contains a 
number of proline and leucine residues.  In contrast, the basic region of Cfp1 is rich in 
lysine and arginine residues.  Alpha helical coiled-coil motifs consist of 2-5 alpha 
helices wrapped around each other into a left-handed helix to form a supercoil stabilized 
by hydrophobic and other interactions (Mason 2004).  In mammals and yeast, the 
coiled-coil motif has been identified in a variety of proteins and may play important 
roles in the structure and function of proteins (Mason 2004).  Coiled-coil motifs are 
present in several DNA-binding proteins, such as leucine zipper factors, and can 
facilitate homo- or hetero-dimerization (Voo 2000).  However, the function of the basic 
and coiled-coil domains in Cfp1 remain unknown.  Also, Cfp1 contains a highly 
conserved cysteine-rich region between the basic and coiled-coil domains referred to as 
the Set1 interaction domain (SID), which mediates the interaction between Cfp1 and the 
Setd1A and Setd1B histone H3K4 methyltransferase complexes (Butler 2008). 
Subcellular localization studies demonstrate that Cfp1 associates with the 
nuclear matrix and exhibits a speckled sub-nuclear distribution (Lee 2002).  Cfp1 
localizes to DAPI-dim regions and with acetylated histones, corresponding to regions of 
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active chromatin (Lee 2002).  Cfp1 contains two nuclear localization signals (amino 
acids 104-122 and 321-360).  However, the minimum region necessary for association 
with the nuclear matrix requires the acidic, basic, and coiled-coil domains (Lee 2002).  
The CXXC DNA-binding domain is not required for targeting of Cfp1 to the nuclear 
matrix, suggesting that Cfp1 localization is directed through protein interactions (Lee 
2002).  The association of Cfp1 with the nuclear matrix is functionally important for the 
transcriptional transactivation activity of Cfp1 (Lee 2002).  In addition, Cfp1 co-
localizes with Mll1 and Setd1A histone H3K4 methyltransferases (Lee 2002; Lee 
2005).    
Cfp1 is crucial for mammalian development because disruption of the CXXC1 
gene in mice results in early embryonic lethality.  Murine embryos lacking Cfp1 fail to 
gastrulate and exhibit peri-implantation lethality around 4.5-6.5 dpc (Carlone 2001).  
The loss of embryonic viability coincides with a time in development when there is a 
global switch in genome methylation (Okano 2002).  Targeted depletion of Cfp1 by 
antisense morpholino oligonucleotide in zebrafish and RNA interference in a human 
myelomonoblastic PLB-985 cell line demonstrate that Cfp1 is required for normal 
hematopoiesis and post-gastrulation development (Young 2006; Young 2007).  
Reduced expression of Cfp1 in zebrafish results in decreased global cytosine 
methylation, anemia, and incomplete vascular development (Young 2006).   
In order to further study Cfp1 function, murine ES cell lines were isolated from 
the inner cell mass of blastocysts lacking the CXXC1 gene (CXXC1-/-) and CXXC1 
heterozygous blastocysts (CXXC1+/-) (Carlone 2005).  Haploinsufficiency of Cfp1 
results in no discernable phenotype.  Interestingly, CXXC1-/- ES cells have a variety of 
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defects when compared to wild-type (CXXC1+/+) ES cells.  The defects observed in 
CXXC1-/- ES cells are corrected upon introduction of a murine Cfp1 expression vector 
(CXXC1-/cDNA), indicating that the CXXC1-/- ES cell phenotype is specifically due to the 
absence of Cfp1 (Carlone 2005).  Murine ES cells lacking Cfp1 exhibit an increase in 
population doubling time due to a 3-fold increase in apoptosis (Carlone 2005).  
However, there is no apparent cell-cycle defect, as CXXC1-/- ES cells display a normal 
cell cycle distribution (Carlone 2005).  Similarly, upon knockdown of Cfp1 in zebrafish 
with an antisense morpholino oligonucleotide, an increase in apoptosis was observed 
(Young 2006).  In contrast, knockdown of Cfp1 in PLB-985 cells did not result in an 
increase in apoptosis but resulted in a cell cycle defect with an increase in cells in G0 
and G1 and a decrease in cells present in S phase (Young 2007).         
ES cells can be maintained in an undifferentiated, pluripotent state by culture in 
the presence of leukemia inhibitory factor (LIF) (Rasmussen, 2003).  When CXXC1+/+ 
ES cells are cultured in suspension in the absence of LIF, they form cell aggregates and 
differentiate into endoderm, mesoderm, and ectoderm (Rasmussen, 2003).  ES cells 
lacking Cfp1 fail to achieve in vitro differentiation following the removal of LIF from 
the media (Carlone 2005).  ES cells lacking Cfp1 form small cell aggregates but fail to 
form an endoderm outgrowth, fail to induce expression of several lineage and 
developmental markers indicative of differentiation, and fail to downregulate Oct4 and 
alkaline phosphatase expression upon induction of differentiation, markers of 
pluripotency (Carlone 2005).  In addition, reduced expression of Cfp1 in PLB-985 cells 
results in impaired myeloid cell differentiation (Young 2007).     
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CXXC1-/- ES cells exhibit ~60-80% decrease in global cytosine methylation 
(Carlone 2005).  In addition, CXXC1-/- ES cells exhibit reduced cytosine methylation at 
single copy genes, Pgk-2 and Rac2, imprinted loci, H19 and Igf2r, and minor satellite 
and IAP retrovirus repetitive elements (Carlone 2005).  Antisense targeting of Cfp1 in 
zebrafish also results in a 60% reduction in global cytosine methylation (Young 2006).  
In contrast, shRNA-mediated knockdown of Cfp1 in PLB-985 cells resulted in reduced 
Dnmt1 protein expression (40%), but no detectable decrease in global cytosine 
methylation (Young 2007).   
CXXC1-/- ES cells exhibit a ~30% decrease in DNA methyltransferase activity 
towards a hemimethylated oligonucleotide substrate, but normal activity towards an 
unmethylated substrate, which demonstrates a deficiency in maintenance 
methyltransferase activity but normal de novo methyltransferase activity (Carlone 
2005).  In addition, CXXC1+/+ and CXXC1-/- ES cells methylate an introduced retroviral 
transgene within forty-eight hours, indicating normal de novo methylation (Carlone 
2005).  However, significant levels of unmethylated provirus persist in the CXXC1-/- ES 
cells, which confirms a defect in DNA maintenance methyltransferase activity (Carlone 
2005).  CXXC1-/- ES cells exhibit ~50% increase in transcript levels of Dnmt1 but 
exhibit ~50% decrease in the level of Dnmt1 protein expression (Carlone 2005).  In 
addition, CXXC1-/- ES cells exhibit a 17% decrease in Dnmt1 protein stability, a 23% 
reduction in Dnmt1 protein synthesis, and a 15% decrease in global protein synthesis 
(J.S. Butler, unpublished data).   
CXXC1-/- ES cells exhibit altered histone modifications including increased 
(~43%) histone H3K4me2 and decreased (~28%) histone H3K9me2 (Lee 2005).  
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Global levels of H3K4 methylation transiently decline once CXXC1+/+ ES cells start to 
differentiate (Lee 2004).  However, following induction of in vitro differentiation, 
CXXC1-/- ES cells exhibit a nearly 4-fold increase in H3K4me3 6 days following the 
removal of LIF from the media (Lee 2005).  Consequently, Cfp1 is postulated to restrict 
the activity of the Setd1A and Setd1B histone H3K4 methyltransferase complexes (Lee 
2005).  Therefore, Cfp1 plays important roles in mammalian development, cell survival, 
hematopoiesis, differentiation, and chromatin structure.  In addition, Cfp1 regulates 
cytosine methylation and histone methylation, suggesting that Cfp1 may mediate 
epigenetic cross-talk between these epigenetic modifications.   
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Methods 
 
I.  Cell Culture 
 
Murine ES cells (CCE916) were cultured on 0.1% gelatin-coated tissue culture 
dishes in media containing high-glucose Dulbecco’s modified Eagle’s media (GIBCO 
BRL, Life Technologies, Grand Island, NY) supplemented with 20% fetal bovine serum 
(GIBCO BRL), 100 Units/ml penicillin/streptomycin (Invitrogen, Carlsbad, CA), 2 mM 
L-glutamine (Invitrogen), 1% non-essential amino acids (Invitrogen), 0.2% leukemia 
inhibitory factor (LIF)-conditioned media (isolated from chinese hamster ovary cells), 
100 nM β-mercaptoethanol, 0.025% HEPES (pH 7.5, Invitrogen), and 1% Hank’s 
balanced salt solution (Invitrogen).  HEK-293 (human embryonic kidney) cells were 
grown in media containing high-glucose Dulbecco’s modified Eagle’s media (GIBCO 
BRL, Life Technologies, Grand Island, NY) supplemented with 10% synthetic Fetal 
Clone III (HyClone, Logan, UT), 2 mM          L-glutamine (Invitrogen, Carlsbad, CA), 
and 50 Units/ml penicillin/streptomycin (Invitrogen).  Cells were cultured at 37°C with 
5% CO2.   
 
II.  Transient Transfection 
HEK-293 cells were transiently transfected using Lipofectamine 2000 
(Invitrogen), per the manufacturer’s protocol.  HEK-293 cells were grown to 
approximately 90% confluency in 10 cm tissue culture dishes and 12 ml of fresh culture 
medium was added 4 h prior to transfection.  Twenty-five micrograms of plasmid DNA 
was mixed with Opti-MEM I reduced serum medium (Invitrogen) to a final volume of 
1.5 ml and incubated at room temperature for 5 min.  Sixty microliters of Lipofectamine 
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2000 was mixed with Opti-MEM I reduced serum medium to a final volume of 1.5 ml 
and combined with the plasmid DNA mixture for 20 min at room temperature.  The 3 
ml mixture of plasmid DNA/liposome complexes were added to the cells and incubated 
at 37°C with 5% CO2 for 24-48 h before collection.   
 
III.  Stable Transfection 
CXXC1-/- ES cells were stably transfected by electroporation.  cDNA sequence 
encoding full-length and various truncations and point mutations of H. sapiens Cfp1 
(hCfp1) were subcloned into pcDNA3.1/Hygromycin mammalian expression vector 
(Invitrogen) and electroporated into CXXC1-/- ES cells.  In addition, the 
pcDNA3.1/Hygro vector without any sequence encoding Cfp1 was electroporated into 
CXXC1-/- ES cells as a vector control.  Thirty micrograms of each plasmid DNA were 
linearized with SspI restriction enzyme for at least 3 h at 37°C.  Digested plasmids were 
then ethanol precipitated and re-suspended in 50 µl ddH2O.  Plasmid linearization was 
verified by running aliquots of the reaction digest on 1.5% agarose gels along with the 
uncut plasmids followed by electrophoresis and visualization of the size of the plasmids 
by ethidium bromide staining using ultraviolet light.   
For electroporation, approximately 1x107 CXXC1-/- ES cells were harvested, 
washed with PBS, re-suspended in 1 ml of electroporation buffer (25 mM HEPES [pH 
7.5] in PBS), and transferred to 4 mm gap electroporation cuvettes (Midwest Scientific, 
St. Louis, MO) containing 25 µg of the linearized DNA.  The pulse controller setting 
was set to infinity on the Gene Pulser II (Biorad, Hercules, CA), and cuvettes 
containing cell/DNA mixture were vortexed lightly then electroporated at 300 V and 
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500 µF capacitance.  Immediately after electroporation, cells were transferred into 
gelatin-coated 15 cm tissue culture dishes containing fresh ES culture medium and 
incubated at 37°C with 5% CO2.  After 24 h of incubation in ES medium, media was 
removed and replaced with ES culture medium containing 200 µg/ml of hygromycin B 
(Sigma-Aldrich, St. Louis, MO).  Hygromycin containing medium was replaced every 
other day for approximately two weeks before single colonies were picked for 
expansion.  For experiments, cells were grown in ES culture media containing 50 µg/ml 
hygromycin B (Sigma).  Expression of FLAG-tagged human Cfp1 was verified by 
Western blot analysis using anti-FLAG (Sigma) or anti-Cfp1 antibodies (Lee 2007). 
 
IV.  Construction of Plasmids 
1.  Construction of hCfp1 pcDNA3.1/Hygro constructs 
In order to generate hCfp1 constructs for stable transfection of the CXXC1-/- ES 
cells, various truncations and mutations of hCfp1 cDNA were cloned into the 
pcDNA3.1/Hygro mammalian expression vector (Invitrogen) using sequential digests.  
The majority of the hCfp1 mutations were made and cloned into pcDNA3.1/Hygro by 
Dr. Jeong-Heon Lee (1-656, 1-656 C169A, 1-481, 1-367, 1-320, 103-481, 103-367, 
302-656, and 361-656).   
Additional Cfp1 mutations made by Dr. Jeong-Heon Lee (1-656 C73A, 1-656 
C375A, 1-656 C208A, 1-656 YCS389AAA, 1-656 C586A, 1-656 C375A,C586A, 213-
481, 318-481, 318-412, 361-481, 361-597) were cloned into the multiple cloning site of 
pcDNA3.1/Hygro as described below.  The sequence encoding the 1-656 C73A 
(PHD1B), 1-656 C586A, and 1-656 C375A,C586A mutations were released from 
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pcDNA3 (Invitrogen) along with the FLAG epitope using HindIII and XbaI and were 
subcloned into the multiple cloning site of pcDNA3.1/Hygro.  The sequence encoding 
the 1-656 C208A (CXXC-B) mutation was released from pBlueScript KS+ (Stratagene, 
La Jolla, CA) using EcoRI and XbaI, and the FLAG epitope was released from 
pcDNA3 containing full length FLAG tagged Cfp1 using HindIII and EcoRI and were 
subcloned into the multiple cloning site of pcDNA3.1/Hygro.   
The cDNA sequence encoding amino acids 213-481 and 318-412 of Cfp1 were 
released from pcDNA3 using EcoRI and XbaI and subcloned into the multiple cloning 
site of pcDNA3.1/Hygro with the FLAG epitope fragment and the amino-terminal 
bipartite nuclear localization signal (NLS) of Cfp1 (amino acids 109-121) was released 
from pFLAG-CMV (Sigma) with BglII and EcoRI.  The cDNA sequence encoding 
amino acids 318-481 and 361-481 of Cfp1 were released from pEGFP-C2 (Clontech, 
Mountain View, CA) using EcoRI and SpeI and subcloned into the multiple cloning site 
of pcDNA3.1/Hygro with the FLAG epitope released from pcDNA3 using EcoRI and 
XbaI.  The cDNA sequence encoding amino acids 361-597 and 422-656 were released 
from pBlueScript KS+ (Stratagene) using XbaI and AflII and subcloned into the 
multiple cloning site of pcDNA3.1/Hygro along with the FLAG epitope and NLS 
released from pcDNA3 with AflII and EcoRI.   
In order to make the Cfp1 361-656 C375A mutation, PCR was carried out using 
pcDNA3.1/Hygro plasmid containing sequence encoding 1-656 C375A as a template 
and using a forward Cfp1 primer upstream of the C375A mutation site and a reverse 
primer in the pcDNA3.1/Hygro vector.  After PCR amplification of the fragment, 
digestion with EcoRI and XbaI released the unwanted Cfp1 and vector sequence.  
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FIGURE 5.  Expression constructs generated for stable expression of hCfp1 and 
hCfp1 mutations.   
The human Cfp1 cDNA constructs encoding full-length Cfp1 and various Cfp1 
mutations were ligated into the pcDNA3.1/Hygro vector at the multiple cloning site.  
Each cDNA was ligated in-frame and downstream of the FLAG-epitope sequence.   
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The Cfp1 fragment was isolated and subcloned with the FLAG epitope and NLS 
released from pcDNA3 with AflII and EcoRI into the multiple cloning site of 
pcDNA3.1/Hygro.  All restriction enzymes were obtained from New England Biolabs 
(Ipswich, MA).  Automated nucleotide sequencing analysis was performed at the 
Indiana University Biochemistry and Biotechnology Facility (IU BBF) to verify 
sequence and insertion of the constructs.      
 
2.  Construction of hCfp1/pcDNA3-Myc and hDNMT1/pcDNA3-FLAG 
constructs  
The hCfp1 deletion mutation encoding amino acids 103-367 was subcloned 
from pcDNA3-FLAG to pcDNA3-Myc by Dr. Jill Sergesketter Butler using EcoRI and 
XbaI.  Site-directed mutagenesis was used to generate hCfp1 sequence encoding 103-
367 C169A using the pcDNA3-Myc 103-367 plasmid as the template for site-directed 
mutagenesis.  The construct was verified by automated sequencing at the IU BBF.  Full 
length hDNMT1 cDNA was released from pBlueScript KS+ and ligated to pcDNA3-
FLAG using EcoRI and NotI by Dr. Jill Sergesketter Butler.   
 
V.  Plasmid Purification and Transformation 
1.  Plasmid Transformation 
In order to transform plasmids conferring ampicillin resistance, GC-5 competent 
cells or α-select silver competent cells (Bioline, Taunton, MA) were thawed on ice.  
Then, 2 µl of plasmid was added to 20 µl of thawed competent cells and incubated on 
ice for 30 min followed by heat-shock at 42°C for 45 sec and addition of 300 µl of 
Luria-broth (LB).  Tubes were shaken at 225 revolutions per minute (rpm) at 37°C for 
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30 min and competent cells were spread onto LB agar plates supplemented with 100 
µg/ml ampicillin.  Plates were incubated at 37°C for 12-18 h before single colonies were 
picked for expansion.   
 
2.  Minipreps 
Plasmid DNA preparations for small scale purification were prepared using a 
plasmid miniprep kit from Sigma.  In order to culture bacteria, 5-6 ml of LB 
supplemented with 100 µg/ml ampicillin was inoculated with transformed bacterial 
colonies and grown at 37°C shaking at 225 rpm for 8-18 h.  The bacterial culture was 
pelleted by centrifugation at 4000 rpm for 4 min at 4°C and plasmid DNA was isolated 
as described by the manufacturer’s protocol. 
 
3.  Maxipreps   
Plasmid DNA preparations for large scale purification were prepared using a 
maxiprep kit from Qiagen (Valencia, CA).  A single bacteria colony was picked and 
grown in 2 ml of LB supplemented with 100 µg/ml ampicillin for 4-6 h at 37°C shaking 
at 225 rpm.  The 2 ml of culture was then used to inoculate 200 ml of LB supplemented 
with 100 µg/ml ampicillin and grown at 37°C shaking at 225 rpm for 12-16 h.  The 
bacterial culture was pelleted by centrifugation at 4000 x g for 15 min at 4°C and 
plasmid DNA was isolated as described by the manufacturer’s protocol.  
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VI.  Site-directed Mutagenesis  
Single and triple amino acid substitutions in hCfp1 were carried out using the 
QuikChange II Site-Directed Mutagenesis Kit (Stratagene) per the manufacturer’s 
protocol.  The primers used for generating amino acid changes in hCfp1 are listed in 
table 1.  Five nanograms of double strand DNA template (pcDNA 3.1/Hygro-FLAG-   
1-656 Cfp1 for full-length Cfp1 mutations or pcDNA3.1/Hygro-FLAG-1-367 Cfp1 for 
1-367 C169A) were combined with 125 ng of each primer, 1 µl of the supplied 2’-
deoxynucleoside 5’-triphosphate (dNTP) mix, 5 µl of 10X reaction buffer, and 1 µl of 
PfuUltra high fidelity DNA polymerase (2.5 Units/µl) in a 50 µl reaction.  Each reaction 
was subjected to the following thermocycling parameters: 95°C for 30 sec, (95°C for 30 
sec, 55°C for 1 min, 68°C for 7 min).  Single amino acid changes required 16 cycles of 
steps 2-4, whereas the triple amino acid change required 18 cycles.  Following 
amplification, reaction products were digested with 1 µl DpnI for 1 h at 37°C to 
eliminate the parental template.  XL1-Blue supercompetent E. coli were transformed by 
adding 2 µl of the digestion reaction, followed by a 30 min incubation on ice and a 45 
sec heat-shock at 42°C.  Reactions were placed on ice for 2 min before adding 0.5 ml of 
NZY+ broth (1% NZ amine [casein hydrolysate], 0.5% yeast extract, 0.5% NaCl, 4% 
glucose, 12.5 µM MgCl2, 12.5 µM MgSO4 [pH 7.5]) and shaking at 250 rpm for 
recovery at 37°C for 1 h.  Transformed bacteria were spread on LB agar plates 
supplemented with 100 µg/ml ampicillin for 24-72 h.  Single colonies were picked for 
expansion and small-scale plasmid preparations were performed as described above.  
DNA was sent for sequencing analysis by the IU BBF to verify amino acid mutations.    
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TABLE 1.  Oligonucleotides Used to Generate FLAG-Cfp1 Mutation Constructs. 
PCR primers were designed per the manufacturer’s recommendations 
(QuickChange II Site-Directed Mutagenesis Kit, Stratagene) which contain nucleotide 
changes in hCfp1 resulting in single or triple amino acid substitutions.  Oligonucleotide 
names designate amino acid changes as well as primer orientation within hCfp1.  
Missense codons are underlined and nucleotide changes are listed following 
oligonucleotide names for forward primers. 
hCfp1 D44A forward: GAC → GCC 
5’ GCTTCATGATCGGGTGTGCCAACTGCAATGAGTGG 3’ 
hCfp1 D44A reverse: 
5’ CCACTCATTGCAGTTGGCACACCCGATCATCAAGC 3’ 
hCfp1 W49A forward: TGG → GCG 
5’ GACAACTGCAATGAGGCGTTCCATGGGGACTGC 3’ 
hCfp1 W49A reverse: 
5’ GCAGTCCCCATGGAACGCCTCATTGCAGTTGTC 3’ 
hCfp1 C169A forward: TGT → GCT 
5’ CGGTCAGCCCGCATGGCTGGTGAGTGTGAGGC 3’ 
hCfp1 C169A reverse: 
5’ GCCTCACACTCACCAGCCATGCGGGCTGACCG 3’ 
hCfp1 C208A forward: TGT → GCC  
5’ GCCGGCTGCGCCAGGCCCAGCTGCGGGCCC 3’ 
hCfp1 C208A reverse: 
5’ GGGCCCGCAGCTGGGCCTGGCGCAGCCGGC 3’  
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hCfp1 C375A forward: TGC → GCG 
5’ CCTGCGTCACTGCCCCAGGCGCTGGGGCCCGGCTGTGTG 3’  
hCfp1 C375A reverse: 
5’ CACACAGCCGGGCCCCAGCGCCTGGGGCAGTGACGCAGG 3’ 
hCfp1 YCS389AAA forward: TATTGCTCA → GCAGCCGCC 
5’CCGCCCAGCCCAGCTCCAAGGCAGCCGCCGATGACTGTGGCATGAA 3’ 
hCfp1 YCS389AAA reverse: 
5’AGCTTCATGCCACAGTCATCGGCGGCTGCCTTGGAGCTGGGCTGGGC 3’ 
    
VII.  Production of 6XHis-tagged Proteins and Electrophoretic Mobility Shift 
Assay (EMSA) 
Production of 6XHis-tagged proteins was performed by Dr. Kui Shin Voo as 
previously described (Lee 2001).  Escherichia coli cells were grown at 37°C to an A600 
of 1.0.  Isopropyl-β-D-thiogalactoside was added to 0.2 mM, and cells were grown for 
an additional 4-6 h.  Cells were harvested and re-suspended in 50 µl of ice-cold PBS/ml 
of culture.  Cells were sonicated on ice for 30 min.  Lysate was isolated by 
centrifugation at 15,000 rpm for 30 min.  Supernatant was loaded onto a His-Trap 
purification column (Amersham Pharmacia Biotech, GE Healthcare, United Kingdom).  
The protein was washed with excess PBS and eluted with 500 mM imidazole.  The 
samples were dialyzed with phosphate-buffered saline containing 10% glycerol, and 
dialysate was stored at -80°C.  For Western blot analysis, 0.5 µg of partially purified 
protein was solubilized in Laemmli sample buffer.  After electrophoresis on a 10-12% 
sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE), proteins were transferred 
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onto a nitrocellulose membrane (Amersham, GE Healthcare).  The membrane was then 
incubated with anti-6XHis-tag monoclonal antibody (R&D Systems, Minneapolis, MN) 
followed by horseradish peroxidase-labeled anti-mouse antiserum and detected using an 
ECL detection kit (Amersham, GE Healthcare).   
EMSA was performed by Dr. Kui Shin Voo as previously described (Skalnik 
1991; Lee 2001).  Briefly, 0.01-0.1 µg of partially purified Cfp1 protein was incubated 
with 0.5 µg of herring sperm DNA (Amresco, Solon, OH) or 1 µg of poly (dA-dT) on 
ice for 15 min in a 40 µl reaction before addition of 40,000 cpm of end-labeled double-
stranded oligo probe and incubation at room temperature for 30 min.  EMSA samples 
were loaded onto a 0.5X TBE (45 mM Tris pH 8.3, 45 mM borate, 1.25 mM EDTA), 6-
9% non-denaturing polyacrylamide gel, and electrophoresis was performed at 200 V at 
room temperature for 2 h.  Oligonucleotide probes were radiolabeled by T4 
polynucleotide kinase using [γ-32P] ATP followed by annealing with equal molar 
complementary strand oligonucleotide.  Radiolabeled probes were resolved by 
electrophoresis on a 10% polyacrylamide gel and eluted by the crush and soak method 
(Sambrook 1999).  
 
VIII.  Isolation of Genomic DNA 
Genomic DNA was isolated from cell lines by collecting cells by centrifugation, 
washing with PBS, and lysing pellets with 600 µl of cell lysis buffer (10 mM Tris [pH 
8.0], 100 mM EDTA, 0.5% SDS).  Cell lysates were then incubated with 4 µl RNAse A 
(Roche, 10 mg/ml) for 15 min at 37°C.  Lysates were then chilled on ice and 200 µl of    
7 M ammonium acetate was added before vortexing the sample for 30 sec and 
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incubating on ice an additional 5 min.  Proteins and debris were pelleted by 
centrifugation at 14,000 x g for 2 min.  The supernatant was transferred to a new 1.5 ml 
microcentrifuge tube, and 300 µl of isopropanol was added and mixed by inversion of 
the tube to precipitate the DNA.  The DNA was pelleted by centrifugation at 14,000 x g 
for 1 min, washed with 300 µl 70% ethanol, and the pellets were air dried and re-
suspended in ddH20.  
   
IX.  Analysis of Global Cytosine Methylation  
Global cytosine methylation was assessed utilizing a methyl acceptance assay as 
previously described (Balaghi 1993). Briefly, 500 ng of genomic DNA was incubated 
with 2 µCi of 3H-methyl-S-adenosyl L-methionine (Amersham, GE Healthcare; 15 
Ci/mmol), and 3 units of SssI (CpG) methylase (New England Biolabs, Ipswich, MA) in 
120 mM NaCl, 10 mM Tris-HCl (pH 7.9), 10 mM EDTA, and 1 mM dithiothreitol 
(DTT) for 1 h at 30°C in a total volume of 30 µl.  The SssI enzyme was then inactivated 
by heating the reaction mixture for 10 min at 65°C.  In vitro methylated DNA was 
isolated by filtration through Whatman DE-81 ion-exchange filters (Fisher Scientific, 
Pittsburgh, PA).  The filters were washed five times with 0.5 M sodium phosphate 
buffer (pH 7.4), air-dried, and the incorporated radioactivity was measured by 
scintillation counting.  Background radioactivity bound to the filter from a reaction 
mixture lacking DNA was subtracted from the values of the reaction mixtures 
containing DNA.  Methylation reactions were performed in duplicate and three 
independent experiments were performed.       
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X.  Southern Blot Analysis    
Analysis of cytosine methylation at Intracisternal A Particle (IAP) retrovirus 
repetitive elements was analyzed by Southern blot.  Ten micrograms of genomic DNA, 
isolated as described above, was digested with either MspI or HpaII restriction enzymes 
overnight at 37°C.  Digested DNA was then separated on 0.6% agarose gels.  Gels were 
rocked for 1 hr in denaturing solution (1.5 M NaCl, 0.5 N NaOH), rocked 2 times for 15 
min in neutralization solution (1 M Tris [pH 7.4], 1.5 M NaCl), rocked for 20 min in 
10X SSC (1.5 M NaCl, 0.15 M sodium citrate), then transferred to nylon membranes 
overnight.  Membranes were pre-hybridized using PerfectHyb (Sigma) for at least 30 
min then dCTP [α-32P]-radiolabeled probes were denatured by boiling for 5 min 
followed by a quick chill on ice before being added to the hybridization solution.  
Membranes were probed for 5-14 h at 65°C then washed two times for 15 min each 
with low stringency wash buffer (2X SSC, 0.5% SDS) at 65°C, then two times for 30 
min each at 65°C with high stringency wash buffer (0.5X SSC, 0.1% SDS).  
Membranes were then exposed to X-ray film at -80°C.    
Probes were labeled by boiling 25-50 µg of the gel purified IAP PCR product 
(amplified from wild-type ES cell DNA using the primers listed in table 2) and water 
(total volume of 27 µl) for 5 min then incubating on ice and adding 5 mM each (dATP, 
dTTP, and dGTP), 5 µl 10X hexanucleotide mix (Roche Diagnostics, Indianapolis, IN), 
2 Units Klenow enzyme (Roche), and 3 µl dCTP α-P32 (Perkin Elmer, Waltham, MA, 
10 mCi/ml).  The reaction was then incubated at 37°C for at least one hour.  After 
incubation, labeled probes were diluted with 50 µl TE buffer (10 mM Tris [pH 7.5], 1 
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mM EDTA) and purified by centrifugation at 735 x g for 2 min through a MicroSpin   
S-200 HR column (Amersham, GE Healthcare).  
 
TABLE 2.  Oligonucleotides used for amplification of IAP probe for cytosine 
methylation analysis by Southern blot.  
The sequence of oligonucleotides used to generate probes for Southern blot 
analysis of the Intracisternal A Partcle (IAP) retrovirus repetitive elements are shown 
below.  PCR amplification was carried out using wild-type ES DNA (CCE916) as a 
template, an annealing temperature of 55°C, and 30 thermocycles (94°C for 30 sec, 
55°C for 30 sec, 72°C for 30 sec).          
IAP Forward 1570:  5’ AACGGGTCAGGGAGCTTATT 3’ 
IAP Reverse 1899:   5’ GGTTACGTCCGAATCGCCGG 3’  
 
XI.  Embryonic Stem Cell Differentiation 
1. Morphological Analysis of Differentiation 
Exponentially growing asynchronous ES cells were trypsinized, washed twice 
with ES culture medium lacking LIF, and 300 cells/drop were plated as hanging drops 
in ES media without LIF on the lid of bacteria culture dishes.  After two days, hanging 
drops containing cell aggregates were collected and moved to the bottom of bacteria 
culture dishes that contained ES culture media without LIF.  Media was changed every 
day and colony morphology was assessed 10 days after initial plating at 10X 
magnification. 
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2.  Detection of Alkaline Phosphatase Activity 
One million ES cells were harvested and washed twice with ES media lacking 
LIF.  Cells were then plated in suspension in ES culture media without LIF in bacteria 
culture dishes and media was changed every day.  After 10 days of culture in the 
absence of LIF, cells were harvested, disaggregated with trypsin, reseeded into gelatin-
coated tissue culture dishes containing ES culture media without LIF and allowed to 
recover overnight.  Alkaline phosphatase activity was histochemically detected using an 
alkaline phosphatase leukocyte detection kit (Sigma).  Briefly, cells were washed with 
PBS and fixed with citrate fixative (18 mM citric acid, 9 mM NaCl, 12 mM surfactant 
buffered at pH 3.6) for 30 sec at room temperature.  Cells were then washed with 
ddH2O and alkaline phosphatase staining solution was added to the cells.  The staining 
solution was made by mixing 1 ml 0.1 M sodium nitrite to 1 ml FRV-Alkaline solution 
(5 mg/ml fast blue BB base, 0.4 M HCl) and 45 ml ddH2O for 2 min at room 
temperature then adding 1 ml Naphthol AS-BI Alkaline solution (4 mg/ml Naphthol 
AS-BI phosphate, 2 M 2-amino-methyl-1,3-propanediol [AMPD] buffer pH 9.5).  Cells 
remained in the staining solution for 15 min at room temperature.  Cells were then 
washed with ddH2O and images were collected at 20X, 10X, or 4X magnification.  
Alkaline phosphatase positive cells were stained purple in color and at least 200 cells 
were scored for each dish.  
 
3. Reverse Transcriptase PCR (RT-PCR) for Analysis of Lineage Markers  
For analysis of developmental and lineage-specific mRNAs expressed during in 
vitro ES cell differentiation, total RNA was isolated from undifferentiated and 
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differentiated cell aggregates 5 and 10 days following removal of LIF from the media as 
described below in RNA isolation.  cDNA was generated using SuperScript II Reverse 
Transcriptase (Invitrogen) per the manufacturer’s protocol.  Briefly, 5 ng of total RNA 
was heated at 65°C for 5-10 min with an appropriate amount of DEPC-treated ddH2O 
then quickly chilled on ice followed by a quick centrifugation. Then, 1 µl Oligo dT 
primer (500 µg/ml, Promega), 1 µl dNTP mix (10 mM each deoxynucleotide 
triphosphate, dATP, dGTP, dCTP, and dTTP), 4 µl 5X first-strand buffer, 2 µl 0.1 M 
DTT, and 1 µl (40 units) of RNasin ribonuclease inhibitor (Promega), and 1 µl (200 
units) of SuperScript II enzyme were added at room temperature.  Reaction mixtures 
were mixed gently and incubated at 42°C for 1 hr.  To remove RNA complementary to 
the cDNA, 1 µl (2 units) of RNase H (New England Biolabs, Ipswish, MA) were added 
to the reaction mixture and incubated at 37°C for 20 min followed by a 2 min 
incubation at 95°C to inactivate the enzyme.   
Single-stranded cDNA (1 µl) was amplified in a 50 µl reaction mixture 
containing 0.2 mM each deoxynucleotide triphosphate, 50 pmol of sense and antisense 
primers listed in table 3, and 1 unit of Taq DNA polymerase (Roche) in 1X buffer 
supplied by the manufacturer (10X PCR buffer with MgCl2).  Cycling conditions for 
PCR were heat denaturing at 94°C for 2 min followed by 30 cycles (23-26 cycles for 
Oct4) at 94°C for 30 s, 55-65°C for 30 s, 72°C for 30 s, and final elongation step at 
72°C for 10 min.  PCR was performed for HPRT to monitor the integrity of the cDNA 
produced by the reverse transcription reaction.  Twenty-five microliters of amplified 
DNA was subjected to electrophoresis on 1.5% agarose gels run in 1X Tris-borate-
EDTA (TBE).   
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TABLE 3.  Primers and annealing temperatures used for analysis of 
developmental and lineage specific markers during in vitro differentiation. 
Brachyury (52°C) 
5’ ATCAAGGAAGGCTTTAGCAAATGGG 3’ 
5’ GAACCTCGGATTCACATCGTGAGA 3’ 
βH1 (55°C) 
5’ AGTCCCCATGGAGTCAAAGA 3’ 
5’ CTCAAGGAGACCTTTGCTCA 3’ 
MHCβ-R (65°C) 
5’ TGCAAAGGCTCCAGGTCTGAGGGC 3’ 
5’ GCCAACACCAACCTGTCCAAGTTC 3’ 
c-fms (55°C) 
5’ CTGAGTCAGAAGCCCTTCGACAAAG 3’ 
5’ CTTTGCCCCAGACCAAAGGCTGTAGC 3’ 
gp-IIB (55°C) 
5’ AGGCAGAGAAGACTCCGGTA 3’ 
5’ TACCGAATATCCCCGGTAAC 3’ 
GATA 4 (65°C) 
5’ CACTATGGGCACAGCACAGCAGCTGG 3’ 
5’ TTGGAGCTGGCCTGCGATGTC 3’  
Oct4 (55°C) 
5’ GGCGTTCTCTTTGGAAAGGTGTTC 3’ 
5’ CTCGAACCACATCCTTCTCT 3’ 
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HPRT (55°C) 
5’ CACAGGACTAGAACACCTGC 3’ 
5’ GCTGGTGAAAAGGACCTCT 3’ 
 
XII.  RNA Isolation 
Total RNA was isolated from ES cells using TRI Reagent (Molecular Research 
Center, Inc., Cincinnati, OH) per the manufacturer’s protocol.  One ml of TRI Reagent 
was added directly to a 10 cm tissue culture dish containing approximately 5 x 106 cells, 
and cells were scraped into a 1.5 ml microcentrifuge tube.  To the lysates, 200 µl of 
chloroform was added and mixed by vigorous vortexing for at least 30 sec followed by 
incubation for 5 min at room temperature.  Lysates were separated by centrifugation at 
16,000 x g for 15 min at 4°C and the aqueous phase was transferred to a fresh 1.5 ml 
tube.  RNA was precipitated with 0.5 volumes of isopropanol followed by inversion and 
incubation at room temperature for 5 min.  RNA was pelleted by centrifugation at 
12,000 x g for 10 min at 4°C, washed with 75% ethanol in diethylpyrocarbonate 
(DEPC)-treated water and re-suspended in DEPC-treated ddH2O. 
 
XIII.  Nuclear Extract Preparation 
Cells were collected and washed with PBS and with hypotonic buffer (10 mM 
HEPES [pH 7.9] at 4°C, 1.5 mM MgCl2, 10 mM KCl), then swollen on ice for 10 min 
in hypotonic buffer before being lysed by Dounce homogenization 10 times.  Nuclei 
were pelleted by centrifugation at 3,000 x g for 10 min at 4°C and supernatant was 
removed.  The pellet was re-suspended in lysis buffer (20 mM Tris HCl [pH 7.4],      
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400 mM NaCl, 5 mM EDTA, 25% glycerol, 0.1% NP-40, 1 mM DTT, and 3% protease 
inhibitor cocktail [Sigma]).  Nuclei were lysed by Dounce homogenization 30 times on 
ice and soluble nuclear extracts were separated from debris by centrifugation at  
     16,000 x g for 10 min at 4°C. 
 
XIV.  Whole Cell Protein Extract Preparation 
Cells were collected and washed once with PBS.  Cells were then lysed in 
cytoskeletal buffer (CSK: 500 mM NaCl, 10% sucrose pH 7.2, 1 mM DTT, 1 mM 
phenylmethylsulfonyl fluoride [PMSF], and 3% protease inhibitor cocktail [Sigma]) by 
Dounce homogenization 30 times on ice and soluble nuclear and cytoplasmic extracts 
were separated from debris by centrifugation at 16,000 x g for 10 min at 4°C.   
 
XV.  Histone Protein Preparation 
Cells were collected and washed twice with ice-cold PBS.  Cells were re-
suspended in triton extraction buffer (TEB: PBS containing 0.5% Triton X-100, 2 mM 
PMSF, 0.02% NaN3) on ice for 10 min with gentle agitation.  Cells were pelleted by 
centrifugation at 3,000 x g for 10 min and the supernatant was discarded.  Cell pellets 
were briefly washed with TEB and isolated by centrifugation at 3,000 x g for 10 min.  
The cell pellet was re-suspended in 0.2 N hydrochloric acid (HCl) and histones were 
extracted overnight at 4°C.  Acid insoluble proteins were removed by centrifugation at 
3,000 x g for 10 min at 4°C and supernatant containing histones was collected.  
Histones were extracted again by re-suspending pellet in fresh 0.2 N HCl and collecting 
supernatant after centrifugation as above.  Histones were precipitated by adding eight 
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volumes acetone and incubating at -20°C overnight.  The histone pellets were then 
washed twice with acetone/100 mM HCl (10:1) and three times with acetone.  Pellets 
were air dried and re-suspended in ddH2O.     
 
XVI.  Subcellular Fractionation 
Cells were collected and washed with ice-cold PBS before being extracted on 
ice for 5 min in extraction buffer (100 mM NaCl, 300 mM sucrose, 10 mM PIPES, 3 
mM MgCl2, 1 mM EGTA, 1 mM PMSF, 1 mM DTT, 0.5% Triton X-100, 1 ug/ml 
protease inhibitor cocktail [Sigma]).  Soluble nuclear and cytoplasmic fraction was 
removed and collected by centrifugation at 5000 x g for 3 min at 4°C.  Chromatin was 
then digested by adding 30 units DNaseI (Roche) in extraction buffer for 20 min at 
37°C.  Chromatin was extracted by adding 1 M ammonium sulfate to a final 
concentration of 0.25 M for 5 min on ice followed by centrifugation at 5,000 x g for 3 
min at 4°C.  Chromatin fraction was removed and further extracted by re-suspending 
pellet in 2 M NaCl in CSK buffer for 5 min on ice followed by centrifugation at     
5,000 x g for 3 min at 4°C.  The NaCl fraction was removed and the pellet containing 
the nuclear matrix fraction was solubilzed with 8 M urea buffer (8 M urea, 100 mM 
NaH2PO4, 10 mM Tris [pH 8.0]) and sonicated on ice. 
 
XVII.  Co-Immunoprecipitation 
Soluble nuclear extracts were diluted to 150 mM NaCl with 20 mM Tris (pH 
7.4), then incubated with 40 µl of FLAG M2-conjugated agarose (Sigma) for 4 h at 4°C.  
FLAG beads were prepared by washing twice with 1X TBS (20 mM Tris-HCl [pH 8.0], 
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150 mM NaCl), twice with 0.1 M glycine-HCl (pH 2.7), and twice again with 1X TBS.  
After bead incubaton with nuclear extracts, beads were washed five times in wash 
buffer (20 mM Tris [pH 7.4], 300 mM NaCl, 0.1% NP-40, 1 mM DTT, 5 mM EDTA, 
25% glycerol) then re-suspended in ddH2O, boiled in 1X Laemmli sample buffer 
(Laemmli 1970), and analyzed by Western blotting as described below.    
 
XVIII.  Western Blot Analysis 
Cell extracts were quantified using the Bradford method (Gebauer 2002), 1X 
Laemmli sample buffer was added, and samples were boiled for 5 min before being 
separated by electrophoresis on 7% (Cfp1, Ape1), 4-12% (Dnmt1, Setd1A), or 12% 
(histones) polyacrylamide gels and transferred to nitrocellulose membranes 
(Amersham).  Membranes were probed with primary antibodies diluted in 5% blotting-
grade blocking reagent (BioRad) in TBS-T (20 mM Tris-HCl [pH 8.0], 150 mM NaCl, 
0.1% Tween 20) and incubated with membranes for 1 hr at room temperature or 
overnight at 4°C.  Nitrocellulose membranes were then washed two times for 15 min 
with TBS-T followed by incubation with appropriate horseradish peroxidase (HRP)-
linked secondary antibodies diluted in 5% blocking solution for 1 h.  Membranes were 
washed two times for 15 min with TBS-T and signal was detected by adding ECL 
detection reagents (Amersham) and autoradiography, then signal was quantified by 
densitometry (Image J, NIH).  The following antibodies were used for immunoblotting: 
mouse monoclonal c-myc and rabbit polyclonal Brg-1 (Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA), mouse monoclonal β-actin and mouse monoclonal FLAG M2 
(Sigma), rabbit polyclonal Setd1A, Wdr82, and Wdr5 (Lee 2007), rabbit polyclonal 
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Ash2 and Rbbp5 (Bethyl Laboratories, Montgomery, TX),  rabbit polyclonal Dnmt1 
(Butler 2008), rabbit polyclonal Cfp1 (Lee 2007), mouse monoclonal Ape1 (Novus 
Biologicals, Littleton, CO), mouse monoclonal Xrcc1 (LabVision, Fremont, CA), rabbit 
polyclonal trimethylated histone H3K4, dimethylated histone H3K9, and total histone 
H3 (Abcam, Cambridge, United Kingdom), and rabbit polyclonal HCF-1 was obtained 
from Winship Herr (Cold Spring Harbor Laboratory, NY).    
In order to strip and remove antibodies and ECL detection reagents from 
Western blots to re-probe with a different antibody, blots were shaken in stripping 
buffer (62.5 mM Tris-HCl [pH 6.7], 2% SDS, 100 mM beta-mercaptoethanol) for 30 
min at 55°C.  In order to determine if signal was completely stripped, blots were 
washed three times for 15 min with TBS-T then ECL detection reagents were added and 
the membrane was exposed to X-ray film.  If the signal was still detectable, additional 
10 min incubations at 55°C in stripping buffer followed by washing with TBS-T and 
checking for signal with ECL detection reagents were carried out until the signal was no 
longer detectable.  After stripping, blots were washed three times for 15 min with TBS-
T then re-probed as above. 
       
XIX.  Cell Growth Curves 
Cell growth rate was determined by performing cell growth curves.  
Exponentially growing asynchronous cells were trypsinized, counted, and 10,000 cells 
were plated in triplicate into 6-well tissue culture dishes.  Cells were harvested and 
counted in triplicate on the second, third, and fourth day after plating, and the average 
was calculated for each time point.  Doubling time was calculated between counts on 
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the third and fourth day using the following equation:  Doubling time= (ln2)(time in 
h)/[(ln average cell count day 4)/(ln average cell count day 3)].     
 
XX.  TUNEL Analysis 
An in situ Cell Death Detection Kit, Flourescein (Roche) was used for detection 
of DNA strand breaks in apoptotic cells by flow cytometry per manufacter’s protocol.  
Briefly, 4-5 x 105 exponentially growing asynchronous cells were harvested and washed 
with PBS.  Cells were then fixed in 4% paraformaldehyde for 20 min at room 
temperature followed by 2 washes with PBS.  Cells were then permeabilized in 
permeablilization solution (0.1% Triton X-100, 0.1% sodium citrate) on ice for 2 min 
then washed twice with PBS.  Cell pellets were then re-supended in 5 µl terminal 
deoxynucleotidyl transferase enzyme solution and 45 µl labeling solution containing 
fluorescein dUTP.  As negative controls for each experiment, cell pellets were re-
suspended in 0.1% bovine serum albumin (BSA) in PBS or 50 µl labeling solution.  Cell 
suspensions were incubated at 37°C with 5% CO2 for 2 h protected from light.  Cells 
were then washed twice with 0.1% BSA in PBS.  Cells were re-suspended in 0.1% BSA 
in PBS and transferred to 5 ml polystyrene round-bottom tubes and analyzed using a 
FACScan flow cytometer and CellQuest software (Becton Dickinson, San Jose, CA).  
  
XXI.  Cell Cycle Analysis  
For cell cycle analysis, 4-5 x 105 exponentially growing asynchronous cells were 
harvested and washed twice with PBS.  Cells were then fixed in ice-cold 70% EtOH at  
-20°C for at least 1 hr.  Prior to analysis, cells were washed twice with PBS and           
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re-suspended in 500 µl propidium iodide buffer (100 µg/ml propidium iodide [Sigma], 
100 mM EDTA, 0.1% Triton X-100, 1 µg RNAseA-DNase free [Roche], in 1X PBS 
[pH 7.4]).  The cell suspension was analyzed using a FACScan flow cytometer (Becton 
Dickinson) and ModFit LT software (Verity Software, Topsham, ME).    
   
XXII.  Sorting of Apoptotic Cells  
Apoptosis was detected using an annexin V-FITC apoptosis detection kit 
(Sigma) per the manufacturer’s protocol. Approximately 3 x 107 cells were collected 
and washed with PBS before being re-suspended in 1 ml of 1X binding buffer (10 mM 
HEPES/NaOH [pH 7.5], 140 mM NaCl, 2.5 mM CaCl2) and transferred to 10 ml 
polystyrene round-bottom tubes (Becton Dickinson).  Then, 20 µl of 50 µg/ml annexin 
V-FITC and 20 µl of 100 µg/ml propidium iodide (PI) were added to each tube except 
the controls.  Three controls containing 5 x 106 cells per tube were run for each 
experiment, cells without annexin V-FITC or PI, cells stained with 2 µl annexin V-FITC 
only, and cells stained with 2 µl PI only.  Tubes were then incubated at room 
temperature for 15 min protected from light.  The cell suspensions were sorted by the 
Indiana University Flow Cytometry Facility using a FACS-STAR flow cytometer 
(Becton Dickinson).  Cells were sorted into two tubes containing PBS, one tube 
collecting non-apoptotic cells as determined as annexinV-FITC negative and PI 
negative, and another tube collecting apoptotic and necrotic cells as determined as 
annexinV-FITC positive, PI-negative, and annexinV-FITC positive, PI-positive.  After 
sorting, cells were pelleted by centrifugation at 4000 rpm and re-suspended in 600 µl 
cell lysis buffer for isolation of genomic DNA as described previously.        
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XXIII.  Colony Forming Assay 
To measure plating efficiency by colony forming assay, exponentially growing 
asynchronous ES cells were trypsinized and counted, then 400 cells were plated into 
gelatin-coated 10 cm tissue culture dishes.  Cells were left undisturbed for 6 days in the 
incubator at 37°C with 5% CO2 in order for colonies to form.  Colonies were then fixed 
in methanol:acetic acid (3:1) then stained with a solution of crystal violet (0.05 grams 
crystal violet powder into 250 ml distilled water).  The number of colonies per 10 cm 
tissue culture dish were counted and plating efficiency was determined by dividing the 
number of colonies by 400 (original number of cells plated).   
Colony forming assay to determine drug sensitivity was carried out in a similar 
manner.  Exponentially growing asynchronous cells were either untreated, vehicle 
control treated, or drug treated at various concentrations for the indicated amounts of 
time.  After drug treatment, cells were washed with PBS, trypsinized, harvested, and 
counted.  Then, 400 cells were plated in gelatin-coated 6 cm tissue culture dishes and 
incubated at 37°C with 5% CO2 undisturbed for 6-8 days in order for colonies to form.  
Colonies were fixed and stained as above and colony counts were normalized back to 
untreated or vehicle controls. 
 
XXIV.  Confocal Microscopy  
ES cells were seeded onto sterilized glass coverslips at a density of 3 x 104 cells 
per well in 24-well tissue culture dishes.  After 48 h of culture on the coverslips, cells 
were washed three times with ice-cold PBS and then fixed with 4% paraformaldehyde 
for 20 min at room temperature followed by three additional washes with ice-cold PBS.  
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Cells were then permeabilized with 0.2% Triton X-100 in PBS for 2 min at room 
temperature followed by 2 washes with ice-cold PBS.  Blocking solution containing 5% 
normal donkey serum in PBS-T (PBS, 0.2% Tween-20) was added for 1 h with shaking 
at room temperature.  Primary antibodies were diluted 1:500 for H3K4me3 (Abcam) 
and 1:500 for Setd1A (Lee 2006) in blocking solution and incubated with coverslips for 
2 h at room temperature.  Coverslips were washed 3 times for 5 min with PBS-T and 
FITC conjugated secondary antibodies (Santa Cruz) diluted 1:200 in blocking solution 
were added for 1 h with shaking at room temperature protected from light.  Coverslips 
were then washed 3 times for 5 min with PBS-T followed by incubation with 0.1 µg/ml 
4’, 6-diaminidino-2-phenylindone (DAPI) solution for 20 min at room temperature 
protected by light.  Briefly, coverslips were washed once with PBS followed by 2 
washes with ddH2O and mounted on slides with Vectashield mounting medium (Vector 
Laboratories, Burlingame, CA).  Images were captured on a Zeiss UV LSM-510 
confocal microscope (Indiana University Center for Biological Microscopy) using a UV 
argon laser (364 nm excitation) for DAPI, and visible argon laser (488 nm excitation) 
for FITC.   
The immunofluorescent images were analyzed with MetaMorph 6.0 (Universal 
Imaging Corporation, West Chester, PA).  Threshold for FITC was adjusted to exclude 
background and non-specific staining, and threshold for DAPI was adjusted to include 
DAPI-bright regions.  The same threshold values were used to analyze each image.  
Quantification of colocalization of positive fluorescent signals was analyzed using 
MetaMorph's colocalization module.  At least 20 nuclei were analyzed for each cell 
line. 
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XXV.  Cell Cycle Synchronization 
In order to synchronize cells before confocal analysis, ES cells were trypsinized 
and plated onto coverglass slips in 24-well dishes as described above.  Cells were 
treated with 200 µM L-Mimosine (Sigma, 50 mM stock in media) for 16 h, media 
containing L-Mimosine was removed, and the cells were washed twice with fresh ES 
culture media and released in fresh ES culture medium.  Cells were fixed with 4% 
paraformaldehyde at various time points and processed for confocal analysis as 
described above. 
 
XXVI.  Drug Treatments and Irradiation 
Stock solutions of DNA damaging and cytotoxic agents were diluted with ES 
culture media to the indicated concentrations, and cells were treated for various 
amounts of time before being harvested, counted, and plated in triplicate for colony 
forming assays.  H2O2 was a stock solution of 8.8 M made in water (Sigma-Aldrich), 
and cells were treated with 0.5, 1, 5, or 10 µM H2O2 for 2 h.  Methyl methanesulfonate 
(MMS) was an 11.8 M stock solution made in water (Sigma), and cells were treated 
with 100, 250, 500, or 800 nM MMS for 3 h.  Etoposide (Sigma) was made into a stock 
solution of 50 mM in dimethyl sulfoxide (DMSO), and cells were treated with 100, 150, 
200, 500, or 1000 nM etoposide or with DMSO vehicle controls for 3 h.  Temozolomide 
(TMZ, LKT Laboratories, St. Paul, MN) was made into a stock solution of 5 mM in 
media, and cells were treated with 10, 15, 25, or 50 µM TMZ for 4 h.  Cis-
diammineplatinum (II) dichloride (Cisplatin, Sigma) was made into a stock solution of 
20 mM in DMSO, and cells were treated with 0.5, 1, 5, or 10 µM cisplatin or DMSO 
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vehicle controls for 3 h.  Irradiation was carried out using a Co-60 gamma unit (Nordion 
International, Kanata, Canada) with various doses at room temperature.  After 
irradiation, the cells were immediately trypsinized, counted, and plated for colony 
formation.  Paclitaxel (Sigma) was made into a 0.01 M stock solution in DMSO, and 
cells were treated with 1, 10, or 25 µM paclitaxel or DMSO vehicle controls for 6 h.  
Methotrexate (Sigma) was made into a 0.01 M stock solution with 1 M sodium 
hydroxide (NaOH), and cells were treated with 1, 5, or 10 µM methotrexate or NaOH 
vehicle controls for 6 h.   
 
XXVII.  Ape1 Endonuclease Activity Assay   
Oligonucleotide gel-based Ape1 endonuclease activity assays were modified as 
a fluorescent assay and performed by Dr. Melissa L. Fishel as previously described 
(Kreklau 2001).  Cells were harvested, washed in cold PBS, and pelleted by 
centrifugation.  Pellets were re-suspended in 0.5-1.0 ml of harvesting buffer (PBS 
containing 2 mM DTT), then kept on ice. The cells were then pulse-sonicated on ice 
three times for 15 s each, debris was pelleted by centrifugation at 14,000 x g at 4°C for 
30 min.  Protein concentration was quantified by measuring absorbance at 595 nm using 
the Bradford Reagent (BioRad, Cambridge, UK).  The 26 bp oligonucleotide substrate 
contained a single THF residue in the middle, yielding a HEX-labeled 13mer fragment 
upon excision. APE/Ref-1 activity was measured by incubating 0.4 pmol HEX-labeled 
(2 pmol/ml) excess oligo substrate with 0.004-0.125 µg cellular protein in a total 
volume of 20 µl of assay buffer (50 mM HEPES, 50 mM KCl, 10 mM MgCl2, 1% BSA, 
0.05% Triton X-100, pH 7.5) at 37°C for 15 min.  Reactions were terminated by adding 
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formamide loading buffer (10 µl), without dyes to each sample.  The results were 
detected by electrophoresis and quantified using the FMBioII fluorescence imaging 
system and software (Hitachi Genetic Systems, South San Francisco, CA). 
 
XXVIII.  H2AX Phosphorylation Expression as a Measure of DNA Damage 
Quantification of phosphorylation of H2AX at Ser139 (Rogakou 1998) by 
Western blot using a phosphorylation-specific H2AX antibody (Upstate, Waltham, MD) 
was used as a measure of DNA DSBs.  ES cells were treated with temozolomide and 
media controls for 4 h or cisplatin and DMSO controls for 3 h.  After the indicated time 
points, exponentially growing cells were harvested, washed with cold PBS, then lysed 
in RIPA  assay buffer containing phosphatase and protease inhibitors (150 mM NaCl, 
10mM Tris [pH 7.2], 0.1% SDS, 1.0% Triton X-100, 1% deoxycholate, 5 mM EDTA,  
1 mM PMSF, 100 µM sodium orthovanadate) (Santa Cruz Biotechnologies, Inc., Santa 
Cruz, CA).  Protein was quantified by the Bradford method as previously described 
(Gebauer 2002), and extracts were solubilized in SDS gel-loading buffer and separated 
by electrophoresis on 12% SDS-polyacrylamide gels.  Mouse monoclonal anti-phospho-
histone H2AX (Upstate) or anti-actin (LabVision) antibodies were used to probe for 
protein levels as described above.  Bands were detected using a chemiluminescence kit 
(Roche, Indianapolis, IN), visualized using Bio-Rad Chemidoc XRS (Hercules, CA) 
and quantified using Chemidoc software, Quantity One 4.6.1.   
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XXIX.  Measurement of Total Platinum in DNA  
Atomic absorption spectroscopy was used to quantitate total platinum on DNA 
as previously described (Fishel 2003).  Exponentially growing cells were treated with 
cisplatin or vehicle for 3 h then collected.  Genomic DNA was isolated from cell lines 
as described above.  Platinum concentration was assessed by Julianne L. Holleran with 
a Perkin-Elmer model 1100 flameless atomic absorption spectrometer (Perkin-Elmer, 
Norwalk, CT) monitoring 265.9 nm.  The temperature program used was as follows: 
ramp over 45 s to 1500°C and hold for 60 s; and atomize at 2700°C with no ramping.  
Argon gas flow was 800 ml/min during all heating steps except atomization, when it 
was interrupted.  Platinum concentrations were determined by comparison with a 
standard curve performed on the same day as the assay (Erkmen 1995).     
 
XXX.  Statistical Analysis 
Experimental data that is represented graphically is shown relative to CXXC1+/+ 
ES cell data.  The values for CXXC1+/+ are arbitrarily set at “1”.  Error bars represent 
standard error, which was calculated by dividing the standard deviation by the square 
root of the number of replicates.  The standard error values for CXXC1+/+ ES cell 
samples were determined by normalizing the raw CXXC1+/+ ES cell values relative to 
the average CXXC1+/+ ES cell values then calculating standard deviation and dividing 
by the square root of the number of replicates.  The p values used to determine 
statistical significance were calculated using two-tailed Student’s t-test with equal 
variance.  Statistical significance was calculated by comparing to the vector control or 
1-656 data.  A p value of <0.05 was considered statistically significant and is denoted 
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with an asterisk.  All graphical and statistical analysis was performed using Microsoft 
Excel software.   
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Results 
 
 
I.  Protein Expression of Cfp1 Mutations and Verification of Functional Domain 
Disruption  
1.  Isolation of CXXC1-/- ES clones expressing various Cfp1 mutations 
CXXC1-/- ES cells exhibit a variety of defects when compared to CXXC1+/+ ES 
cells.  The defects observed in CXXC1-/- ES cells are corrected upon introduction of a 
full-length Cfp1 expression vector (amino acids 1-656), indicating that the CXXC1-/- ES 
cell phenotype is specifically due to the absence of Cfp1 (Carlone 2005).  The ability of 
wild-type Cfp1 to rescue the defects observed in CXXC1-/- ES cells provides a 
convenient method to assess structure-function relationships of Cfp1.  In order to 
analyze structure-function relationships of Cfp1, various cDNA constructs encoding 
FLAG-epitope tagged Cfp1 fragments and mutations (Fig. 6) were stably expressed in 
CXXC1-/- ES cells and then analyzed for rescue activity.  The parental expression vector 
that does not contain any Cfp1 sequence was electroporated into CXXC1-/- ES cells as a 
vector control (vector).  Stably transfected clones were isolated and expanded, and 
clones were screened for FLAG-Cfp1 protein expression by Western blot analysis (Fig. 
7).  The expression level of full-length Cfp1 protein (amino acids 1-656) was compared 
to the expression level of Cfp1 in CXXC1+/+ ES cells using a Cfp1 antibody.  For each 
stably transfected clone, the protein expression level of Cfp1 was determined and 
compared to full-length FLAG-Cfp1 protein by Western blot analysis using an anti-
FLAG antibody.  This allowed the expression level of the Cfp1 fragments and 
mutations to be compared to that of the CXXC1+/+ ES cells because the Cfp1 antibody 
does not recognize all of the Cfp1 mutations.   
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FIGURE 6.  Cfp1 fragments and mutations. 
A schematic representation of full-length Cfp1, including the amino acid 
position of each domain indicated below the schematic, and Cfp1 fragments and 
mutations that were stably expressed in CXXC1-/- ES cells.  The filled circle at the N-
terminus of Cfp1 represents the FLAG epitope, while NLS represents a nuclear 
localization signal derived from the amino-terminal bipartite nuclear localization signal 
of Cfp1 (amino acids 109-121) (Lee 2002).  The “X” indicates the approximate location 
of the amino acid point mutations of conserved amino acids within the PHD1, CXXC, 
SID, and PHD2 domains.  The residues included in each contruct and the point 
mutations at the indicated residue are listed to the right of each Cfp1 schematic.    
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FIGURE 7.  Protein expression of Cfp1 fragments and mutations.  
Western blot analysis of clones was performed to determine the protein 
expression level of FLAG-Cfp1 mutations compared to the expression level of Cfp1 in 
CXXC1+/+ ES cells.  Whole cell protein extracts were analyzed using antiserum raised 
against Cfp1 or FLAG, and β-actin was used as a loading control.  The corresponding 
graph to the right represents the relative Cfp1 protein expression for three independent 
experiments, with error bars representing standard error.  Experiments were carried out 
using 2-3 independent stably expressing clones and data for representative clones are 
shown.       
 88 
Expression of the FLAG-Cfp1 polypeptides before, during, and after each 
experiment was analyzed because the transgene has been shown to turn off in some 
clones when higher passage numbers are analyzed (data not shown).  Also, when grown 
in normal ES culture medium without hygromycin, one transgene has been shown to 
turn off within 5 days (data not shown).  Therefore, the stably transfected clones were 
grown in the presence of 50 µg/µl of hygromycin for all experiments.  Each experiment 
was conducted with CXXC1+/+ and CXXC1-/- ES cells along with clones expressing 
vector or full-length Cfp1 (1-656) as controls.  In addition, experiments were conducted 
when clones were of similar passage number (passage number takes into account every 
time the cells are frozen or thawed, and every time the cells are trypsinized in order to 
be split; passage numbers were ~10-25 for all experiments).     
Targeted depletion of Cfp1 in zebrafish results in decreased global cytosine 
methylation, anemia, and incomplete vascular development (Young 2006).  In addition, 
targeted depletion (~70%) of Cfp1 expression by RNA interference in a human 
myelomonoblastic PLB-985 cell line results in impaired myeloid cell differentiation 
(Young 2007).  CXXC1+/- ES cells express ~50% of Cfp1 protein compared to 
CXXC1+/+ ES cells and do not demonstrate a phenotype (Carlone 2005).  Therefore, it 
appears that there is a critical threshold amount of Cfp1 that is needed for proper Cfp1 
function.  Consequently, ES clones were selected for analysis that expressed at least 
50% of the level of Cfp1 observed in CXXC1+/+ ES cells.  If protein expression of the 
Cfp1 mutations is less than 50% of CXXC1+/+ ES cell levels, a negative result for rescue 
can be misinterpreted due to the fact that there may not be enough Cfp1 protein present 
to be biologically relevant.  Cfp1 361-597 is an exception.  The highest expressing 
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clone analyzed exhibited ~32% of the protein expression level of Cfp1 in CXXC1+/+ ES 
cells but retains rescue activity (see below).  Therefore, the low (<50% of Cfp1 in 
CXXC1+/+ ES cells) protein expression of Cfp1 361-597 does not affect its rescue 
function. 
  Two or three independent clones were analyzed for each construct due to the 
fact that the transgene may have inserted into a region of the genome that alters cell 
function, and representative data are shown.  Clones were selected for analysis that had 
the highest Cfp1 protein expression of all clones screened for each particular Cfp1 
mutation.  If two independent clones rescued or failed to rescue any phenotype, it was 
concluded that the phenotype is due to the presence or absence of certain Cfp1 
functions.  A summary of the rescue activity for each clone analyzed is presented in 
Table 8 and Table 9.  There are some discrepancies between clones for some Cfp1 
mutations.  However, the trend is that clones that express higher protein levels of the 
Cfp1 proteins have positive rescue activity compared to clones that express lower Cfp1 
protein levels of the same Cfp1 mutations.  Ths reinforces the concept that there is an 
important threshold level of Cfp1 protein which is necessary for proper Cfp1 function.   
 
2.  Mutations that abolish DNA-binding activity or Setd1 association of 
Cfp1 
To further define the functional domains required for Cfp1-mediated rescue 
activity, point mutations that abolish DNA-binding activity of Cfp1 or interaction of 
Cfp1 with the Setd1 histone H3K4 methyltransferase complexes were analyzed.  Protein 
alignment between species reveals conservation of the CXXC and SID domains of 
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FIGURE 8.  Mutations in the CXXC and SID domains of Cfp1 that abolish DNA-
binding activity of Cfp1 or interaction of Cfp1 with the Setd1 complexes. 
(A)  A multi-species alignment of the CXXC domain of Cfp1 is shown.  
Asterisks mark identical amino acid residues conserved between species, while (:) 
indicates a conserved amino acid substitution, and (.) indicates a semi-conserved amino 
acid substitution.  Amino acids chosen for site-directed mutagenesis are indicated with 
an arrow.  EMSA was performed by Dr. Kui Shin Voo (Lee 2001) using a CpG-
oligonucleotide probe containing a non-methylated CpG motif with wild-type or 
mutated Cfp1 expressed as 6XHis-tagged fusion proteins.  The bottom panel represents 
Western blot analysis using anti-6XHis antibody, demonstrating the expression and 
recovery of each recombinant protein.    
(B)  A multi-species alignment of the SID domain of Cfp1 is shown.  Asterisks 
mark identical amino acid residues conserved between species, while (:) indicates a 
conserved amino acid substitution, and (.) indicates a semi-conserved amino acid 
substitution.  Amino acids chosen for site-directed mutagenesis are indicated with an 
arrow.  Point mutations of conserved amino acids within the SID domain were made; 
C375A is a cysteine to alanine point mutation, and YCS(389-391)AAA is a triple 
mutation where tyrosine, cysteine, and serine have been mutated to alanines by site-
directed mutagenesis.  FLAG immunoprecipitation was carried out by Dr. Jeong-Heon 
Lee using wild-type or the indicated Cfp1 mutations (Butler 2008).  Western blot 
analysis was performed to determine interaction of Cfp1 with Setd1A, Setd1B, and the 
other protein components of the Setd1 complexes using antisera directed against 
Setd1A, Setd1B, Ash2, Rbbp5, Wdr5, Wdr82, and Cfp1. 
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Cfp1 (Fig. 8).  Arrows indicate conserved amino acids that were mutated by site-
directed mutagenesis (Fig. 8).  Mutations C169A and C208A are cysteine to alanine 
point mutations that have previously been shown to abolish DNA-binding activity of 
Cfp1 (Lee 2001).  EMSA was performed by Dr. Kui Shin Voo using a CpG-
oligonucleotide probe containing a non-methylated CpG motif with wild-type or 
mutated Cfp1 containing amino acids 142-260 expressed as 6XHis-tagged fusion 
proteins.  The top panel indicates that Cfp1 mutations C169A or C208A abolish Cfp1 
DNA-binding activity.  The bottom panel represents Western blot analysis using anti-
6XHis antibody, demonstrating the expression and recovery of each recombinant 
protein (Fig. 8).   
Mutation of conserved amino acids were made by Dr. Jeong-Heon Lee within 
the SID domain, C375A and YCS389AAA, and have previously been shown to ablate 
Cfp1 interaction with the Setd1A and Setd1B histone H3K4 methyltransferases 
complexes (Butler 2008).  FLAG immunoprecipitation was carried out by Dr. Jeong-
Heon Lee using wild-type Cfp1 (1-656) or the indicated Cfp1 mutations.  Western blot 
analysis was performed to determine interaction of Cfp1 with Setd1A, Setd1B, and the 
other protein components of the Setd1 complexes (Fig. 8).  These results indicate that 
Cfp1 mutations C375A or YCS389AAA abolish Cfp1 interaction with the Setd1A and 
Setd1B proteins, along with the other protein components of the Setd1 complexes, 
including Ash2, Rbbp5, Wdr5, and Wdr82 (Lee 2005; Lee 2007).  
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3.  Additional Cfp1 mutations within the PHD domains 
PHD domains are structured around two zinc ions coordinated by cysteine and 
histidine residues, and several PHD proteins are involved in chromatin-mediated 
transcriptional regulation (Ragvin 2004).  Recent studies have shown that PHD domains 
are binding modules for unmodified and methylated H3K4 and methylated H3K36 
(Martin 2001; Ruthenberg 2007; Li 2006; Pena 2006; Shi 2006; Shi 2007).  For 
example, the PHD1 domain of Spp1, the yeast homologue of Cfp1, binds methylated 
histone H3K4 (Shi 2007).  However, it remains to be determined whether the PHD 
domains of mammalian Cfp1 also bind to modified H3K4, and whether they function in 
transcriptional regulation.   
Point mutations of conserved cysteine residues within the PHD1 (C29A and 
C73A) and PHD2 (C586A) domains were made by site-directed mutagenesis.  
Previously, a mutation within the PHD2 domain (C580A) was shown to abolish Cfp1 
interaction with the Setd1A complex (Butler 2008).  To examine whether the C586A 
mutation within the PHD2 domain of Cfp1 affects the interaction of Cfp1 with Setd1A, 
CXXC1-/- ES cells stably expressing FLAG-Cfp1 (1-656, 1-656 C580A, and 1-656 
C586A) were immunoprecipitated from nuclear extracts using anti-FLAG-M2 
conjugated agarose.  However, despite multiple attempts, the efficiency of the FLAG 
immunoprecipitation was always low and the detection of Setd1A with full-length Cfp1 
(1-656) was barely detectable (data not shown).  Therefore, it is unclear whether the 
Cfp1 C586A mutation ablates Cfp1 interaction with Setd1A.  Consequently, the 
functional significance of the PHD mutations within Cfp1 (C29A, C73A, and C586A) 
remain elusive.    
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4.  DNA-binding activity of Cfp1 is not required for interaction with Dnmt1   
Cfp1 physically interacts with Dnmt1, the major maintenance DNA cytosine 
methyltransferase (Butler 2008).  The minimum regions of Cfp1 sufficient to interact 
with Dnmt1 include amino acids 1-123, 103-367, and 361-656 (Butler 2008).  Previous 
data revealed that the C375A mutation that abolishes Cfp1 interaction with the Setd1 
histone H3K4 methyltransferase complexes does not ablate Cfp1 interaction with 
Dnmt1 (Butler 2008).  Therefore, Cfp1 interacts with Dnmt1 independently of its 
association with the Setd1 complexes (Butler 2008).  To examine whether the C169A 
mutation that abolishes DNA-binding activity of Cfp1 (Lee 2001) affects the interaction 
of Cfp1 with Dnmt1, full-length FLAG-Dnmt1 and Myc-Cfp1 (103-367 and 103-367 
C169A) were transiently expressed in HEK-293 cells, and FLAG-Dnmt1 was 
immunoprecipitated from nuclear extracts using anti-FLAG M2 conjugated agarose.  
The immunoprecipitated extracts were subjected to Western blot analysis using 
antiserum against the Myc and FLAG epitopes.  Empty vectors were cotransfected to 
serve as a negative control for FLAG immunoprecipitation.  These results indicate that 
both Cfp1 103-367 and Cfp1 103-367 C169A interact with full-length Dnmt1 (Fig. 9).  
Therefore, disruption of Cfp1 DNA-binding activity (C169A) does not ablate Cfp1 103-
367 interaction with Dnmt1.   
 
5.  Mutated forms of Cfp1 are associated with the nuclear matrix   
It was reported that endogenous Cfp1 in HEK-293 and NIH-3T3 (mouse 
embryonic fibroblasts) cells is associated with the nuclear matrix and exhibits a 
speckled nuclear distribution (Lee 2001).  In addition, nuclear matrix association was 
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FIGURE 9.  Ablation of Cfp1 DNA-binding activity does not affect Cfp1 
interaction with Dnmt1.   
Nuclear extracts were prepared from HEK-293 cells transiently expressing Myc-
hCfp1 (103-367 or 103-367 C169A) and FLAG-hDnmt1 (full length), as indicated 
above the lanes, and subjected to FLAG immunoprecipitation.  Western blot analysis 
with Myc antiserum was used to detect Myc-hCfp1 (103-367 and 103-367 C169A).  
The membrane was re-probed with FLAG antiserum to verify FLAG-hDnmt1 protein 
expression and Myc immunoprecipitation efficiency.  Transfection and 
immunoprecipitation of the empty vectors served as a negative control for the FLAG 
immunoprecipitation.   
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FIGURE 10.  Cfp1 is associated with the nuclear matrix.   
Biochemical fractionation was carried out to determine subcellular localization of 
Cfp1 in HEK-293 and CXXC1+/+ ES cells.  Sequential nuclear extraction into soluble, 
chromatin-associated, and nuclear matrix-associated fractions was carried out on total 
cell lysates (NaCl represents a salt wash, Nuc. Mat. represents the nuclear matrix 
fraction).  Equivalent proportions of each fraction were subjected to Western blot 
analysis using antiserum directed against the FLAG-epitope.  Blots were also probed 
with antisera directed against histone H3 and NuMA (nuclear mitotic apparatus protein) 
to verify fractionation of the chromatin-associated and nuclear matrix-associated 
fractions, respectively.   
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TABLE 4.  Summary of Cfp1 subcellular localization data.   
The table presents a summary of biochemical fractionation data derived from 
CXXC1-/- ES cells expressing indicated Cfp1 mutations.  The presence of Cfp1 in the 
indicated fraction is indicated by (+), with relative amounts of Cfp1 indicated between 
one and three (+) present.  Absence of Cfp1 is indicated with (-), and NA represents not 
applicable.   
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shown to be important for Cfp1 transcriptional transactivation activity (Lee 2001).  
Sequential nuclear extraction into soluble, chromatin-associated, and nuclear matrix 
fractions was carried out on total cell lysates isolated from HEK-293 and CXXC1+/+ ES 
cells.  Equivalent proportions of each fraction were subjected to Western blot analysis 
using antiserum directed against the FLAG-epitope.  Blots were probed with antiserum 
against histone H3 and NuMA (nuclear mitotic apparatus protein) to verify fractionation 
of the chromatin-associated and nuclear matrix fractions, respectively.  Consistent with 
previous data, biochemical fractionation of HEK-293 and CXXC1+/+ ES cells 
demonstrated that Cfp1 is partially associated with the soluble fraction, and the majority 
of Cfp1 is associated with the nuclear matrix (Fig. 10).  The controls used for 
fractionation indicate enrichment of histone H3 in the chromatin-associated fraction, 
and enrichment of NuMA in the nuclear matrix fraction.  Similarly, subcellular 
localization of the mutated forms of Cfp1 expressed in CXXC1-/- ES cells was 
determined by biochemical fractionation followed by Western blot analysis (data not 
shown), and summary of the data is presented in Table 4.  For all Cfp1 mutations 
analyzed, at least partial nuclear matrix association was observed.    
 
6.  Summary  
The data presented in this portion of the dissertation introduces the various Cfp1 
fragments and mutations analyzed for the structure-function studies.  Point mutations 
C169A and C208A within the CXXC domain abolish DNA-binding activity of Cfp1.  
Mutations C375A and YCS389AAA within the SID domain abolish Cfp1 interaction 
with the Setd1A and Setd1B histone H3K4 methyltransferase complexes.  Additional 
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mutations of conserved cysteines within the PHD1 and PHD2 domains were made 
(C29A, C73A, and C586A) but the functional significance of these mutations remains 
unknown.  In addition, Cfp1 that lacks DNA-binding activity (103-367 C169A) or 
interaction with the Setd1 complexes (361-656 C375A) still retains interaction with 
Dnmt1.  Biochemical fractionation revealed that Cfp1 is associated with the nuclear 
matrix in HEK-293 and CXXC1+/+ ES cells.  In addition, Cfp1 mutations that were 
experimentally analyzed are at least partially associated with the nuclear matrix.    
  
II.  Analysis of Cfp1 functional properties required to rescue cell population 
doubling time and plating efficiency 
1. Analysis of population doubling time in CXXC1-/- ES cells expressing  
Cfp1 mutations  
Previous studies indicate that CXXC1-/- ES cells exhibit decreased cell growth 
(Carlone 2005).  In order to determine the functional properties of Cfp1 required to 
rescue the decreased cell growth, cell growth curves for CXXC1-/- ES cells expressing 
Cfp1 mutations were analyzed.  Cells were plated on day 0 and counted in triplicate 
daily for 4 days.  Cell population doubling time was calculated using cell counts on day 
3 and day 4 when ES cells were in exponential growth.  Consistent with previous 
studies, CXXC1+/+ ES cells exhibit a population doubling time of ~11 hours, whereas 
CXXC1-/- ES cells exhibit a 2-fold increase in population doubling time (~22 hours) 
(Fig. 11B).  A significant decrease in cell growth (as measured by doubling time) was 
observed in vector ES cells (~23 hours).  In contrast, cell growth was rescued upon 
expression of full-length Cfp1 1-656 (doubling time ~10 hours) (Fig. 11B).   
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Cell growth curves were performed for CXXC1-/- ES cells expressing Cfp1 
mutations (data not shown).  The population doubling time for the various Cfp1 
mutations indicates that full-length Cfp1 mutations that contain single amino acid point 
mutations rescue ES cell growth (1-656 C29A, 1-656 C73A, 1-656 C169A, 1-656 
C208A, 1-656 C375A, 1-656 C586A), along with 1-656 YCS389AAA.  In addition,   
N-terminal truncations of Cfp1 (302-656 and 361-656) rescued population doubling 
time.  In contrast, full-length Cfp1 with double point mutations (1-656 C169A, C375A 
and 1-656C169A,YCS389AAA), C-terminal truncations of Cfp1 (1-481, 1-367, 1-367 
C169A, and 1-320), or C- and N-terminal truncations (103-481, 103-367, 318-481,  
318-412, and 361-481) failed to rescue doubling time (Fig. 11B).  Therefore, Cfp1 361-
597 (containing the SID, coiled-coil, and PHD2 domains) contains the minimum protein 
domains of Cfp1 required to rescue the population doubling time.  However, removal of 
the PHD2 domain (Cfp1 361-481) from C-terminal Cfp1 results in loss of rescue 
activity.  In addition, ablation of Setd1 association of Cfp1 361-656 (361-656 C375A) 
results in loss of rescue activity, indicating the importance of the SID and PHD2 
domains within the C-terminal half of Cfp1 for ES cell growth. 
 
2.  CXXC1-/- ES cells exhibit normal cell cycle distribution 
CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing Cfp1 1-656 or vector 
control were examined for cell cycle distribution using propidium iodide (PI) staining 
followed by flow cytometric analysis.  Consistent with previously published results 
(Carlone 2005), there was no significant difference in cell cycle distribution in any cell 
line examined (Fig. 12).  This indicates that Cfp1 is not required for appropriate ES cell 
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FIGURE 11.  Population doubling time of CXXC1-/- ES cells expressing Cfp1 
mutations. 
Cell growth rates were measured by growth curves for CXXC1+/+, CXXC1-/-, and 
CXXC1-/- ES cells expressing Cfp1 1-656 or the indicated Cfp1 mutations for 4 days.  
The growth curve for CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing Cfp1      
1-656 and vector control is shown (A).  Cells were plated in triplicate for each 
experiment, and the graph summarizes the average of three independent experiments.  
Population doubling time was calculated for average cell counts between days 3 and 4 
during the growth curve analysis.  The table represents the average doubling times and 
standard errors for the indicated cell lines for three independent experiments.  Asterisks 
denote a statistically significant (p<0.05) difference compared to CXXC1-/- ES cells 
expressing Cfp1 1-656.  
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FIGURE 12.  CXXC1-/- ES cells exhibit normal cell cycle distribution. 
CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing Cfp1 1-656 or the vector 
control were collected in log phase growth and analyzed for cell cycle distribution using 
propidium iodide staining.  The bar graph represents an average of three independent 
experiments with error bars representing standard error.   
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cycle distribution.  Consequently, additional CXXC1-/- ES cell clones expressing Cfp1 
mutations were not analyzed for cell cycle distribution. 
 
3.  Apoptosis analysis in CXXC1-/- ES cells expressing Cfp1 mutations 
CXXC1-/- ES cells exhibit an increased population doubling time and normal cell 
cycle distribution.  Therefore, the slower growth of the CXXC1-/- ES cells may be due to 
an increase in doubling time in cells undergoing apoptosis.  Previous data using 
Annexin V and PI staining revealed that ~11% of CXXC1+/+ ES cells are dead or 
undergoing apoptosis and ~33% of CXXC1-/- ES cells are dead or undergoing apoptosis.  
In addition, levels of apoptosis can be rescued upon expression of full-length Cfp1 in 
CXXC1-/- ES cells (Carlone 2005).  Apoptosis is a form of programmed cell death and 
involves a series of biochemical events that lead to a variety of morphological changes, 
including blebbing, changes to the cell membrane such as loss of membrane asymmetry 
and attachment, cell shrinkage, nuclear fragmentation, chromatin condensation, and 
chromosomal DNA fragmentation (Kerr 1972).  Cleavage of genomic DNA during 
apoptosis can be identified by labeling free 3’-OH termini with modified nucleotides in 
an enzymatic reaction.  TUNEL (terminal deoxynucleotidyl transferase dUTP nick end 
labeling) was performed as a flow cytometric assay to measure the amount of 
fluorescein labeled nucleotides incorporated onto free 3’-OH ends using the enzyme 
terminal deoxynucleotidyl transferase in order to determine relative amounts of 
apoptosis in CXXC1-/- ES cells expressing Cfp1 mutations (Fig. 13A).  TUNEL analysis 
revealed levels of apoptosis similar to that of CXXC1+/+ ES cells in CXXC1-/- ES cells 
expressing Cfp1 mutations that rescued population doubling time (1-656 C29A,  
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FIGURE 13.  Apoptosis analysis in CXXC1-/- ES cells expressing Cfp1 mutations. 
CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing the vector control, Cfp1 
1-656, or the indicated Cfp1 truncations and mutations were collected in log phase 
growth and analyzed for apoptosis using TUNEL assay (A).  CXXC1+/+ ES cells 
incubated with the fluorescein nucleotide label without enzyme were used as a control 
for background staining (label only).  The numbers represent the percent of cells 
positive for TUNEL staining (upper right and lower right quadrants).  The graphs 
summarize an average of three independent experiments with error bars representing 
standard error (B).  Asterisks denote a statistically significant (p<0.05) difference 
compared to CXXC1-/- ES cells expressing Cfp1 1-656.   
B 
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1-656 C73A, 1-656 C169A, 1-656 C208A, 1-656 C375A, 1-656 C586A, 1-656 
YCS389AAA, 302-656 and 361-656) (Fig. 13B).  In contrast, a significant increase in 
apoptosis was observed in CXXC1-/- ES cells expressing Cfp1 mutations that exhibit a 
lengthened population doubling time (1-656 C169A, C375A, 1-656 C169A, 
YCS389AAA, 1-481, 1-367, 1-367 C169A, 1-320, 103-481, 103-367, 318-481,       
318-412, 361-656 C375A, and 361-481) (Fig. 13B).  Consistent with population 
doubling time rescue ability, Cfp1 361-597 (containing the SID, coiled-coil, and PHD2 
domains) contains the minimum protein domains of Cfp1 identified to rescue apoptosis.  
However, removal of the PHD2 domain (Cfp1 361-481) from C-terminal Cfp1 results 
in loss of apoptosis rescue activity.  Ablation of Setd1 association of Cfp1 361-656 
(361-656 C375A) also results in loss of rescue activity, indicating the importance of the 
PHD2 and SID domains within the C-terminal half of Cfp1 for inhibition of apoptosis in 
ES cells.  This data reveals that CXXC1-/- ES cells expressing Cfp1 mutations that 
exhibit a lengthened population doubling time also exhibit increased apoptosis.    
 
4. Plating efficiency of CXXC1-/- ES cells expressing Cfp1 mutations 
Plating efficiency, or colony forming ability, is the percentage of seeded cells 
that give rise to cell colonies, and provides a method to analyze cell survival and cell 
adherence.  Plating efficiency is approximately 38% for CXXC1+/+ ES cells and is 
significantly decreased (~14%) in CXXC1-/- ES cells (Fig. 14).  These results indicate 
that fewer ES cells survive and form a colony in the absence of Cfp1.  CXXC1-/- ES 
cells expressing Cfp1 1-481 (containing the PHD1, CXXC, acidic, basic, and coiled-
coil domains) and Cfp1 302-656 (containing the basic, SID, coiled-coil, and PHD2  
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FIGURE 14.  Plating efficiency in CXXC1-/- ES cells expressing Cfp1 mutations.  
The graphs represent plating efficiency in CXXC1+/+, CXXC1-/-, and CXXC1-/- 
ES cells expressing vector control, full-length Cfp1 (1-656), or the indicated Cfp1 
fragments and mutations.  Plating efficiency was determined by counting the number of 
colonies formed after plating 400 cells.  The graphs summarize results from at least 
three independent experiments, performed in triplicate, with error bars representing 
standard error.  Asterisks denote a statistically significant (p<0.05) difference compared 
to CXXC1-/- ES cells expressing full-length Cfp1 (1-656).   
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domains) demonstrate appropriate plating efficiency (Fig. 14).  Surprisingly, expression 
of either the amino half of Cfp1 (1-367; containing the PHD1, CXXC, acidic, and basic 
domains) or the carboxyl half of Cfp1 (361-656; containing the coiled-coil, SID, and 
PHD2 domain) is sufficient to rescue the plating efficiency defect observed in CXXC1-/- 
ES cells.  However, removal of the basic domain (Cfp1 1-320), PHD1 domain (Cfp1 
103-481 and 103-367), or PHD2 domain (Cfp1 318-412, 318-481, and 361-481) results 
in a significant decrease in plating efficiency, indicating an important role for the basic 
domain and PHD1 domain in CXXC1-/- ES cells expressing N-terminal Cfp1 fragments, 
and PHD2 domain in  CXXC1-/- ES cells expressing C-terminal Cfp1 fragments.   
Ablation of DNA-binding activity of the amino half of Cfp1 (1-367 C169A), or 
disruption of the Setd1 histone H3K4 methyltransferase complex interaction with the 
carboxyl half of Cfp1 (361-656 C375A), results in loss of plating efficiency rescue 
activity (Fig. 14).  This indicates that DNA-binding activity of Cfp1 1-367, or 
interaction of Cfp1 361-656 with the Setd1 histone H3K4 methyltransferase complexes 
is essential for appropriate ES cell plating efficiency.  In addition, CXXC1-/- ES cells 
expressing full-length Cfp1 containing single amino acid point mutations rescue plating 
efficiency (1-656 C29A, 1-656 C73A, 1-656 C169A, 1-656 C208A, 1-656 C375A, and 
1-656 C586A), along with 1-656 YCS389AAA.  However, introduction of point 
mutations to abolish both DNA-binding activity of Cfp1 and interaction of Cfp1 with 
the Setd1 complexes (1-656 C169A, C375A or 1-656 C169A, YCS389AAA) results in 
loss of plating efficiency rescue activity.  This indicates that retention of either DNA-
binding activity of Cfp1 or interaction of Cfp1 with the Setd1 histone H3K4 
methyltransferase complexes is required to rescue ES cell plating efficiency.     
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5. Summary  
The data presented in this portion of the dissertation reveals that CXXC1-/- ES 
cells exhibit slower growth due to an increase in apoptosis, but exhibit a normal cell 
cycle distribution.  CXXC1-/- ES cells expressing Cfp1 mutations were analyzed for 
population doubling time, apoptosis, and plating efficiency.  CXXC1-/- ES cells 
expressing Cfp1 mutations that exhibit an increased population doubling time also 
exhibit an increase in apoptosis.  Interestingly, Cfp1 N-terminal truncations (361-597 
and 361-656; containing the SID, coiled-coil, and PHD2 domains) are sufficient to 
rescue population doubling time and apoptosis.  However, ablation of Cfp1 361-656 
interaction with the Setd1 complexes results in loss of population doubling time and 
apoptosis rescue activity.  The majority of CXXC1-/- ES cells expressing Cfp1 mutations 
that exhibit increased population doubling time also exhibit decreased plating efficiency 
except for C-terminal truncations (1-481 and 1-367), which rescue plating efficiency 
despite having increased population doubling times.  Interestingly, these data reveal that 
either half of Cfp1 is sufficient to rescue ES cell plating efficiency (Cfp1 1-367, 
containing the PHD1, CXXC, acidic, and basic domains; and Cfp1 361-656, containing 
the SID, coiled-coil and PHD2 domains).  A summary of the population doubling time, 
apoptosis, and plating efficiency rescue activity of CXXC1-/- ES cells expressing Cfp1 
mutations is presented in Table 5.   
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TABLE 5.  Summary of population doubling time, apoptosis, and plating efficiency 
rescue activity. 
The table presents a summary of rescue data for CXXC1-/- ES cells expressing 
the indicated Cfp1 mutations.  The ability to rescue the indicated defect is indicated 
with (+), and an inability to rescue (significant [p<0.05] difference compared to Cfp1 1-
656) is indicated with (-).   
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III.  Analysis of Cfp1 Functional Domains Required to Rescue Cytosine 
Methylation and in vitro Differentiation    
1.  DNA-binding activity of Cfp1 is not essential for appropriate global 
cytosine methylation 
ES cells demonstrate a 60-80% decrease in global cytosine methylation in the 
absence of Cfp1 (Carlone 2005).  The CXXC domain is a cysteine-rich domain that 
functions as the sole DNA-binding domain of Cfp1 (Lee 2001).  Cfp1 binds specifically 
to unmethylated CpG motifs and localizes to euchromatin (Lee 2001; Lee 2002).          
S. cerevisiae, S. pombe, and C. elegans lack cytosine methylation, and their respective 
Cfp1 homologues lack the CXXC domain.  Therefore, the CXXC domain is expected to 
play a crucial role in the regulation of cytosine methylation.  Consequently, experiments 
were performed to determine if DNA-binding activity of Cfp1 plays an essential role in 
the regulation of cytosine methylation.  Global cytosine methylation was analyzed using 
a DNA methyl acceptance assay.  This assay utilizes an in vitro methylation reaction to 
quantify transfer of radiolabled methyl groups from S-Adenosyl-L-Methionine onto 
genomic DNA sites that are not methylated (Fowler 1998).  Therefore, the amount of 
radiolabeled methyl groups that are incorporated into a DNA sample is inversely related 
to the native DNA methylation status.   
Consistent with previous data, DNA derived from CXXC1-/- or vector ES cells 
accepts approximately 3.5-fold more methyl groups than DNA derived from CXXC1+/+ 
ES cells, indicating a ~70% decrease in global cytosine methylation in cells lacking 
Cfp1 (Carlone 2005; Fig. 15).  The reduced cytosine methylation observed in CXXC1-/-  
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FIGURE 15. Cfp1 has redundancy of function for rescue of global cytosine 
methylation. 
Global cytosine methylation levels were determined by methyl acceptance assay 
for genomic DNA isolated from CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing 
vector control, full-length Cfp1 (1-656), or the indicated Cfp1 truncations.  The graph 
represents the results from three independent experiments with error bars representing 
standard error.  Asterisks denote a statistically significant (p<0.05) difference compared 
to CXXC1-/- ES cells expressing full-length Cfp1 (1-656).  
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ES cells is rescued by expression of full-length Cfp1 protein (1-656) (Fig. 15).  
Consistent with plating efficiency, expression of Cfp1 1-481 in CXXC1-/- ES cells 
(containing the PHD1, CXXC, acidic, basic, and coiled-coil domains), and Cfp1 302-
656 (containing the basic, coiled-coil, SID, and PHD2 domains) rescue global cytosine 
methylation (Fig. 15, Fig. 17).  In addition, expression of either the amino half of Cfp1 
(1-367; containing the PHD1, CXXC, acidic, and basic domains) or the carboxyl half of 
Cfp1 (361-597 and 361-656; containing the coiled-coil, SID, and PHD2 domains) is 
sufficient to rescue global cytosine methylation (Fig. 15, Fig. 16).  Therefore, Cfp1 
DNA-binding activity is not essential to maintain appropriate cytosine methylation 
levels, because Cfp1 361-597 and 361-656 rescue global cytosine methylation despite 
lacking the CXXC DNA-binding domain.  In contrast, the basic domain is indispensable 
for Cfp1 1-367 rescue activity because removal of the basic domain (Cfp1 1-320) 
results in failure to rescue global cytosine methylation (Fig. 15).   
In contrast to their inability to rescue plating efficiency, CXXC1-/- ES cells 
expressing Cfp1 103-481 (containing the CXXC, acidic, basic, and coiled-coil 
domains), or Cfp1 103-367 (containing the CXXC, acidic, and basic domains) rescue 
global cytosine methylation, indicating that the PHD1 domain is not essential for 
appropriate global cytosine methylation (Fig. 15, Fig. 17).  In contrast, CXXC1-/- ES 
cells expressing Cfp1 318-481 (containing the basic, SID, and coiled-coil domains), 
Cfp1 318-412 (containing the basic and SID domains), or Cfp1 361-481 (containing the 
SID and coiled-coil domains) demonstrate decreased cytosine methylation, indicating 
that the PHD2 domain is required for cytosine methylation rescue activity of the C-
terminal half of Cfp1 (Fig. 15, Fig. 17).  
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FIGURE 16.  DNA-binding activity of Cfp1 or interaction with the Setd1 histone 
methyltransferase complexes is required for appropriate cytosine methylation. 
Global cytosine methylation levels were determined by methyl acceptance assay 
for genomic DNA isolated from CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing 
vector control, full-length Cfp1 (1-656), or the indicated Cfp1 mutations.  The graphs 
represent three independent experiments with error bars representing standard error.  
Asterisks denote a statistically significant (p<0.05) difference compared to full-length 
Cfp1 (1-656).   
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Consistent with plating efficiency, DNA isolated from CXXC1-/- ES cells 
expressing full-length Cfp1 that lacks DNA-binding activity (1-656 C169A or 1-656 
C208A), or full-length Cfp1 that lacks interaction with the Setd1 histone H3K4 
methyltransferase complexes (1-656 C375A or 1-656 YCS389AAA), rescue global 
cytosine methylation (Fig. 16, Fig. 17).  However, ablation of DNA-binding activity of 
Cfp1 1-367 (1-367 C169A), or disruption of Cfp1 361-656 interaction with the Setd1 
histone H3K4 methyltransferase complexes (361-656 C375A) results in failure to 
rescue global cytosine methylation (Fig. 16).  In addition, failure to rescue global 
cytosine methylation was observed in DNA isolated from CXXC1-/- ES cells expressing 
full-length Cfp1 containing both point mutations (1-656 C169A, C375A or 1-656 
C169A, YCS389AAA).  Consistent with plating efficiency, this indicates that retention 
of either DNA-binding activity of Cfp1 or interaction of Cfp1 with the Setd1 H3K4 
histone methyltransferase complexes is required for appropriate global cytosine 
methylation.  
 
2.  Increased apoptosis in CXXC1-/- ES cells is not responsible for the 
observed decrease in global cytosine methylation 
In order to determine if the increased apoptosis observed in CXXC1-/- ES was 
responsible for the decreased global cytosine methylation observed in CXXC1-/- ES 
cells, CXXC1+/+ and CXXC1-/- ES cells were sorted by flow cytometry based on 
Annexin V and PI staining.  Fractions of healthy cells were collected (Annexin V 
negative, PI negative), and fractions of dead cells or cells undergoing apoptosis were 
collected (Annexin V positive, PI negative and Annexin V positive, PI positive)        
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FIGURE 17.  Healthy CXXC1-/- ES cells exhibit decreased global cytosine 
methylation.    
CXXC1+/+ and CXXC1-/- ES cells were sorted based on healthy (Annexin V 
negative, propidium iodide [PI] negative) and apoptotic/dead cells (Annexin V positive, 
PI negative and Annexin V positive, PI positive) as demonstrated by schematic (A).  
Immediately after sorting, genomic DNA was isolated from the indicated groups and 
analyzed for global cytosine methylation using methyl acceptance assay (B).  The graph 
summarizes the results from three independent experiments with error bars representing 
standard error.  Asterisks denote a statistically significant (p<0.05) difference compared 
to healthy CXXC1+/+ ES cells.  
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(Fig. 18A).  Controls used for setting boundaries for collected fractions were CXXC1+/+ 
ES cells unstained, stained with PI only, or stained with Annexin V only.  After sorting, 
genomic DNA was isolated, and global cytosine methylation was analyzed by methyl 
acceptance assay as described previously.  Healthy (non-apoptotic) CXXC1-/- ES cell 
DNA accepts ~2-fold more methyl groups than healthy CXXC1+/+ ES cell DNA, 
indicating a ~50% decrease in global cytosine methylation.  Apoptotic or dead    
CXXC1-/- ES cell DNA exhibits ~63% (~2.7-fold increase in methyl groups) decrease in 
global cytosine methylation.  Importantly, collection of exponentially growing healthy 
and apoptotic CXXC1-/- ES cell DNA exhibits ~50% decrease in global cytosine 
methylation (Fig. 17).  Consequently, the increased apoptosis observed in CXXC1-/- ES 
cells cannot account for the observed decrease in global cytosine methylation.   
 
3.  Decreased cytosine methylation at IAP repetitive elements in CXXC1-/- 
ES expressing Cfp1 mutations that exhibit decreased global cytosine methylation   
CXXC1-/- ES cells demonstrate decreased site-specific cytosine methylation at 
repetitive genomic elements (intracisternal A particle retroviral repeats [IAP] and minor 
satellite repetitive elements), imprinted genes (H19, Igf2r), and single copy genes (Rac2 
and Pgk-2) (Carlone 2005).  Southern blot analysis was used to analyze cytosine 
methylation at IAP retroviral repeats in CXXC1-/- ES cells expressing Cfp1 mutations 
(Fig. 18, Fig. 19, Fig. 20).  IAP repeats are endogenous retroviral sequences present in 
multiple copies in the mouse genome and normally demonstrate a high level of cytosine 
methylation (Puech 1996).  The cytosine methylation status of IAP repeats was 
investigated by isolating total genomic DNA and digesting with the restriction enzyme  
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FIGURE 18.  Cfp1 has redundancy of function for cytosine methylation of 
repetitive elements. 
Total genomic DNA was isolated from CXXC1+/+, CXXC1-/-, and CXXC1-/- ES 
cells expressing vector control, Cfp1 1-656, or the indicated Cfp1 truncations.  Genomic 
DNA was digested with MspI or HpaII, and Southern blot analysis was performed using 
a radiolabeled probe specific for IAP retrovirus repetitive elements.  Arrows indicate 
bands that demonstrate cytosine hypo-methylation.  
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FIGURE 19.  DNA-binding activity of Cfp1 or interaction with the Setd1 histone 
methyltransferase complexes is important for cytosine methylation of repetitive 
elements.  
Total genomic DNA was isolated from CXXC1+/+, CXXC1-/-, and CXXC1-/- ES 
cells expressing vector control, Cfp1 1-656, or the indicated Cfp1 mutations.  Genomic 
DNA was digested with MspI or HpaII, and Southern blot analysis was performed using 
a radiolabeled probe specific for IAP retrovirus repetitive elements.  Arrows indicate 
bands that demonstrate cytosine hypo-methylation.   
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FIGURE 20.  IAP cytosine methylation in CXXC1-/- ES cells expressing additional 
Cfp1 mutations.    
Total genomic DNA was isolated from CXXC1+/+, CXXC1-/-, and CXXC1-/- ES 
cells expressing vector control, Cfp1 1-656, or the indicated Cfp1 mutations.  Genomic 
DNA was digested with MspI or HpaII, and Southern blot analysis was performed using 
a radiolabeled probe specific for IAP retrovirus repetitive elements.  Arrows indicate 
bands that demonstrate cytosine hypo-methylation.   
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MspI or its cytosine methylation-sensitive isoschizomer HpaII.  MspI and HpaII 
recognize the same tetranucleotide sequence (5’-CCGG-3’) but MspI cleaves DNA 
irrespective of the presence of 5-methylcytosine.  Therefore, the degree of HpaII 
digestion is inversely proportional to the amount of cytosine methylation present.  In 
Southern blot analysis using an IAP-specific probe, only fragments larger than 4 kb 
were observed following HpaII digestion of DNA isolated from CXXC1+/+, and   
CXXC1-/- ES cells expressing Cfp1 1-656, 1-481, 1-367, 103-481, 103-367, 302-656, 
361-656, and 361-597, indicating a high degree of cytosine methylation present at IAP 
repeats (Fig. 18, Fig. 20).  In contrast, low molecular weight fragments were observed 
in DNA isolated from CXXC1-/-, vector, and CXXC1-/- ES cells expressing Cfp1 1-320, 
318-412, 318-481, and 361-481, indicating decreased cytosine methylation present at 
the IAP repeats (Fig. 18, Fig. 20).  This demonstrates that CXXC1-/- ES cells expressing 
Cfp1 fragments that exhibit decreased global cytosine methylation also exhibit 
decreased cytosine methylation of IAP repeats.  In addition, only fragments larger than 
4 kb were observed with HpaII digestion of DNA isolated from CXXC1+/+ and   
CXXC1-/- ES cells expressing Cfp1 1-656 C29A, 1-656 C73A, 1-656 C169A, 1-656 
C208A, 1-656 C375A, 1-656 YCS389AAA, and 1-656 C586A, indicating a high degree 
of cytosine methylation present at the IAP repeats (Fig. 19, Fig. 20).  In contrast, low 
molecular weight fragments were observed in DNA isolated from CXXC1-/-, vector, and 
CXXC1-/- ES cells expressing Cfp1 1-367 C169A, 361-656 C375A, 1-656 C169A, 
C375A, and 1-656 C169A, YCS389AAA, indicating decreased cytosine methylation 
present at the IAP repeats (Fig. 19, Fig. 20).  Therefore, disruption of DNA-binding 
activity of Cfp1 1-367, disruption of Cfp1 361-656 interaction with the Setd1 histone 
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H3K4 methyltransferase complexes, or ablation of both DNA-binding and interaction 
with the Setd1 complexes within full-length Cfp1 1-656, results in a dramatic decrease 
in both global cytosine methylation and cytosine methylation at IAP repeats.  
  
4.  Decreased Dnmt1 protein expression in CXXC1-/- ES expressing Cfp1 
mutations that exhibit decreased global cytosine methylation    
CXXC1-/- ES cells exhibit ~50% decrease in Dnmt1 protein expression and 
decreased maintenance DNA methyltransferase activity (Carlone 2005).  Western blot 
analysis was performed to determine the protein expression level of Dnmt1 in    
CXXC1-/- ES cells expressing Cfp1 mutations compared to CXXC1+/+ ES cells (Fig. 21, 
Fig. 22, Fig. 23).  CXXC1+/+ and CXXC1-/- ES cells expressing Cfp1 1-656, 1-481,       
1-367, 103-481, 103-367, 302-656, 361-597, and 361-656 exhibit rescued Dnmt1 
protein levels similar to that of CXXC1+/+ ES cells (Fig. 21, Fig. 23).  In contrast, failure 
to rescue Dnmt1 protein expression was observed in CXXC1-/-, vector, and CXXC1-/- ES 
cells expressing Cfp1 1-320, 318-412, 318-481, and 361-481 (Fig. 21, Fig. 23).  These 
data indicate that CXXC1-/- ES cells expressing Cfp1 fragments that rescue cytosine 
methylation (1-656, 1-481, 1-367, 103-481, 103-367, 361-597, and 361-656) also 
exhibit appropriate Dnmt1 protein expression.  However, CXXC1-/- ES cells expressing 
Cfp1 1-320, 318-412, 318-481, and 361-481 are unable to maintain appropriate global 
cytosine and demonstrate decreased Dnmt1 protein expression.  In addition, CXXC1-/- 
ES cells expressing Cfp1 1-656 C29A, 1-656 C73A, 1-656 C169A, 1-656 C208A,       
1-656 C375A, 1-656 YCS389AAA, and 1-656 C586A rescue Dnmt1 protein expression  
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FIGURE 21. Cfp1 exhibits redundancy of function for appropriate Dnmt1 protein 
expression. 
Western blot analysis was performed on whole cell protein extracts collected 
from CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing vector control, Cfp1        
1-656, or the indicated Cfp1 truncations using antisera directed against Dnmt1 and β-
actin as a loading control.  The graph summarizes results from at least three 
independent experiments with error bars representing standard error.  Asterisks denote a 
statistically significant (p<0.05) difference compared to CXXC1-/- ES cells expressing 
full-length Cfp1 (1-656).   
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FIGURE 22.  DNA-binding activity of Cfp1 or interaction with the Setd1 histone 
methyltransferase complexes is important for appropriate Dnmt1 protein 
expression. 
Western blot analysis was performed on whole cell protein extracts derived from 
CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing vector control, Cfp1 1-656, or 
the indicated Cfp1 mutations using antisera directed against Dnmt1 and β-actin as a 
loading control.  The graph represents results from at least three independent 
experiments with error bars representing standard error.  Asterisks denote a statistically 
significant (p<0.05) difference compared to full-length Cfp1 (1-656).        
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 FIGURE 23.  Dnmt1 protein expression in CXXC1-/- ES cells expressing additional 
Cfp1 mutations.   
Western blot analysis was performed on whole cell protein extracts derived from 
CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing vector control, Cfp1 1-656, or 
the indicated Cfp1 mutations using antisera directed against Dnmt1 and β-actin as a 
loading control.  The graph represents results from at least three independent 
experiments with error bars representing standard error.  Asterisks denote a statistically 
significant (p<0.05) difference compared to full-length Cfp1 (1-656).     
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(Fig. 22, Fig. 23).  In contrast, a significant decrease in Dnmt1 protein expression was 
observed in CXXC1-/- ES cells expressing Cfp1 1-367 C169A, 361-656 C375A, 1-656 
C169A,C375A, and 1-656 C169A, YCS389AAA (Fig. 22, Fig. 23).  These data indicate 
that CXXC1-/- ES cells expressing Cfp1 mutations that exhibit appropriate levels of 
cytosine methylation (1-656 C29A, 1-656 C73A, 1-656 C169A, 1-656 C208A, 1-656 
C375A, 1-656 YCS389AAA, and 1-656 C586A) also exhibit appropriate Dnmt1 protein 
expression.  However, CXXC1-/- ES cells expressing Cfp1 1-367 C169A, 361-656 
C375A, 1-656 C169A, C375A, and 1-656 C169A, YCS389AAA are unable to maintain 
appropriate global cytosine methylation and demonstrate decreased Dnmt1 protein 
expression, indicating that retention of either DNA-binding activity of Cfp1 or Setd1 
interaction is required for appropriate Dnmt1 protein expression.  
   
5.  CXXC1-/- ES cells expressing Cfp1 mutations that rescue cytosine 
methylation can achieve in vitro differentiation 
ES cells can be maintained in an undifferentiated, pluripotent state by culture in 
the presence of LIF (Rasmussen 2003).  When CXXC1+/+ ES cells are cultured in 
suspension in the absence of LIF, they form cell aggregates and differentiate into the 
three germ layers: endoderm, mesoderm, and ectoderm (Rasmussen 2003).         
CXXC1-/- ES cells fail to achieve in vitro differentiation following the removal of LIF 
from the media (Carlone 2005).  Dynamic changes in DNA methylation and alterations 
in histone modifications are necessary for in vitro differentiation of ES cells (Hattori 
2004; Rasmussen 2003; Lee 2002).   
 130 
 
FIGURE 24.  Cfp1 has redundancy of function for in vitro differentiation.    
(A)  Colony morphology following induction of differentiation, magnification 
10X.  CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing the vector control, Cfp1 
1-656, or the indicated Cfp1 truncations were cultured in the absence of LIF for           
10 days. 
(B)  CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing vector control, Cfp1 
1-656, or the indicated Cfp1 truncations were grown in the absence of LIF for 10 days.  
After 10 days, cells were harvested, disaggregated with trypsin, reseeded into gelatin-
coated tissue culture dishes, and stained for alkaline phosphatase activity using a 
leukocyte detection kit, magnification 10X.  Numbers represent percent of cells positive 
for alkaline phosphatase activity.  At least 200 cells were scored for each experiment. 
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FIGURE 25.  CXXC1-/- ES cells expressing Cfp1 mutations that exhibit 
appropriate global cytosine methylation achieve in vitro differentiation.   
(A)  Colony morphology following induction of differentiation, magnification 
10X.  CXXC1+/+, CXXC1-/-,  and CXXC1-/- ES cells expressing vector control, Cfp1      
1-656, or the indicated Cfp1 mutations were cultured in the absence of LIF for 10 days. 
(B)  CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing vector control, Cfp1 
1-656, or the indicated Cfp1 mutations were grown in the absence of LIF for 10 days.  
After 10 days, cells were harvested, disaggregated with trypsin, reseeded into gelatin-
coated tissue culture dishes, and stained for alkaline phosphatase activity using a 
leukocyte detection kit, magnification 10X.  Numbers represent percent of cells positive 
for alkaline phosphatase activity.  At least 200 cells were scored for each experiment. 
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CXXC1-/- ES cells expressing various Cfp1 fragments were cultured under 
conditions to promote differentiation to assess their ability to achieve in vitro  
differentiation.  Following growth in media lacking LIF, CXXC1+/+, and CXXC1-/- ES 
cells expressing Cfp1 1-656, 1-481, 1-367, 103-481, 302-656, 361-597, and 361-656 
grew large cell aggregates (embryoid bodies) and formed a prominent outgrowth 
characteristic of endoderm differentiation (Fig. 24, Fig. 26).  CXXC1-/- ES cells 
expressing Cfp1 103-367 formed outgrowth that looked similar to CXXC1+/+ ES cells, 
but had a slight decrease in the amount of outgrowth present.  In contrast, CXXC1-/-, 
vector, and CXXC1-/- ES cells expressing Cfp1 1-320, 318-412, 318-481, and 361-481 
exhibited cell aggregates that remained small and failed to produce an outgrowth (Fig. 
24, Fig. 26), indicating an inability to achieve differentiation.   
The differentiation of ES cells is a highly regulated process that correlates with 
the expression or repression of a panel of specific markers, which can be used to 
analyze the differentiation process (Kanellopoulou 2005).  Molecular markers were 
analyzed to assess the ability of CXXC1-/- ES cells expressing Cfp1 fragments to 
achieve in vitro differentiation.  Alkaline phosphatase is a marker of pluripotency in ES 
cells and becomes down-regulated upon cellular differentiation (Wobus 1997).  
CXXC1+/+, and CXXC1-/- ES cells expressing Cfp1 1-656, 1-481, 1-367, 103-481,    
361-597, 302-656, 361-597, and 361-656 demonstrate a very low number of cells       
(1-8%) that express alkaline phosphatase activity 10 days following removal of LIF, 
indicating that almost all of the cells have achieved in vitro differentiation (Fig. 24, Fig. 
26).  Approximately 25% of CXXC1-/- ES cells expressing Cfp1 103-367 express 
alkaline phosphatase activity, indicating that the majority of these cells have achieved  
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FIGURE 26.  Analysis of in vitro differentiation in CXXC1-/- ES cells expressing 
additional Cfp1 mutations. 
(A)  Colony morphology following induction of differentiation, magnification 
10X.  CXXC1+/+, CXXC1-/-,  and CXXC1-/- ES cells expressing vector control, Cfp1      
1-656, or the indicated Cfp1 mutations were cultured in the absence of LIF for 10 days. 
(B)  CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing vector control, Cfp1 
1-656, or the indicated Cfp1 mutations were grown in the absence of LIF for 10 days.  
After 10 days, cells were harvested, disaggregated with trypsin, reseeded into gelatin-
coated tissue culture dishes, and stained for alkaline phosphatase activity using a 
leukocyte detection kit, magnification 10X.  Numbers represent percent of cells positive 
for alkaline phosphatase activity.  At least 200 cells were scored for each experiment. 
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differentiation (Fig. 24).  In contrast, CXXC1-/-, vector, and CXXC1-/- ES cells 
expressing Cfp1 1-320, 318-412,  318-481, and 361-481 retain alkaline phosphatase 
activity following removal of LIF (~90-98% of cells), indicating that the majority of 
these cells failed to achieve in vitro differentiation (Fig. 24, Fig. 26). 
Upon culture in media without LIF, CXXC1+/+ and CXXC1-/- ES cells expressing 
Cfp1 1-656 C29A, 1-656 C73A, 1-656 C169A, 1-656 C208A, 1-656 C375A, and 1-656 
YCS389AAA grew larger cell aggregates and formed a prominent embryoid body 
outgrowth characteristic of differentiation (Fig. 25, Fig. 26).  In contrast, CXXC1-/-, 
vector, and CXXC1-/- ES cells expressing Cfp1 1-367 C169A, 361-656 C375A, 1-656 
C169A, C375A and 1-656 C169A, YCS389AAA formed cell aggregates that remained 
small and failed to produce an outgrowth, indicating an inability to achieve 
differentiation (Fig. 25, Fig. 26).  After 10 days of culture in the absence of LIF, 
CXXC1+/+ and CXXC1-/- ES cells expressing Cfp1 mutations 1-656 C29A, 1-656 C73A, 
1-656 C169A, 1-656 C208A, 1-656 C375A, 1-656 YCS389AAA, and 1-656 C586A 
demonstrated a very small proportion of cells (1-5%) that retained expression of 
alkaline phosphatase activity, a marker of pluripotency, indicating that nearly all of the 
cells had achieved in vitro differentiation (Fig. 25, Fig. 26).  In contrast, CXXC1-/-, 
vector, and CXXC1-/- ES cells expressing Cfp1 1-367 C169A, 361-656 C375A, 1-656 
C169A, C375A, and 1-656 C169A, YCS389AAA retain alkaline phosphatase activity 
(~90-98%), indicating that these cells retained stem cell properties and failed to achieve 
in vitro differentiation (Fig. 25, Fig. 26). 
Oct4 is a transcription factor that is expressed in pluripotent ES and germ cells, 
functions as a suppressor of differentiation, and is a master regulator of pluripotency  
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FIGURE 27.  CXXC1-/- ES cells expressing Cfp1 fragments induce expression of 
lineage and developmental markers upon in vitro differentiation.   
 CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing vector control, Cfp1 1-
656, or the indicated Cfp1 truncations were cultured in the absence of LIF to induce 
differentiation.  Cells were collected at day 0 (undifferentiated) and day 10 after 
induction of differentiation.  Total RNA was isolated and RT-PCR was performed to 
analyze the expression of Oct4, a marker of undifferentiated ES cells and HPRT, a 
housekeeping gene that serves as a control for cDNA quantity and integrity along with 
the following lineage and developmental specific markers: Brachyury (mesoderm);      
β-H1 (primitive erythroid); c-fms (myeloid); gp-IIB (megakaryocyte); and GATA-4 
(endoderm).  
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FIGURE 28.  CXXC1-/- ES cells expressing Cfp1 mutations that morphologically 
exhibit an outgrowth induce expression of lineage and developmental markers.    
CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing vector control, Cfp1     
1-656, or the indicated Cfp1 mutations were cultured in the absence of LIF to induce 
differentiation.  Cells were collected at day 0 (undifferentiated) and day 10 after 
induction of differentiation.  Total RNA was isolated and RT-PCR was performed to 
analyze the expression of Oct4, a marker of undifferentiated ES cells, and HPRT, a 
housekeeping gene that serves as a control for cDNA quantity and integrity along with 
the following lineage and developmental specific markers: Brachyury (mesoderm);      
β-H1 (primitive erythroid); c-fms (myeloid); gp-IIB (megakaryocyte); and GATA-4 
(endoderm).   
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that controls lineage commitment (Niwa 2000; Pesce 2001; Loh 2006).  When ES cells 
are triggered to differentiate, Oct4 becomes down-regulated.  Oct4 mRNA expression 
was assessed by RT-PCR in undifferentiated ES cells (day 0) and 10 days following 
induction of differentiation.  The ratio of Oct4 mRNA expression to HPRT was used to 
assess whether Oct4 mRNA expression changed upon removal of LIF.  Similar to 
alkaline phosphatase activity, Oct4 mRNA expression was down-regulated in 
CXXC1+/+ and CXXC1-/- ES cells expressing Cfp1 1-656, 1-481, 1-367, 103-481,      
103-367, 302-656, 361-597, and 361-656, indicating the ability to achieve in vitro 
differentiation (Fig. 27, Fig. 29).  In contrast, Oct4 mRNA expression persists in 
CXXC1-/-, vector, and CXXC1-/- ES cells expressing Cfp1 1-320, 318-412, 318-481, and 
361-481 indicating that these cells failed to differentiate (Fig. 27, Fig. 29).  
CXXC1+/+ ES cells induce expression of developmental and lineage-specific 
gene markers following removal of LIF, including Brachyury (mesoderm), β-H1 
(primitive erythroid), gp-IIb (megakaryocyte), c-fms (myeloid), MHC-β (cardiac 
muscle), and GATA-4 (visceral/parietal endoderm).  In contrast, CXXC1-/- ES cells fail 
to induce expression of these differentiation markers upon removal of LIF (Carlone 
2005).  Consistent with alkaline phosphatase activity, CXXC1-/- ES cells expressing 
Cfp1 1-656, 1-481, 1-367, 103-481, 103-367, 361-597, and 361-656 induce expression 
of these developmental and lineage-specific markers 10 days following removal of LIF 
(Fig. 28, Fig. 29).  In contrast, CXXC1-/-, vector, and CXXC1-/- ES cells expressing Cfp1 
1-320, 318-412, 318-481, and 361-481 fail to induce expression of these markers (Fig. 
28, Fig. 29).  In addition, Oct4 mRNA expression was down-regulated following 
growth in media lacking LIF in CXXC1+/+ and CXXC1-/- ES cells expressing Cfp1  
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FIGURE 29.  CXXC1-/- ES cells expressing Cfp1 mutations that morphologically 
exhibit an outgrowth induce expression of lineage and developmental markers.    
CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing vector control, Cfp1     
1-656, or the indicated Cfp1 mutations were cultured in the absence of LIF to induce 
differentiation.  Cells were collected at day 0 (undifferentiated), day 5, and day 10 after 
induction of differentiation.  Total RNA was isolated and RT-PCR was performed to 
analyze the expression of Oct4, a marker of undifferentiated ES cells, and HPRT, a 
housekeeping gene that serves as a control for cDNA quantity and integrity along with 
the following lineage and developmental specific markers: Brachyury (mesoderm);      
β-H1 (primitive erythroid); MHC-β (cardiac muscle); c-fms (myeloid); gp-IIB 
(megakaryocyte); and GATA-4 (endoderm).  
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1-656 C29A, 1-656 C73A, 1-656 C169A, 1-656 C208A, 1-656 C375A, 1-656 
YCS389AAA, and 1-656 C586A, indicating an ability to achieve in vitro differentiation 
(Fig. 28, Fig. 29).  In contrast, following growth in media lacking LIF, CXXC1-/-, 
vector, and CXXC1-/- ES cells expressing Cfp1 1-367 C169A, 361-656 C375A, 1-656 
C169A, C375A, and 1-656 C169A, YCS389AAA retain Oct4 mRNA expression levels 
similar to that of undifferentiated cells, indicating that these cells have not achieved 
differentiation (Fig. 28, Fig. 29).   
CXXC1-/- ES cells expressing Cfp1 1-656 C29A, 1-656 C73A, 1-656 C169A,   
1-656 C208A, 1-656 C365A, and 1-656 YCS389AAA express the developmental and 
lineage-specific gene markers 10 days following removal of LIF (Fig. 27, Fig. 28).  In 
contrast, CXXC1-/-, vector, and CXXC1-/- ES cells expressing Cfp1 1-367 C169A,     
361-656 C375A, 1-656 C169A, C375A, and 1-656 C169A, YCS389AAA do not 
express the markers 10 days following removal of LIF (Fig. 27, Fig. 28).   
These experiments reveal that Cfp1 DNA-binding activity is not essential for 
differentiation of ES cells because CXXC1-/- ES cells expressing Cfp1 361-656, a Cfp1 
fragment that lacks the CXXC DNA-binding domain, demonstrate ability to achieve 
differentiation.  In addition, Cfp1 103-367 (containing the CXXC, acidic, and basic 
domains) is sufficient for differentiation, indicating that the PHD1 and SID domain of 
Cfp1 is not essential for differentiation.  However, the basic domain is indispensable 
and important for Cfp1 1-367 because removal of the basic domain (Cfp1 1-320; 
containing the PHD1, CXXC, and acidic domains) results in an inability to achieve 
differentiation.  In addition, CXXC1-/- ES cells expressing Cfp1 318-481, 318-412, and 
361-481 fail to differentiate, whereas CXXC1-/- ES cells expressing Cfp1 361-656  
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TABLE 6.  Summary of global cytosine methylation, IAP cytosine methylation, 
Dnmt1 protein expression, and differentiation rescue activity. 
The table presents a summary of the rescue data for CXXC1-/- ES cells 
expressing the indicated Cfp1 mutations.  The ability to rescue each indicated defect is 
indicated by a (+), an inability to rescue (significant [p<0.05] difference compared to 
Cfp1 1-656) is indicated by a (-).      
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achieve differentiation, indicating that the PHD2 domain is required for differentiation 
rescue activity of the C-terminal half of Cfp1.  
These results are consistent with plating efficiency and cytosine methylation 
rescue activity, and indicate that expression of either Cfp1 1-367 or Cfp1 361-656 in 
CXXC1-/- ES cells is sufficient to rescue in vitro differentiation.  However, ablation of 
the DNA-binding activity of the amino half of Cfp1 (1-367 C169A), or disruption of the 
Setd1 histone H3K4 methyltransferase complex interaction with the carboxyl half of 
Cfp1 (361-656 C375A), results in loss of differentiation rescue activity.  In addition, 
ablation of both DNA-binding activity of Cfp1, and Cfp1 interaction with the Setd1 
histone H3K4 methyltransferase complexes within full-length Cfp1 (1-656 C169A, 
C375A or 1-656 C169A, YCS389AAA) results in loss of rescue activity.  This indicates 
that retention of either DNA-binding activity of Cfp1 or Setd1 interaction is required for 
ES cell differentiation.  
 
6.  Summary 
The data presented in this portion of the dissertation reveals that the increase in 
apoptosis observed in CXXC1-/- ES cells does not explain the decreased global cytosine 
methylation.  CXXC1-/- ES cells expressing Cfp1 mutations that rescue global cytosine 
methylation also rescue cytosine methylation of IAP repeats, Dnmt1 protein expression, 
and in vitro differentiation.  Interestingly, consistent with plating efficiency, expression 
of either the amino half of Cfp1 (1-367) or carboxyl half of Cfp1 (361-656) is sufficient 
to correct the global cytosine methylation, IAP repeat cytosine methylation, Dnmt1 
protein expression, and in vitro differentiation.  Additional studies revealed that a point 
 145 
mutation (C169A) that abolishes DNA-binding activity of Cfp1 ablates the rescue 
activity of the 1-367 Cfp1 fragment, and a point mutation (C375A) that abolishes the 
interaction of Cfp1 with the Setd1A and Setd1B histone H3K4 methyltransferase 
complexes ablates the rescue activity of the 361-656 Cfp1 fragment.  Introduction of 
both mutations (C169A and C375A or C169A and YCS389AAA) ablates the rescue 
activity of the full-length Cfp1 protein.  These results indicate that retention of either 
DNA-binding activity or Setd1 association of Cfp1 is required for appropriate ES cell 
cytosine methylation, Dnmt1 protein expression, and ability to achieve in vitro 
differentiation.  A summary of the global cytosine methylation, IAP cytosine 
methylation, Dnmt1 protein expression, and in vitro differentiation rescue activity of 
CXXC1-/- ES cells expressing Cfp1 mutations is presented in Table 6.    
   
IV. Analysis of Cfp1 Functional Properties Required to Rescue Histone 
Methylation 
1.  CXXC1-/- ES cells exhibit decreased Setd1A protein expression  
Cfp1 interacts with the Setd1A and Setd1B histone H3K4 methyltransferase 
complexes, which contain Setd1A or Setd1B, Cfp1, Rbbp5, Wdr5, Ash2, and Wdr82 
(Lee 2005).  Host Cell Factor (HCF-1) is a conserved, essential protein initially 
identified as a co-regulator for the herpes simplex virus transcriptional activator Vp16 
(Kristie 1995).  HCF-1 interacts with Setd1A, and promoter occupancy of HCF-1 is 
essential for transcriptional activation via recruitment of Mll1 and Setd1A histone 
H3K4 methyltransferases (Narayanan 2007).  Real-time PCR analysis demonstrates that 
steady state mRNA levels of Setd1A and Setd1B are elevated ~7-fold (Setd1A) and    
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FIGURE 30.  Cfp1 is required for appropriate expression of Setd1A and Setd1B.  
(A)  Real-time RT-PCR analysis was performed to assess Setd1A and Setd1B 
mRNA levels in CXXC1+/+, CXXC1-/-, CXXC1-/vector (CXXC1-/- ES cells expressing 
vector control), or CXXC1-/cDNA ES cells (CXXC1-/- ES cells expressing full-length 
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mCfp1).  The graph summarizes mSetd1A and mSetd1B transcript levels relative to 
GAPDH from three independent experiments with error bars indicating standard error.  
Asterisks denote statistically significant differences (p<0.05) compared to CXXC1+/+ ES 
cells.   
(B)  Nuclear protein extracts were isolated for CXXC1+/+, CXXC1+/-, CXXC1-/-, 
CXXC1-/vector, or CXXC1-/cDNA ES cells and subjected to Western blot analysis using 
antisera directed against the Setd1A complex components Setd1A, Ash2, Rbbp5, Wdr5, 
Wdr82, and HCF-1.  The membrane was also probed with anti-Brg1 antiserum as a 
loading control.  The graph summarizes average Setd1A protein expression from at 
least three independent experiments with error bars representing standard error.  
Asterisks denote a statistically significant (p<0.05) decrease in relative amount of 
Setd1A protein expression compared to CXXC1+/+ ES cells.   
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~9-fold (Setd1B) in CXXC1-/- and CXXC1-/vector ES cells (CXXC1-/- ES cells stably 
transfected with parental expression vector lacking any Cfp1 sequence) compared to 
CXXC1+/+ ES cells and are restored to wild-type levels in CXXC1-/cDNA (CXXC1-/- ES 
cells stably expressing wild-type mouse Cfp1) ES cells (Fig. 30A).   
Previous data indicated that CXXC1-/- ES cells express appropriate protein levels 
of Setd1A, Ash2, and Rbbp5 (Lee 2005).  In order to confirm these data, Western blot 
analysis was performed to determine the protein expression level of Setd1A and the 
Setd1A complex components (Cfp1, Rbbp5, Wdr5, Wdr82, Ash2), along with HCF-1 in 
CXXC1+/+, CXXC1+/-, CXXC1-/-, CXXC1-/cDNA, and CXXC1-/vector ES cells (Fig. 30B).  In 
contrast to what was previously published (Lee 2005), a significant decrease in Setd1A 
protein expression (approximately 50% of wild-type) was observed in CXXC1-/- and 
CXXC1-/vector ES cells (Fig. 30B).  The previous study used a commercial antibody for 
Setd1A, and the detection signal was fairly low.  In contrast, the results reported here 
use antibody generated by Proteintech Group by using recombinant GST-Setd1A 
fragment (amino acids 258-458, supplied by Dr. Jeong-Heon Lee) as antigen (Lee 
2007).  Expression of Setd1A protein was rescued in CXXC1-/cDNA ES cells, indicating 
that the decreased protein expression of Setd1A in CXXC1-/- ES cells is a consequence 
of lack of Cfp1 protein expression (Fig. 30B).  CXXC1+/- express approximately 50% of 
Cfp1 protein expression as CXXC1+/+ ES cells (Carlone 2005), and exhibit a slight 
decrease in Setd1A protein expression.  In contrast, no difference in protein expression 
was observed for the other Setd1A complex components (Rbbp5, Wdr5, Wdr82, Ash2), 
or HCF-1 in any cell line (Fig. 30B).  Consequently, these findings indicate that 
increased transcript levels of Setd1A in CXXC1-/- ES cells does not reflect the decreased 
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steady state protein level of Setd1A.  Therefore, the decreased steady state Setd1A 
protein level cannot be explained by reduced transcription of the SETD1A gene.  
Multiple attempts were made to analyze Setd1B protein expression in the ES cell lines.  
However, in contrast to HEK-293 and various other cell lines, the Setd1B antibodies 
never gave a clear Western blot signal in ES cells.  Therefore, it is unclear whether 
appropriate Setd1B protein expression is observed in the absence of Cfp1.   
 
2.  DNA-binding activity of Cfp1 or association of Cfp1 with the Setd1 
complexes is required to rescue Setd1A protein expression 
CXXC1-/- ES cells exhibit a ~50% decrease in Setd1A protein expression (Fig. 
30B).  In order to determine the functional domains of Cfp1 necessary to rescue 
decreased Setd1A protein expression, Western blot analysis was performed to 
determine Setd1A protein expression in CXXC1-/- ES cells expressing Cfp1 mutations.  
CXXC1-/- ES cells expressing Cfp1 1-481 (containing the PHD1, CXXC, acidic, basic, 
and coiled-coil domains), or Cfp1 302-656 (containing the basic, coiled-coil, SID, and 
PHD2 domains) rescue Setd1A protein expression (Fig. 31, Fig. 32).  Surprisingly, 
expression of either the amino half of Cfp1 (1-367; containing the PHD1, CXXC, 
acidic, and basic domains) or the carboxyl half of Cfp1 (361-656; containing the coiled-
coil, SID, and PHD2 domains, and 361-597; containing the coiled-coil, SID, and PHD2 
domains) is sufficient to rescue Setd1A protein expression (Fig. 31, Fig. 32).  In 
contrast, the basic domain is indispensable for Cfp1 1-367 rescue activity because 
removal of the basic domain (Cfp1 1-320) results in failure to rescue Setd1A protein 
expression (Fig. 31).  In addition, Cfp1 103-481 (containing the CXXC, acidic, basic,  
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FIGURE 31.  Cfp1 has redundancy of function for appropriate protein expression 
of Setd1A.   
Western blot analysis was performed on whole cell protein extracts collected 
from CXXC1+/+, CXXC1-/-, vector control, and CXXC1-/- ES cells expressing Cfp1 1-656 
or the indicated Cfp1 mutations using antisera directed against Setd1A and β-actin as a 
loading control.  Each graph represents the relative amount of Setd1A protein 
expression normalized to β-actin from at least three independent experiments, with error 
bars representing standard error.  Asterisks denote a statistically significant (p<0.05) 
difference compared to CXXC1-/- ES cells expressing full-length Cfp1 (1-656).             
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FIGURE 32.  DNA-binding activity of Cfp1 or association of Cfp1 with the Setd1 
complexes is required for appropriate protein expression of Setd1A.   
Western blot analysis was performed on whole cell protein extracts collected 
from CXXC1+/+, CXXC1-/-, vector control, and CXXC1-/- ES cells expressing Cfp1 1-656 
or the indicated Cfp1 mutations using antisera directed against Setd1A and β-actin as a 
loading control.  Each graph represents the relative amount of Setd1A protein 
expression normalized to β-actin from at least three independent experiments, with error 
bars representing standard error.  Asterisks denote a statistically significant (p<0.05) 
difference compared to CXXC1-/- ES cells expressing full-length Cfp1 (1-656).   
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and coiled-coil domains), and Cfp1 103-367 (containing the CXXC, acidic, and basic 
domains) rescue Setd1A protein expression, indicating that the PHD1 domain is not 
essential for appropriate Setd1A protein expression (Fig. 31, Fig. 32).  Therefore, Cfp1 
interaction with Setd1A is not required to rescue Setd1A protein expression because 
Cfp1 mutations that lack the SID domain (1-367, 103-481 and 103-367) exhibit 
appropriate Setd1A protein expression.  In addition, Cfp1 DNA-binding activity is not 
required for appropriate Setd1A protein expression because Cfp1 361-656 lacks the 
CXXC domain and retains rescue activity.  However, CXXC1-/- ES cells expressing 
Cfp1 318-481 (containing the basic, SID, and coiled-coil domains), Cfp1 318-412 
(containing the basic and SID domains), or Cfp1 361-481 (containing the SID and 
coiled-coil domains) demonstrate decreased Setd1A protein expression, indicating that 
the PHD2 domain is required for Setd1A protein expression rescue activity of the        
C-terminal half of Cfp1 (Fig. 31, Fig. 32).    
CXXC1-/- ES cells expressing full-length Cfp1 mutations (1-656 C29A, 1-656 
C73A, 1-656 C169A, 1-656 C208A, 1-656 C375A, 1-656 YCS389AAA, and 1-656 
C586A) rescue protein expression levels of Setd1A (Fig. 32, Fig. 33).  However, 
ablation of DNA-binding activity of Cfp1 1-367 (1-367 C169A) or disruption of Cfp1 
361-656 interaction with the Setd1 histone H3K4 methyltransferase complexes (361-
656 C375A) results in failure to rescue Setd1A protein expression (Fig. 32).  In 
addition, failure to rescue Setd1A protein expression was observed in CXXC1-/- ES cells 
expressing full-length Cfp1 containing both point mutations (1-656 C169A, C375A or 
1-656 C169A, YCS389AAA).  Consistent with plating efficiency, cytosine methylation, 
and in vitro differentiation, these data indicate that retention of either DNA-binding 
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activity of Cfp1 or interaction of Cfp1 with the Setd1 histone H3K4 methyltransferase 
complexes is required to rescue Setd1A protein expression.    
 
3. CXXC1-/- ES cells exhibit altered histone methylation  
Previous data indicates that CXXC1-/- ES cells exhibit altered histone 
modifications including increased (~43%) histone H3K4me3 and decreased (~28%) 
histone H3K9me2 (Lee 2005).  Global levels of histone H3K4 methylation transiently 
decline once CXXC1+/+ ES cells start to differentiate (Lee 2004).  However, 6 days 
following removal of LIF from the media and induction of in vitro differentiation, 
CXXC1-/- ES cells exhibit a nearly 4-fold increase in H3K4me3 (Lee 2005).  
Consequently, Cfp1 is postulated to restrict the activity of the Setd1A and Setd1B 
histone H3K4 methyltransferase complexes (Lee 2005).  In order to confirm the 
previously reported elevated levels of histone H3K4 methylation, CXXC1+/+, CXXC1-/-, 
CXXC1-/cDNA, and CXXC1-/vector ES cells were cultured under conditions to promote 
differentiation and histones were isolated after 6 days to assess the global levels of 
H3K9me2 and H3K4me3.  The level of histone H3K9me2 is slightly reduced (~20-
25%) and H3K4me3 is significantly elevated (~2-fold) in CXXC1-/- and CXXC1-/vector ES 
cells (Fig. 33).  In addition, global levels of H3K9me2 and H3K4me3 were rescued in 
the CXXC1-/cDNA ES cells.  This confirms reduced global levels of H3K9me2 and 
increased H3K4me3 in the absence of Cfp1.  However, the magnitude of H3K4me3 
difference reported here is 2-fold as opposed to the previously reported 4-fold (Lee 
2007).  Discrepancy in the fold change may be due to differences in loading controls  
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FIGURE 33.  Cfp1 is required for appropriate levels of H3K9me2 and H3K4me3. 
Histone protein extracts were isolated at day 6 following removal of LIF from 
the media from CXXC1+/+, CXXC1+/-, CXXC1-/-, CXXC1-/vector, and CXXC1-/cDNA ES 
cells.  Histone protein extracts were subjected to Western blot analysis using antiserum 
directed against histone H3K4me3.  The membrane was also probed with total histone 
H3 antiserum as a loading control.  The graph summarizes average levels of global 
H3K4me3 from at least three independent experiments with error bars representing 
standard error.  Asterisks denote a statistically significant (p<0.05) increase in relative 
amount of H3K4me3 compared to CXXC1+/+ ES cells.    
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used between experiments.  The previous study used coomassie blue staining of total 
histones, whereas this study used an antibody directed against total histone H3 as a 
loading control.   
 
4.  Neither DNA-binding activity of Cfp1 nor association of Cfp1 with the 
Setd1 complexes is required to rescue histone H3K9 methylation 
 CXXC1-/- ES cells exhibit slightly (~20-25%) reduced global levels of 
H3K9me2.  In order to determine the functional domains of Cfp1 necessary to rescue 
the decreased levels of H3K9me2, Western blot analysis was performed to determine 
H3K9me2 levels in CXXC1-/- ES cells expressing Cfp1 mutations.  CXXC1-/- ES cells 
expressing Cfp1 1-481 (containing the PHD1, CXXC, acidic, basic, and coiled-coil 
domains) can rescue H3K9me2 levels (Fig. 34).  In addition, CXXC1-/- ES cells 
expressing either the amino half of Cfp1 (1-367; containing the PHD1, CXXC, acidic, 
and basic domains) or the carboxyl half of Cfp1 (361-656; containing the coiled-coil, 
SID, and PHD2 domains) is sufficient to rescue H3K9me2 levels (Fig. 34).  On the 
other hand, the basic domain is indispensable for Cfp1 1-367 rescue activity because 
removal of the basic domain (Cfp1 1-320) results in failure to rescue H3K9me2 levels 
(Fig. 34).  In addition, Cfp1 103-367 (containing the CXXC, acidic, and basic domains) 
rescues H3K9me2 levels, indicating that the PHD1 domain is not essential for 
appropriate histone H3K9 methylation (Fig. 34).  In contrast, CXXC1-/- ES cells 
expressing Cfp1 318-481 (containing the basic, SID, and coiled-coil domains) exhibit 
decreased H3K9me2 levels, indicating that the PHD2 domain is required for H3K9me2 
rescue activity of the C-terminal half of Cfp1 (Fig. 34).   
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FIGURE 34.  Cfp1 has redundancy in function for appropriate levels of H3K9me2. 
Western blot analysis was performed on histone extracts collected from 
CXXC1+/+, CXXC1+/-, CXXC1-/-, and CXXC1-/- ES cells expressing vector control or 
Cfp1 1-656 using antisera directed against histone H3K9me2 and total histone H3 as a 
loading control.  The graph represents relative H3K9me2 expression normalized to total 
histone H3 protein expression from at least three independent experiments with error 
bars representing standard error.   
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FIGURE 35.  DNA binding activity of Cfp1 or association of Cfp1 with the Setd1 
complexes is required for appropriate global levels of H3K9me2.   
Western blot analysis was performed on histone extracts collected from 
CXXC1+/+, CXXC1-/-, vector control, and CXXC1-/- ES cells expressing Cfp1 1-656 or 
the indicated Cfp1 mutations using antisera directed against histone H3K9me2 and total 
histone H3 as a loading control.  The graph summarizes relative levels of H3K9me2 
normalized to total histone H3 protein expression from at least three independent 
experiments, with error bars representing standard error.   
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CXXC1-/- ES cells expressing full-length Cfp1 mutations (1-656 C169A and     
1-656 C375A) also rescue global levels of H3K9me2 (Fig. 35).  However, ablation of 
DNA-binding activity of Cfp1 1-367 (1-367 C169A) or disruption of Cfp1 361-656 
interaction with the Setd1 histone H3K4 methyltransferase complexes (361-656 
C375A) results in a significant decrease in H3K9me2 levels (Fig. 35).  This indicates 
that DNA-binding activity of Cfp1 1-367, and interaction of Cfp1 361-656 with the 
Setd1 histone H3K4 methyltransferase complexes is essential for appropriate histone 
H3K9 methylation.  However, a decrease in H3K9me2 expression was observed in 
CXXC1-/- ES cells expressing full-length Cfp1 containing both point mutations (1-656 
C169A, C375A).  This indicates that retention of either DNA-binding activity of full-
length Cfp1 or interaction of full-length Cfp1 with the Setd1 histone H3K4 
methyltransferase complexes is required to rescue histone H3K9me2 levels.  
   
5.  Retention of either DNA-binding activity of Cfp1 or association of Cfp1 
with the Setd1 complexes is required to rescue histone H3K4 methylation 
CXXC1-/- ES cells exhibit a ~2-fold increase in global levels of H3K4me3 6 days 
following induction of differentiation.  In order to determine the functional domains of 
Cfp1 necessary to rescue the increased levels of H3K4me3, Western blot analysis was 
performed to determine global levels of H3K4me3 in CXXC1-/- ES cells expressing 
Cfp1 mutations. CXXC1-/- ES cells expressing Cfp1 mutations were cultured under 
conditions to induce in vitro differentiation and histones were isolated at day 6 to assess 
the global levels of H3K4me3.  CXXC1-/- ES cells expressing Cfp1 1-481 (containing  
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FIGURE 36.  Cfp1 has redundancy in function for appropriate levels of H3K4me3. 
        Western blot analysis was performed on histone extracts collected from 
CXXC1+/+, CXXC1-/-, vector control, and CXXC1-/- ES cells expressing Cfp1 1-656 or 
the indicated Cfp1 truncations using antisera directed against histone H3K4me3 and 
total histone H3 as a loading control.  The graph summarizes relative levels of 
H3K4me3 normalized to total histone H3 protein expression from at least three 
independent experiments with error bars representing standard error.  Asterisks denote a 
statistically significant (p<0.05) difference compared to CXXC1-/- ES cells expressing 
full-length Cfp1 (1-656). 
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FIGURE 37.  DNA-binding activity of Cfp1 or association of Cfp1 with the Setd1 
complexes is required for appropriate global levels of H3K4me3.   
Western blot analysis was performed on histone extracts collected from 
CXXC1+/+, CXXC1-/-, vector control, and CXXC1-/- ES cells expressing full-length Cfp1 
(1-656) or the indicated Cfp1 mutations using antiserum directed against histone 
H3K4me3 and total histone H3 as a loading control.  The graph represents relative 
H3K4me3 expression normalized to total histone H3 protein expression from at least 
three independent experiments with error bars representing standard error.  Asterisks 
denote a statistically significant (p<0.05) difference compared to CXXC1-/- ES cells 
expressing full-length Cfp1 (1-656).  
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the PHD1, CXXC, acidic, basic, and coiled-coil domains) rescue H3K4me3 levels (Fig. 
36).  In addition, CXXC1-/- ES cells expressing either the amino half of Cfp1 (1-367; 
containing the PHD1, CXXC, acidic, and basic domains) or the carboxyl half of Cfp1 
(361-656; containing the coiled-coil, SID, and PHD2 domains) is sufficient to rescue 
H3K4me3 levels (Fig. 36).  In contrast, the basic domain is indispensable for Cfp1       
1-367 rescue activity because removal of the basic domain (Cfp1 1-320) results in 
failure to rescue H3K4me3 levels (Fig. 36).  In addition, Cfp1 103-367 (containing the 
CXXC, acidic, and basic domains) rescues H3K4me3 levels, indicating that the PHD1 
domain is not essential for appropriate histone H3K9 methylation (Fig. 36).  In contrast, 
CXXC1-/- ES cells expressing Cfp1 318-481 (containing the basic, SID, and coiled-coil 
domains) exhibit increased H3K4me3 levels, indicating that the PHD2 domain is 
required for H3K4me3 rescue activity of the C-terminal half of Cfp1 (Fig. 36).  
However, disruption of DNA binding activity of Cfp1 1-367 (1-367 C169A) or 
disruption of Cfp1 361-656 interaction with the Setd1A and Setd1B histone H3K4 
methyltransferase complexes (361-656 C375A) results in significantly elevated levels 
of H3K4me3 (Fig. 37).  In addition, a significant increase in H3K4me3 was observed in 
CXXC1-/- ES cells expressing full-length Cfp1 containing both point mutations (1-656 
C169A, C375A).  Therefore, consistent with Setd1A protein expression and H3K9me2 
levels, these data indicate that retention of either DNA-binding activity of Cfp1 or 
interaction of Cfp1 with the Setd1 histone H3K4 methyltransferase complexes is 
required to rescue global levels of H3K4me3.  
  
 
 163 
6. Cfp1 is required to restrict subnuclear localization of Setd1A protein and 
H3K4me3 to euchromatin   
Cfp1 has previously been shown to localize to euchromatin nuclear speckles and 
exhibit localization that was entirely distinct from heterochromatin markers such as 
HP1α, Mbd1, and Mecp2, but partially overlapping with euchromatin markers such as   
acetylated histones, sites of transcription, and RNA splicing (Lee 2002).  In addition, 
Setd1A and Setd1B are found in nuclear speckles that demonstrate euchromatin 
localization (Lee 2007).  Setd1A and Setd1B exhibit a largely non-overlapping 
subnuclear localization, suggesting that each of these closely related proteins is targeted 
to a unique set of genomic sites (Lee 2007).  However, little is known regarding the 
molecular mechanisms required for targeting the Setd1A complex.  Therefore, 
subnuclear localization of Setd1A protein and H3K4me3 was determined in relation to 
DAPI (4,6-diamidino-2-phenylindone) staining in CXXC1+/+, CXXC1-/-, CXXC1-/-  ES 
cells expressing Cfp1 1-656 and the empty vector by confocal immunofluorescense.   
Heterochromatin is characterized by dense DNA methylation and 
hypoacetylated histones, whereas transcriptionally active euchromatin is characterized 
by hypomethylated DNA and acetylated core histones (Weintraub 1976).  DAPI is a 
fluorescent stain that binds to DNA, and the more condensed structure of 
heterochromatin is characterized by DAPI-bright staining.  Quantification of percent 
overlap of Setd1A localization with DAPI-bright heterochromatin regions reveals a 
significant increase in colocalization of Setd1A with DAPI-bright heterochromatin 
regions in CXXC1-/- and CXXC1-/vector ES cells (Fig. 38).  In addition, rescue of 
subnuclear localization of Setd1A was observed in CXXC1-/- ES cells expressing  
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FIGURE 38.  Cfp1 is required to restrict Setd1A subnuclear localization to 
euchromatin. 
Endogenous nuclear distribution of Setd1A was detected in CXXC1+/+,   
CXXC1-/-, vector control, and CXXC1-/- ES cells expressing full-length Cfp1 (1-656) 
using rabbit anti-Setd1A antibody and bovine anti-rabbit IgG-fluorescein isothiocyanate 
(FITC)-conjugated secondary antibody.  Nuclei were counterstained with 4,6-
diamidino-2-phyenylindole (DAPI) and observed by confocal microscopy.  
Colocalization is indicated by a yellow color in the merged and colocalization images.   
The white numbers inside the image figure indicate the percent colocalized signals for 
that nucleus.  The numbers outside the image summarize the average percent overlap of 
Setd1A with DAPI-bright heterochromatin and standard error for at least 30 nuclei.  The 
asterisks denote a statistically significant difference (p<0.05) compared to CXXC1+/+ ES 
cells.   
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FIGURE 39.  Cfp1 is required to restrict H3K4me3 subnuclear localization to 
euchromatin. 
Endogenous nuclear distribution of H3K4me3 was detected in CXXC1+/+, 
CXXC1-/-, vector control, and CXXC1-/- ES cells expressing full-length Cfp1 (1-656) 
using rabbit anti-H3K4me3 antibody and bovine anti-rabbit IgG-fluorescein 
isothiocyanate (FITC)-conjugated secondary antibody.  Nuclei were counterstained with 
DAPI and observed by confocal microscopy.  Colocalization is indicated by a yellow 
color in the merged and colocalization images.  The white numbers inside the image 
figure indicate the percent colocalized signals for that nucleus.  The numbers outside the 
image summarize the average percent overlap of Setd1A with DAPI-bright 
heterochromatin and standard error for at least 30 nuclei.  The asterisks denote a 
statistically significant difference (p<0.05) compared to CXXC1+/+ ES cells.        
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Cfp1 1-656 (Fig. 38).  These results demonstrate that ES cells lacking Cfp1 exhibit mis-
localization of Setd1A with regions of heterochromatin.   
The Setd1A complex exhibits histone methyltransferase activity that is specific 
for histone H3K4 (Lee 2005).  Therefore, subnuclear localization of histone H3K4me3, 
a product of Setd1A methyltransferase activity, was analyzed by confocal 
immunofluorescence.  Quantification of percent overlap of H3K4me3 with DAPI-bright 
heterochromatin regions indicates a significant increase in colocalization of H3K4me3 
with DAPI-bright heterochromatin regions in CXXC1-/- and CXXC1-/- ES cells 
expressing vector (Fig. 39).  In addition, rescue of colocalization of H3K4me3 was 
observed in CXXC1-/- ES cells expressing Cfp1 1-656 (Fig. 39).  These results 
demonstrate that ES cells lacking Cfp1 exhibit mis-localization of Setd1A and 
H3K4me3 with DAPI-bright regions of heterochromatin.  Therefore, Cfp1 is important 
for restricting subnuclear localization of Setd1A and H3K4me3 to euchromatin.   
Individual CXXC1-/- ES cell nuclei exhibit a range of colocalization of Setd1A 
and H3K4me3 with DAPI-bright heterochromatin (5%-30% colocalization).  The data 
reported here are the average colocalization of ~30 nuclei for each cell line.  However, 
~20-30% mis-localization of Setd1A and H3K4me3 with DAPI-bright heterochromatin 
was observed in ~35-40% of CXXC1-/- and vector control ES cell nuclei examined.  A 
varied range of colocalization may be a consequence of variations in cell cycle stage 
between cell nuclei.  In mammals, Setd1A localizes to the 5’ ends of actively expressed 
genes and interacts with RNA polymerase II containing its C-terminal domain (CTD) 
phosphorylated at serine 5 (Ser5-P CTD), a mark which is associated with transcription  
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FIGURE 40.  Changes in distribution of CXXC1-/- ES cells within the cell cycle does 
not affect the magnitute of mis-localization of H3K4me3 with DAPI-bright 
heterochromatin.   
CXXC1+/+ and CXXC1-/- ES cells were treated with L-mimosine for 16 h, then 
collected for cell cycle distribution using propidium iodide staining and flow cytometry 
and also fixed with 4% formaldehyde at 0, 4 h, 8 h, 11 h, and 24 h after treatment for 
analysis by confocal immunofluorescence to determine subnuclear localization of 
H3K4me3.  Endogenous nuclear distribution of H3K4me3 was detected using rabbit 
anti-H3K4me3 antibody and bovine anti-rabbit IgG-fluorescein isothiocyanate (FITC)-
conjugated secondary antibody.  Nuclei were counterstained with DAPI and observed 
by confocal microscopy.  Quantification of percent colocalization of positive 
fluorescent signals for DAPI-bright and H3K4me3 was analyzed using MetaMorph's 
colocalization module.      
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initiation (Lee 2008).  Regulation of RNA polymerase II basal activity changes during 
the cell cycle, where transcription activity is low in the S and G2 phases and high in 
early G1 phase (Yonaha 2005).  Therefore, cells in G1 phase that exhibit increased 
transcriptional activity may exhibit increased mis-localization of Setd1A and 
H3K4me3.  CXXC1+/+ and CXXC1-/- ES cells were treated with L-mimosine, an iron 
chelator that inhibits DNA replication and arrests cells in G1, and analyzed for 
H3K4me3 subnuclear localization at various time points after treatment to determine if 
enrichment of CXXC1-/- ES cells in particular phases of the cell cycle would augment 
the subnuclear mis-localization of H3K4me3.  However, no significant difference in the 
magnitude of H3K4me3 colocalization with DAPI-bright heterochromatin was observed 
between untreated and treated cells at any time point analyzed (Fig. 40).   
 
7.  Full-length Cfp1 is required to restrict the Setd1A histone 
methyltransferase complex and H3K4me3 to euchromatin 
CXXC1-/- ES cells expressing Cfp1 mutations were analyzed to determine the 
functional domains of Cfp1 required for restricting the Setd1A histone 
methyltransferase complex to euchromatin.  Subnuclear localization of Setd1A and 
H3K4me3 was determined in relation to DAPI staining in CXXC1+/+, CXXC1-/-, and 
CXXC1-/- ES cells expressing Cfp1 mutations by confocal immunofluorescense as 
previously described.  CXXC1+/+ ES cells and CXXC1-/- ES cells expressing Cfp1 1-656 
exhibit very little Setd1A and H3K4me3 localization in DAPI-bright heterochromatic 
regions (Fig. 41, Fig. 42).  In contrast, CXXC1-/- ES cells expressing Cfp1 1-656 
C169A, 1-656 C375A, 1-367, 361-656, 1-367 C169A, 361-656 C375A, and  
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FIGURE 41.  Full-length Cfp1 is required to restrict Setd1A protein subnuclear 
localization to euchromatin. 
(A)  Endogenous nuclear distribution of Setd1A was detected in CXXC1+/+, 
CXXC1-/-, vector control, and CXXC1-/- ES cells expressing full-length Cfp1 (1-656) or 
the indicated Cfp1 mutations using rabbit anti-Setd1A antibody and bovine anti-rabbit 
IgG-fluorescein isothiocyanate (FITC)-conjugated secondary antibody.  Nuclei were 
counterstained with DAPI and observed by confocal microscopy.  Colocalization is 
indicated by a yellow color in the merged and colocalization images.  The white 
numbers inside the image figure indicate the percent colocalized signals for that 
nucleus.  The numbers outside the image summarize the average percent overlap of 
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Setd1A with DAPI-bright heterochromatin and standard error for at least 30 nuclei.  The 
asterisks denote a statistically significant difference (p<0.05) compared to CXXC1-/- ES 
cells expressing Cfp1 1-656.   
(B)  The graph summarizes the average percent overlap of Setd1A with DAPI-
bright heterochromatin for at least 30 nuclei.  The error bars represent standard error, 
and asterisks denote a statistically significant difference (p<0.05) compared to    
CXXC1-/- ES cells expressing Cfp1 1-656.  Quantification of percent colocalization of 
positive fluorescent signals for DAPI-bright and Setd1A was analyzed with the same 
threshold for each image using MetaMorph's colocalization module.      
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FIGURE 42.  Full-length Cfp1 is required to restrict H3K4me3 subnuclear 
localization to euchromatin.    
Endogenous nuclear distribution of H3K4me3 was detected in CXXC1+/+, 
CXXC1-/-, vector control, and CXXC1-/- ES cells expressing full-length Cfp1 (1-656) and 
the indicated Cfp1 mutations using rabbit anti-H3K4me3 antibody and bovine anti-
rabbit FITC-conjugated secondary antibody.  Nuclei were counterstained with DAPI 
and observed by confocal microscopy.  Colocalization is indicated by a yellow color in 
the merged and colocalization images.  The white numbers inside the image figure 
indicate the percent colocalized signal for that nucleus.  The numbers outside the image 
summarize the average percent overlap of H3K4me3 with DAPI-bright heterochromatin 
and standard error for at least 30 nuclei.  The asterisks denote a statistically significant 
difference (p<0.05) compared to CXXC1-/- ES cells expressing Cfp1 1-656.   
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FIGURE 43.  Full-length Cfp1 is required to restrict H3K4me3 subnuclear 
localization to euchromatin.    
(A)  Endogenous nuclear distribution of H3K4me3 was detected in CXXC1+/+, 
CXXC1-/-, vector control, and CXXC1-/- ES cells expressing full-length Cfp1 (1-656) and 
the indicated Cfp1 mutations using rabbit anti-H3K4me3 antibody and bovine anti-
rabbit FITC-conjugated secondary antibody.  Nuclei were counterstained with DAPI 
and observed by confocal microscopy.  Colocalization is indicated by a yellow color in 
the merged image and colocalization images.  The white numbers inside the image 
figure indicate the percent colocalized signal for that nucleus.  The numbers outside the 
image summarize the average percent overlap of H3K4me3 with DAPI-bright 
heterochromatin and standard error for at least 30 nuclei.  The asterisks denote a 
statistically significant difference (p<0.05) compared to CXXC1-/- ES cells expressing 
Cfp1 1-656.   
(B)  The graph summarizes the average percent overlap of H3K4me3 with 
DAPI-bright heterochromatin for at least 30 nuclei.  The error bars represent standard 
error, and asterisks denote a statistically significant difference (p<0.05) compared to 
CXXC1-/- ES cells expressing Cfp1 1-656.  Quantification of percent colocalization of 
positive fluorescent signals for DAPI-bright and H3K4me3 was analyzed with the same 
threshold for each image using MetaMorph's colocalization module.       
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1-656 C169A, C375A exhibit a significant increase in localization of Setd1A and 
H3K4me3 to DAPI-bright heterochromatic regions (Fig. 41, Fig. 42).  Quantification of 
percent overlap of Setd1A and H3K4me3 localization with DAPI-bright 
heterochromatin regions indicates a significant increase in co-localization of Setd1A 
and H3K4me3 with DAPI-bright heterochromatin regions in CXXC1-/- ES cells 
expressing Cfp1 1-656 C169A, 1-656 C375A, 1-367, 361-656, 1-367 C169A, 361-656 
C375A, and 1-656 C169A, C375A (Fig. 41, Fig. 42).  In contrast to rescue activity for 
Setd1A protein expression and global levels of histone methylation, full-length Cfp1 is 
required to restrict the Setd1A complex and histone H3K4me3 to euchromatin, 
indicating that Cfp1 PHD domains, DNA-binding activity, and Cfp1 association with 
the Setd1A histone methyltransferase complex are required for restricting subnuclear 
localization of Setd1A and H3K4me3 to euchromatin.  
 
8.  Summary 
The data presented in this portion of the dissertation reveals that CXXC1-/- ES 
cells expressing Cfp1 mutations that exhibit reduced Setd1A protein expression also 
exhibit slightly reduced levels of histone H3K9me2 and elevated levels of histone 
H3K4me3.  Interestingly, consistent with plating efficiency, cytosine methylation, and 
in vitro differentiation, expression of either the amino half of Cfp1 (1-367) or carboxyl 
half of Cfp1 (361-656) is sufficient to rescue Setd1A protein expression and histone 
methylation defects observed in CXXC1-/- ES cells.  Additional studies revealed that a 
point mutation (C169A) that abolishes DNA-binding activity of Cfp1 ablates the rescue 
activity of the 1-367 Cfp1 fragment, and a point mutation (C375A) that abolishes the 
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interaction of Cfp1 with the Setd1A and Setd1B histone H3K4 methyltransferase 
complexes ablates the rescue activity of the 361-656 Cfp1 fragment.  Introduction of 
both mutations (C169A and C375A) ablates the rescue activity of the full-length Cfp1 
protein.  These results indicate that retention of either DNA-binding activity or Setd1 
association of Cfp1 is required for appropriate Setd1A protein expression and global 
levels of histone methylation.  In contrast, full-length Cfp1 (1-656) is required to restrict 
subnuclear localization of Setd1A protein and histone H3K4me3 to euchromatic 
regions, indicating that Cfp1 DNA-binding activity and Cfp1 interaction with the 
Setd1A histone methyltransferase complex are both required for proper subnuclear 
localization of Setd1A and histone H3K4me3.  A summary of the Setd1A protein 
expression, histone methylation, and Setd1A and H3K4me3 subnuclear localization 
rescue activity of CXXC1-/- ES cells expressing Cfp1 mutations is presented in Table 7.  
A summary of all the rescue activity data for each individual clone analyzed is 
presented in Table 8 and Table 9.  
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TABLE 7.  Summary of Setd1A protein expression and histone methylation data. 
The table represents a summary of the rescue data for CXXC1-/- ES cells 
expressing the indicated Cfp1 mutations.  Ability to rescue indicated defect is indicated 
with (+), an inability to rescue (significant [p<0.05] difference compared to Cfp1 1-656) 
is indicated by a (-), and ND represents that the indicated analysis was not determined 
for that particular Cfp1 mutation (local. refers to subnuclear localization of Setd1A and 
histone H3K4me3 to euchromatin).   
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ND-------821-656 CC4-2 12
ND-------641-656 CC4-2 1
1-656 C169A,YCS389AAA
--------541-656 CC2A
--------941-656 CC3A
1-656 C169A,C375A
ND+++++++54C4-2 2
ND+++++++78C4-2 
1-656 YCS389AAA
-+++++++60Cys1 5
-+++++++102Cys1 1D
1-656 C375A
ND+++++\\57C586A 2D
ND+++++\+98C586A 1D
1-656 C586A
ND+++-+++74CXXCB 1D
ND+++++++86CXXCB 6D
ND+++++++94CXXCB 2D
1-656 C208A
-+++++++651-656 7A 
-+++-+++40PFCX6
1-656 C169A
NDND+\++\+54PHD1B-8
NDND++++++67PHD1B-4
1-656 C73A
+ND++++++127EPHD1A2
+ND++-\-\79EPHD1A1
1-656 C29A
++++++++92PFCGBP3
++++++++111PFCGBP2
++++++++108PFCGPB1
1-656
---------EVec3
---------Evec1
--------
-EVec2
Vector
Setd1A/H3K4me3 
Targeting
Histone
MeSetd1ADIFF.Dnmt1
Cytosine 
MePEGrowth
CFP1 Protein 
% of 
CXXC1+/+clone
 
TABLE 8.  Summary of Cfp1 full-length clone data. 
The table represents a summary of clone rescue data for CXXC1-/- ES cells 
expressing indicated Cfp1 mutations.  Ability to rescue indicated defect is indicated 
with (+), an inability to rescue (significant [p<0.05] difference compared to Cfp1 1-656) 
is indicated with (-), an intermediate ability to rescue is indicated with (\), and ND 
represents that the indicated analysis was not determined for that particular Cfp1 
mutation (PE, plating efficiency; Me, methylation; Dnmt1 and Setd1A, protein 
expression; DIFF., in vitro differentiation).  
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TABLE 9.  Summary of Cfp1 truncation clone data. 
The table represents a summary of clone rescue data for CXXC1-/- ES cells 
expressing indicated Cfp1 mutations.  Ability to rescue indicated defect is indicated 
with (+), inability to rescue (significant [p<0.05] difference compared to Cfp1 1-656) is 
indicated with (-), an intermediate ability to rescue is indicated with (\), and ND 
represents that the indicated analysis was not determined for that particular Cfp1 
mutation (PE, plating efficiency; Me, methylation; Dnmt1 and Setd1A, protein 
expression, DIFF., in vitro differentiation).  
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V.  Analysis of Cfp1 Function in DNA Damage Sensitivity 
1.  CXXC1-/- ES cells exhibit hypersensitivity to DNA damaging agents 
  Ionizing radiation (IR) and consequent reactive oxygen species (ROS) lead to 
breaks in the phosphodiester backbone of DNA as well as oxidative modifications of 
bases.  IR also generates abasic sites, either directly by free radical attack at 
deoxyribose or by formation of oxidized bases that are substrates for DNA glycosylases 
(Mitra 2002).  IR causes DNA DSBs either directly or indirectly by forming clusters of 
oxidative damage, which can be converted to DNA breaks during repair (Courtemanche 
2004).  These lesions are particularly dangerous for proliferating cells and DNA 
damage must be efficiently recognized and removed before DNA replication and 
chromosome segregation (Costelloe 2006).  CXXC1+/+ and CXXC1-/- ES cells were 
exposed to increasing amounts of IR before being plated for assessment of clonogenic 
survival.  CXXC1-/- ES cells exhibit decreased cell survival compared to CXXC1+/+ at 
100 rad and a significant decrease in cell survival at 200 rad and 400 rad           
treatment (Fig. 44A).   
In order to determine if CXXC1+/+ and CXXC1-/- ES cells showed differences in 
clonogenic survival after treatment with an alkylating DNA damaging agent,    
CXXC1+/+ and CXXC1-/- ES cells were treated with increasing amounts of methyl 
methanesulfonate (MMS) and analyzed for colony forming ability.  The majority (50-
80%) of damaged DNA bases caused by therapeutic alkylating agents are N-alkyl 
purines, which can be converted to abasic sites either by DNA glycosylase-mediated 
cleavage or by spontaneous hydrolysis of the glycosylic linkage between deoxyribose 
and the altered base (Lhomme 1999).  Alkylating agents induce modification (or loss) 
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of bases.  The most abundant lesions produced by MMS are N-methylpurines, which 
are repaired by BER (Atain 2006).  CXXC1-/- ES cells exhibit increased sensitivity to 
MMS compared to CXXC1+/+ cells at every concentration of MMS treatment, and a 
significant decrease was observed at 250 nM, 500 nM, and 800 nM treatment (Fig. 
44B).   
Etoposide is a DNA damaging agent that causes DNA single strand breaks and 
double strand breaks (DSBs) (Ross 1978).  Etoposide causes DNA damage through 
inhibition of topoisomerase II and activation of oxidation-reduction reactions to produce 
derivatives that bind directly to DNA (Liu 1989).  Topoisomerase II carries out 
breakage and reunion reactions of DNA which are necessary for transcription and DNA 
replication.  CXXC1-/- ES cells exhibit an increased sensitivity to etoposide at every 
concentration analyzed, and a significant decrease in cell survival compared to 
CXXC1+/+ ES cells at 100 nM, 500 nM, and 1 µM etoposide concentrations (Fig. 44C).   
Cisplatin (cis-diamminedichloroplatinum, cis-DDP) is one of the most effective 
chemotherapeutic anti-neoplastic agents, whose action is believed to result from its 
interactions with DNA.  The N7 atoms of guanine and adenine are the main binding 
sites for platinum complexes in DNA (Widlak 2006).  The DNA adducts induced by 
cisplatin include monoadducts, interstrand and intrastrand DNA cross-links and DNA-
protein cross-links that interfere with DNA replication and transcription (Widlak 2006).  
In addition, ROS are generated following cisplatin treatment (Yang 2005).  CXXC1-/- ES 
cells exhibit a significant decrease in cell survival compared to CXXC1+/+ ES cells at all 
concentrations tested (0.5 µM, 1 µM, 5 µM, and 10 µM) (Fig. 44D).   
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FIGURE 44.  Sensitivity of CXXC1+/+ and CXXC1-/- ES cells to DNA damaging 
agents. 
Clongogenic survival of CXXC1+/+ and CXXC1-/- ES cells after treatment with 
ionizing radiation (A), methyl methanesulfonate (B), etoposide (C), cisplatin (D), 
temozolomide (E), or hydrogen peroxide (F).  Each point represents the mean ± 
standard error from the results of at least 3 experiments, with each experiment 
representing 3 dishes per treatment group. Asterisks denote a statistically significant 
(p<0.05) difference compared to CXXC1+/+ ES cells.   
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Temozolomide (TMZ) is an alkylating agent that is non-enzymatically 
hydrolyzed in solution to an active compound that methylates DNA primarly at the N7 
and O6 positions of guanine and the N3 of adenine (Mutter 2006).  Hypersensitivity to 
TMZ was observed in CXXC1-/- ES cells, and a significant decrease was observed at all 
concentrations tested (25 µM, 50 µM, and 100 µM) (Fig. 44E).   
Hydrogen peroxide (H2O2) is an agent that generates ROS that lead to oxidative 
DNA damage, the most abundant being a base modification to 7,8-dihydro-8-
oxoguanine (8-oxoG) that can cause DNA DSBs (Daroui 2004).  Similar to cisplatin 
and TMZ, hypersensitivity to H2O2 was observed in CXXC1-/- ES cells, and a significant 
decrease in cell survival was observed at all concentrations (1 µM, 5 µM, and 10 µM) 
(Fig. 44F).      
Taken together, these results indicate that CXXC1-/- ES cells are hypersensitive 
to DNA damaging agents that cause DNA strand breaks (IR and etoposide), alkylation 
(MMS, TMZ), DNA cross-links (cisplatin), and oxidative (IR, H2O2, cisplatin) damage 
compared to CXXC1+/+ ES cells.  CXXC1-/- ES cells exhibit an extended population 
doubling time due to an increase in apoptosis (Carlone 2005).  Therefore, longer time 
points for colony formation were analyzed in case CXXC1-/- ES cells colonies take 
longer to arise.  However, there was no difference in number of colonies formed for 
either the CXXC1+/+ or CXXC1-/- ES cell lines after an extended incubation time (data 
not shown).     
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FIGURE 45.  Sensitivity of CXXC1+/+ and CXXC1-/- ES cells to non-genotoxic 
agents. 
Clonogenic survival of CXXC1+/+ and CXXC1-/- ES cells after treatment with 
methotrexate (A), or paclitaxel (B).  Each point represents the mean ± standard error 
from the results of at least 3 experiments, with each experiment representing 3 dishes 
per treatment group. 
  
 
 
 
 
 187 
2.  CXXC1-/- ES cells do not demonstrate hypersensitivity to non-genotoxic 
agents 
CXXC1-/- ES cells display a variety of defects when compared to CXXC1+/+ ES 
cells, including an increased population doubling time due to an increase in apoptosis, 
an inability to undergo in vitro differentiation, decreased global and gene-specific 
cytosine methylation, and altered covalent modifications of histone proteins (Carlone 
2005; Lee 2005).  Due to the variety of defects observed in the CXXC1-/- ES cells 
compared to CXXC1+/+ ES cells, we suspected that CXXC1-/- ES cells suffering such 
stresses might be sensitive to any cytotoxic agent.  In order to test this possibility, 
CXXC1+/+ and CXXC1-/- ES cells were treated with methotrexate (MTX) or paclitaxel 
(taxol) and analyzed for colony forming ability.  MTX is an inhibitor of dihydrofolate 
reductase, an enzyme which is needed for thymidine synthesis, resulting in inhibition of 
DNA replication which leads to cell death (Longo-Sorbello 2001; McGuire 2003).  
Taxol is an anti-mitotic agent that interferes with microtubule growth by hyper-
stabilizing microtubule structure, thereby blocking cell cycle progression and leading to 
apoptosis (Abal 2003).  There was no significant difference in cell survival between 
CXXC1+/+ and CXXC1-/- ES cells after treatment with MTX (Fig. 45A) or with taxol 
(Fig. 45B).  CXXC1+/+ and CXXC1-/- ES cells were treated with additional higher 
concentrations of MTX and taxol (up to 50 µM MTX and 75 µM taxol) for various 
amounts of time and no significant difference in cell survival was observed at any 
concentration (data not shown).  These data indicate that the hypersensitivity of  
CXXC1-/- ES cells is specific to DNA damaging agents and is not a general sensitivity to 
any cytotoxic agent.   
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3.  Expression of Cfp1 in CXXC1-/- ES cells rescues the hypersensitivity to 
DNA damaging agents  
Previous experiments demonstrated that expression of full-length wild-type 
Cfp1 protein in CXXC1-/- ES cells (CXXC1-/cDNA) corrects the defects observed in 
CXXC1-/- ES cells (Carlone 2005).  To determine if reconstitution of Cfp1 in       
CXXC1-/- ES cells rescues the hypersensitivity to DNA damaging agents, CXXC1+/+, 
CXXC1-/-, and  CXXC1-/cDNA ES cells were treated with TMZ, cisplatin, and H2O2 and 
analyzed for clonogenic survival.  CXXC1-/- ES cells demonstrate hypersensitivity to 
TMZ, cisplatin, and H2O2 (Fig. 46).  In contrast, CXXC1-/cDNA ES cells demonstrate 
sensitivity to TMZ, cisplatin, and H2O2 similar to CXXC1+/+ ES cells (Fig. 46).  This 
indicates that expression of Cfp1 rescues the hypersensitivity of CXXC1-/- ES cells to 
DNA damaging agents, indicating that the increased sensitivity is specifically due to 
loss of Cfp1.   
 
4.  Hypersensitivity of CXXC1-/- ES cells to DNA damaging agents is not 
solely caused by decreased cytosine methylation 
CXXC1-/- ES cells exhibit a significant increase in the amount of euchromatin 
compared to CXXC1+/+ ES cells, as demonstrated by a 60-80% decrease in global 
cytosine methylation and an increase in H3K4 di- and tri-methylation, marks associated 
with euchromatin, and a decrease in histone H3K9 di-methylation, a mark associated 
with more condensed heterochromatin (Carlone 2005; Lee 2005).  Since CXXC1-/- ES 
cells exhibit a more open chromatin structure than CXXC1+/+ ES cells, it was 
hypothesized that the DNA in CXXC1-/- ES cells is more accessible to genotoxic agents  
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FIGURE 46.  Sensitivity of CXXC1+/+, CXXC1-/-, and CXXC1-/cDNA ES cells to DNA 
damaging agents.  
Clonogenic survival of CXXC1+/+, CXXC1-/-, and CXXC1-/cDNA ES cells after 
treatment with temozolomide (A), cisplatin (B), or hydrogen peroxide (C).  Each point 
represents the mean ± standard error from the results of at least 3 experiments, with 
each experiment representing 3 dishes per treatment group. Asterisks denote a 
statistically significant (p<0.05) difference compared to CXXC1+/+ ES cells.   
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due to a more relaxed, open chromatin structure, and this could potentially explain the 
increased sensitivity to DNA damaging agents.  Dnmt enzymes are responsible for the 
establishment and maintenance of DNA methylation patterns in mammals (Li 2002).  
Dnmt1 plays a major role in maintaining global methylation patterns (Li 2002).  
DNMT1-/- ES cells have a greater decrease in global cytosine methylation compared to 
CXXC1-/- ES cells.  Therefore, the sensitivity toDNA damaging agents was analyzed in 
DNMT1-/- ES cells to determine if a global loss of cytosine methylation accounts for the 
increased sensitivity of CXXC1-/- ES cells to genotoxic agents.  Global cytosine 
methylation was analyzed using a DNA methyl acceptance assay as previously 
described.  Genomic DNA derived from CXXC1-/- or DNMT1-/- ES cells can accept 
approximately 2.5 and 3-fold more methyl groups than DNA derived from      
CXXC1+/+ ES cells, indicating ~60% decrease in global cytosine methylation on 
CXXC1-/- ES cell DNA and ~67% decrease on DNMT1-/- ES cell DNA (Fig. 47).  In 
addition, expression of wild-type Cfp1 in CXXC1-/- ES cells (CXXC1-/cDNA) rescues the 
decreased cytosine methylation, indicating that the global loss of cytosine methylation 
observed in  CXXC1-/- ES cell DNA is specifically due to loss of Cfp1.   
To determine if DNMT1-/- ES cells exhibit hypersensitivity to DNA damaging 
agents, DNMT1-/-, CXXC1+/+, and CXXC1-/- ES cells were treated with cisplatin, TMZ, 
and H2O2 and analyzed for clonogenic survival.  Interestingly, DNMT1-/- ES cells show 
sensitivity to cisplatin, TMZ, and H2O2 similar to that of CXXC1+/+ ES cells (Fig. 47).  
DNMT1-/- ES cells also exhibit sensitivity similar to that of CXXC1+/+ ES cells upon 
treatment with the cytotoxic agents MTX and taxol (Fig. 48).  These data indicate that  
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FIGURE 47.  DNA damaging agent sensitivity in CXXC1+/+, CXXC1-/-, and 
DNMT1-/- ES cells. 
 (A)  Global cytosine methylation levels were determined by methyl acceptance 
assay for genomic DNA isolated from CXXC1+/+, CXXC1-/-, CXXC1-/cDNA, and   
DNMT1-/- ES cells.  The graph represents the results from three independent 
experiments and error bars represent standard error.  Asterisks denote a statistically 
significant (p<0.05) difference compared to CXXC1+/+ ES cell DNA.   
(B)  Clonogenic survival of CXXC1+/+, CXXC1-/-, and DNMT1-/- ES cells after 
treatment with cisplatin (B), temozolomide (C), or hydrogen peroxide (D).  Each point 
represents the mean ± standard error from at least 3 experiments, with each experiment 
representing 3 dishes per treatment group. Asterisks denote a statistically significant 
(p<0.05) difference compared to CXXC1+/+ ES cells.  
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FIGURE 48.  Sensitivity of CXXC1+/+, CXXC1-/-, CXXC1-/cDNA, and DNMT1-/- ES 
cells to non-genotoxic agents. 
Clonogenic survival of CXXC1+/+, CXXC1-/-, and DNMT1-/- ES cells after 
treatment with methotrexate (A), or paclitaxel (B).  Each point represents the mean ± 
standard error from the results of at least 3 experiments, with each experiment 
representing 3 dishes per treatment group. 
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DNMT1-/- ES cells do not demonstrate hypersensitivity to DNA damaging agents (TMZ, 
cisplatin, and H2O2) compared to CXXC1+/+ ES cells, indicating that the 
hypersensitivity of CXXC1-/- ES cells cannot be explained by a reduction in global 
cytosine methylation. 
 
5.  CXXC1-/- ES cells exhibit decreased Ape1 protein expression and 
endonuclease activity 
The majority of DNA damaging agents that CXXC1-/- ES cells exhibit increased 
sensitivity to cause lesions that can be repaired by the BER pathway.  Microarray 
analysis demonstrates that mRNA expression of genes involved in DNA repair 
pathways are altered in CXXC1-/- ES cells compared to CXXC1+/+ ES cells (data not 
shown).  Interestingly, CXXC1-/- ES cells demonstrate decreased (~33%) mRNA 
expression of Ape1 (data not shown).  Ape1 is the major apurinic/apyrimidinic 
endonuclease activity in human cells responsible for recognition and incision of non-
coding AP sites in DNA arising as a consequence of spontaneous, chemical, or DNA 
glycosylase-mediated hydrolysis of the Ν-glycosyl bond initiated by the BER pathway 
(Raffoul 2004; Demple 1994).  In addition, targeted depletion of Ape1 protein by anti-
sense oligonucleotides renders mammalian cells hypersensitive to several DNA 
damaging agents including MMS, TMZ, cisplatin, and H2O2 (Walker, 1998; Yang, 
2005; Ono, 1994).  Therefore, the protein expression level and endonuclease activity of 
Ape1 was determined in CXXC1+/+, CXXC1-/-, and DNMT1-/- ES cells.   
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FIGURE 49.  Ape1 protein expression and endonuclease activity in CXXC1+/+, 
CXXC1-/-, and DNMT1-/- ES cells.  
(A)  Western blot analysis was performed on protein extracts collected from 
CXXC1+/+, CXXC1-/-, DNMT1-/-, and CXXC1-/cDNA ES cells using antiserum directed 
against Cfp1, Dnmt1, Ape1, Xrcc1, and β-actin as a loading control.  The graph 
represents results from at least three independent experiments and error bars represent 
standard error.  Asterisk denotes a significant (p<0.05) decrease in Ape1 protein 
expression when compared to CXXC1+/+ ES cells.  
(B)  Ape1 endonuclease activity was analyzed in CXXC1+/+, CXXC1-/-, and 
DNMT1-/- ES cells using an oligonucleotide gel-based Ape1 activity assay performed by 
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Dr. Melissa L. Fishel.  A 26 bp oligonucleotide substrate contained a single THF residue 
in the middle, yielding a HEX-labeled 13-mer fragment upon excision.  Ape1 activity 
was measured by incubating HEX-labeled excess oligo substrate with 15.63 ng and 7.81 
ng cellular protein followed by quantification of the level of the 13-mer (AP 
endonuclease cleavage product) relative to the 26-mer substrate.  The bottom panel is 
Western blot analysis for β-actin using 2.5 µg whole cell extract to show equal protein 
concentration of CXXC1+/+, CXXC1-/-, and DNMT1-/- ES cells using same protein 
extracts utilized for the Ape1 endonuclease activity assay.  The graph represents results 
from at least three independent experiments and error bars represent standard error.  
Asterisks denotes a significant (p<0.05) decrease in Ape1 endonuclease activity when 
compared to CXXC1+/+ ES cells.  
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Western blot analysis revealed ~50% decrease in Ape1 protein expression in 
CXXC1-/- ES cells and a slight increase in Ape1 protein expression in DNMT1-/- ES cells 
(Fig. 49).  In addition, expression of Cfp1 in the CXXC1-/- ES cells (CXXC1-/cDNA) was 
sufficient to reconstitute Ape1 protein expression back to levels observed in CXXC1+/+ 
ES cells (Fig. 49).  In contrast, protein expression of another downstream component  
involved in the BER pathway, Xrcc1, was unchanged between CXXC1+/+ and     
CXXC1-/- ES cells (Fig. 49A).  Xrcc1 functions as both a scaffold protein and modulator 
of BER via functional and physical interaction with Ape1, bridging the incision and 
nick-sealing steps of BER (Raffoul 2004).  Xrcc1 interacts with DNA ligase III and 
DNA β-polymerase to play a role to regenerate an intact DNA strand (Kulkari 2008).  
Ape1 endonuclease activity assays were performed by Dr. Melissa Fishel.  Ape1 
endonuclease activity was measured by incubation of protein cell extracts with a 26-mer 
HEX-labeled oligonucleotide substrate that contains an AP site.  A 13-mer 
oligonucleotide is produced upon cleavage of the AP site by Ape1 endonuclease 
activity.  The amount of cleavage product (13-mer) relative to the amount of original 
substrate oligonucleotide (26-mer) is indicative of Ape1 endonuclease activity.  
Consistent with Ape1 protein levels, Ape1 endonuclease activity is significantly     
(~40-50%) decreased in CXXC1-/- ES cells compared to CXXC1+/+ ES cells (Fig. 49B).   
Immunoprecipitation was performed to determine if Ape1 interacts with Cfp1.  
Full-length FLAG-epitope tagged Cfp1 was expressed in human embryonic kidney 
(HEK-293) cells, followed by isolation of FLAG agarose beads and detection of 
interacting protein by Western blot.  However, Ape1 was not detected as a pull-down 
product with Cfp1 (Fig. 50).  Ape1 subcellular localization is controlled by a strictly  
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FIGURE 50.  Ape1 does not interact with Cfp1.   
Nuclear extracts prepared from Human embryonic kidney (HEK-293) cells 
expressing FLAG-Cfp1 (full-length 1-656, 1-656 C580A, or 1-656 C586A) were 
subjected to FLAG-immunoprecipitation followed by western blot analysis.  Western 
blots were probed with Ape1 and FLAG antibodies.   
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FIGURE 51.  Ape1 is distributed throughout the nucleus and cytoplasm in ES 
cells.   
Endogenous nuclear distribution of Ape1 was detected in CXXC1+/+ and   
CXXC1-/- ES cells using mouse anti-Ape1 antibody and bovine anti-mouse IgG-
fluorescein isothiocyanate (FITC)-conjugated secondary antibody.  Nuclei were 
counterstained with 4,6-diamidino-2-phyenylindole (DAPI) and observed by confocal 
microscopy.   
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regulated process and is quite variable, where some cell types exhibit only nuclear 
localization of Ape1, others display only cytoplasmic, while others show both nuclear 
and cytoplasmic localization of Ape1 (Tell 2005).  In addition, Ape1 subcellular 
distribution pattern is linked to different pathological conditions, including cancer and 
neurodegenerative diseases (Tell 2009).  Therefore, immunohistochemical staining 
followed by confocal microscope analysis was carried out to determine if there was a 
difference in the subcellular localization of Ape1 in CXXC1+/+ and CXXC1-/- ES cells.  
However, there was no apparent difference in Ape1 localization in CXXC1-/- ES cells 
compared to CXXC1+/+ ES cells (Fig. 51).  Each cell line demonstrated a punctate 
staining of Ape1 distributed mostly within the nucleus with very little cytoplasmic 
localization (Fig. 51).  
  
6.  CXXC1-/- ES cell DNA exhibits increased incorporation of platinum 
To determine whether the increased cytotoxicity of CXXC1-/- ES cells to 
cisplatin correlated with higher levels of DNA damage, atomic absorption spectroscopy 
was performed by Julianne Holleran at the University of Pittsburgh to evaluate the total 
amount of platination on DNA in CXXC1+/+ and CXXC1-/- ES cells.  Immediately after 
treatment with 200 or 300 µM cisplatin, there was an increase in the amount of 
platinum/µg DNA in CXXC1-/- ES cell DNA compared to CXXC1+/+ ES cell DNA (Fig. 
52A).  Because CXXC1-/- ES cells demonstrate a significant increase in euchromatin, the 
increased incorporation of platinum may be due to increased accessibility of cisplatin to 
CXXC1-/- ES cell DNA.    
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FIGURE 52.  CXXC1-/- ES cells accumulate increased DNA damage.  
(A)  CXXC1+/+ and CXXC1-/- ES cells were treated with 100, 200, or 300 µM 
cisplatin for 3 hrs.  Genomic DNA was isolated and atomic absorption spectroscopy 
was carried out by Julianne Holleran at the University of Pittsburgh to determine the 
amount of platinum incorporated onto the DNA.  The graph summarizes the results 
from three independent experiments and error bars represent standard error.  Asterisk 
denotes a significant (p<0.05) increase in platinum incorporation compared to 
CXXC1+/+ ES cells.  
(B)  CXXC1+/+ and CXXC1-/- ES cells were treated with 10 µM cisplatin or 
DMSO vehicle controls for 3 h.  Cells were collected at 0, 3, 6, 14, and 24 h after the 
removal of cisplatin from the media.  Protein extracts were isolated and subjected to 
Western blot analysis by Dr. Melissa L. Fishel.  The graph represents results from one 
experiment, and the amount of H2AX-γ is normalized to actin expression. 
 202 
7.  CXXC1-/- ES cells demonstrate increased H2AX-γ formation upon DNA 
damage 
Chromatin surrounding a DSB is modified for direct recruitment of DNA 
damage response proteins, with recruitment often being mediated by specific covalent 
histone modifications, and modification of compacted chromatin structure to facilitate 
DNA repair (Costelloe 2006).  As another marker of DNA damage, we measured the 
level of H2AX phosphorylation (H2AX-γ) in CXXC1+/+ and CXXC1-/- ES cells after 
cisplatin- and TMZ-induced DNA damage.  Phosphorylation of H2AX is catalyzed by 
DNA damage checkpoint protein kinases, ATM (ataxia-telangiectasia-mutated protein 
kinase), ATR (ATM/Rad3 related kinase), and DNA-PK (DNA-dependent protein 
kinase) in human cells as a marker of DSBs.  These kinases are recruited to DSBs 
through their association with partner proteins that recognize DNA lesions either 
directly or indirectly (Wurtele 2006).  The functions of H2AX-γ include chromatin 
modification and facilitating a checkpoint that prevents cell division as a consequence 
of DNA damage (Bassal 2005).  Repair of DNA DSBs is expected to be important for 
ES cells due to the high basal level of H2AX-γ (Tichy 2008).  Treatment with cisplatin 
markedly increases H2AX-γ levels in CXXC1+/+ and CXXC1-/- ES cells compared to 
untreated controls at 6, 14, and 24 hr following cisplatin treatment (Fig. 52B). Multiple 
experiments were conducted and representative data is shown. There was a trend toward 
an increase in H2AX-γ with cisplatin and TMZ treatment in CXXC1-/- ES cells at 0, 6, 
14, and 24 hr following 3 h (cisplatin 10 µM) or 4 hr (TMZ 1 µM) treatment but the 
data was only significant directly after 4 hr TMZ treatment (data not shown).  
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FIGURE 53.  Redundant functional domains within the Cfp1 protein rescue 
hypersensitivity to TMZ and cisplatin.      
Clonogenic survival for CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing 
vector, full-length Cfp1 1-656, Cfp1 1-367, or Cfp1 361-656 after treatment with 
temozolomide (A) or cisplatin (B).  Each point represents the mean ± standard error 
from results of at least 3 experiments, with each experiment representing 3 dishes per 
treatment group.  All data points located below asterisks denote statistically significant 
decreases compared to full-length Cfp1 (1-656).   
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8.  Redundant functional domains within the Cfp1 protein rescue 
hypersensitivity to TMZ and cisplatin 
CXXC1+/+, CXXC1-/-, and  CXXC1-/- ES cells expressing full-length Cfp1 1-656, 
or Cfp1 truncations 1-367 and 361-656  were analyzed for clonogenic survival after 
treatment with TMZ and cisplatin.  CXXC1-/- ES cells expressing Cfp1 truncations       
1-367 and 361-656 demonstrated sensitivity to TMZ and cisplatin similar to    
CXXC1+/+  and CXXC1-/- ES cells expressing full-length Cfp1 1-656 (Fig. 53).  In 
contrast, CXXC1-/- ES cells and vector control cells demonstrate a significant decrease 
in cell survival following treatment with TMZ or cisplatin (Fig. 53).  Therefore, 
CXXC1-/- ES cells expressing either Cfp1 1-367 (containing the PHD1, CXXC, acidic, 
and basic domains) or 361-656 (containing the coiled coil, SID, and PHD2 domain) is 
sufficient to rescue the hypersensitivity to TMZ and cisplatin, indicating redundant 
functional domains within the Cfp1 protein can rescue DNA damage sensitivity.   
 
9.  Cfp1 DNA-binding activity or interaction with the Setd1 complexes is 
required to rescue hypersensitivity to TMZ and cisplatin and Ape1 protein 
expression 
Hypersensitivity to TMZ and cisplatin was observed in CXXC1-/- ES cells 
expressing Cfp1 mutations 1-367 C169A, 361-656 C375A, and 1-656 C169A, C375A 
(Fig. 54).  In contrast, Cfp1 1-656 C169A and 1-656 C375A showed sensitivity to TMZ 
and cisplatin similar to that of CXXC1+/+ and CXXC1-/- ES cells expressing full-length 
Cfp1 1-656 (Fig. 54).  These structure-function studies reveal that a point mutation 
(C169A) that abolishes DNA binding activity of Cfp1 ablates the rescue activity of the  
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FIGURE 54.  DNA-binding activity of Cfp1 or interaction with the Setd1 
complexes is required to rescue DNA damage hypersensitivity.    
Clonogenic survival for CXXC1+/+, CXXC1-/-, and CXXC1-/- ES cells expressing 
vector, full-length Cfp1 (1-656), and various Cfp1 mutations after treatment with 
temozolomide (A) or cisplatin (B).  Each point represents the mean ± standard error 
from results of at least 3 experiments, with each experiment representing 3 dishes per 
treatment group.  All data points located below asterisks denote statistically significant 
decreases compared to full-length Cfp1 (1-656).  
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FIGURE 55.  Ape1 protein expression in CXXC1-/- ES cells expressing Cfp1 
mutations.     
Western blot analysis performed on protein extracts collected from CXXC1+/+, 
CXXC1-/-, vector control, and CXXC1-/- ES cells expressing full-length Cfp1 or the 
indicated Cfp1 mutations using antisera directed against Ape1 and β-actin as a loading 
control.  The graph represents results from at least three independent experiments with 
error bars representing standard error.  Asterisks denote a statistically significant 
(p<0.05) difference compared to full-length Cfp1 (1-656).   
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1-367 fragment, and a point mutation (C375A) that abolishes the interaction of Cfp1 
with the Setd1A and Setd1B histone H3K4 methyltransferase complexes ablates the 
rescue activity of the 361-656 Cfp1 fragment.  In addition, introduction of both point 
mutations (C169A and C375A) ablates the rescue activity of the full-length Cfp1 
protein.  These results indicate that retention of either DNA-binding activity of Cfp1 or 
association of Cfp1 with the Setd1 complexes is required to rescue hypersensitivity to 
TMZ and cisplatin.    
                             
10.  Decreased Ape1 protein expression in Cfp1 mutations that exhibit 
hypersensitivity to DNA damaging agents 
Western blot analysis was performed to determine the protein expression level 
of Ape1 in CXXC1-/- ES cells expressing Cfp1 mutations compared to CXXC1+/+ ES 
cells.  Interestingly, Cfp1 mutations that exhibit hypersensitivity to TMZ and cisplatin 
(Cfp1 1-367 C169A, 361-656 C375A, and 1-656 C169A, C375A) also demonstrate a 
significant decrease in Ape1 protein expression (Fig. 55).  In contrast, CXXC1-/- ES cells 
expressing Cfp1 mutations that rescue sensitivity to TMZ and cisplatin (Cfp1 1-656,    
1-656 C169A, 1-656 C375A, 1-367, and 361-656) also rescue Ape1 protein expression 
(Fig. 55).  This reveals a correlation between Ape1 protein expression levels and 
sensitivity of CXXC1-/- ES cells expressing Cfp1 mutations to DNA damaging agents. 
 
11.  Summary     
The results presented in this portion of the dissertation demonstrate the 
importance of Cfp1 for DNA damaging agent sensitivity and Ape1 protein expression.   
 208 
In the absence of Cfp1, ES cells demonstrate hypersensitivity to a variety of DNA 
damaging agents, including IR, etoposide, MMS, TMZ, cisplatin, and hydrogen 
peroxide but do not demonstrate hypersensitivity to non-genotoxic agents MTX and 
taxol.  DNA damage hypersensitivity is rescued upon expression of Cfp1 in        
CXXC1-/- ES cells.  In contrast, DNA damage hypersensitivity was not observed in 
DNMT1-/- ES cells.  CXXC1-/- ES cells exhibit ~50% decrease in protein expression of 
Ape1 and ~45-50% decrease in Ape1 endonuclease activity, a dual function enzyme 
involved in DNA base excision repair and redox activation of transcription factors.  In 
contrast, DNMT1-/- ES cells exhibit a slight increase in Ape1 protein expression and 
endonuclease activity.  In addition, CXXC1-/- ES cell DNA incorporates more platinum, 
and CXXC1-/- ES cells accumulate increased amounts of H2AX-γ after treatment with 
TMZ and cisplatin.  Structure-function analysis revealed that either the amino half of 
Cfp1 (amino acids 1-367) or carboxyl half of Cfp1 (amino acids 361-656) are sufficient 
to rescue the hypersensitivity to DNA damaging agents and decreased Ape1 protein 
expression, demonstrating that Cfp1 contains redundant functional domains.  Additional 
structure-function studies revealed that retention of either DNA-binding activity or 
interaction with the Setd1A and Setd1B histone H3K4 methyltransferase complexes is 
required to rescue the hypersensitivity to DNA damaging agents and decreased Ape1 
protein expression.  A summary of the DNA damage agent sensitivity and Ape1 protein 
expression rescue activity of CXXC1-/- ES cells expressing Cfp1 mutations is presented 
in Table 10.  
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--551084 18B
--841084Cys18A
361-656 C375A
++58905-6
++57905-2
361-656
--1291-367 2A
--891-367 1C
1-367 C169A
++631101-8
++911101-4
1-367
--541-656 CC2A
--941-656 CC3A
1-656 C169A,C375A
++60Cys1 5
++102Cys1 1D
1-656 C375A
++1041-656 7A 
++40PFCX6
1-656 C169A
++111PFCGBP2
++108PFCGPB1
1-656
--NAEvec1
--NAEVec2
Vector
APE1 protein
TMZ, Cisplatin
sensitivity
CFP1 protein 
%CXXC1+/+clone
 
TABLE 10.  Summary of TMZ and cisplatin sensitivity and Ape1 protein 
expression rescue. 
The table presents a summary of the rescue data for CXXC1-/- ES cells 
expressing indicated Cfp1 mutations.  Ability to rescue the indicated defect is indicated 
with (+), inability to rescue (significant [p<0.05] difference compared to Cfp1 1-656) is 
indicated with (-), and NA represents not applicable.  
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Discussion 
 
I.  DNA-binding Activity of Cfp1 or Interaction with the Setd1 Complexes is 
Important for ES Cell Plating Efficiency, Cytosine Methylation, Histone 
Methylation, In vitro Differentiation, and DNA Damage Sensitivity 
The structure-function studies presented in this dissertation reveal that 
expression of either the N-terminal half of Cfp1 (1-367; containing the PHD1, CXXC, 
acidic, and basic domains) or the C-terminal half of Cfp1 (361-656; containing the SID, 
coiled-coil, and PHD2 domains) in CXXC1-/- ES cells is sufficient to rescue ES cell 
plating efficiency, cytosine methylation, Dnmt1 protein expression, Setd1A protein 
expression, histone methylation, in vitro differentiation, DNA damage sensitivity, and 
Ape1 protein expression.  However, ablation of Cfp1 1-367 DNA-binding activity (1-
367 C169A) or ablation of Cfp1 361-656 interaction with the Setd1 histone H3K4 
methyltransferase complexes (361-656 C375A) results in loss of rescue activity.  In 
addition, ablation of DNA-binding activity and interaction with the Setd1 complexes 
within full-length Cfp1 (1-656 C169A, C375A or 1-656 C169A, YCS389AAA) results 
in loss of rescue activity, indicating that retention of either DNA-binding activity or 
interaction with the Setd1 complexes is required for Cfp1 function in ES cell plating 
efficiency, cytosine methylation, histone methylation, in vitro differentiation, and DNA 
damage sensitivity.  The Cfp1 1-367 fragment and Cfp1    361-656 fragment overlap by 
seven amino acids (361-367).  However, this overlapping portion of Cfp1 (361-367) is 
not sufficient to rescue because Cfp1 318-481 (containing the basic, SID, and coiled-
coil domains) retains this region but fails to rescue any defect.   
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1.  Cfp1 rescue activity for appropriate ES cell growth, apoptosis, and 
plating efficiency  
This section of the study investigated the functional properties of Cfp1 
necessary to rescue the growth, apoptosis, and plating efficiency defects observed in 
CXXC1-/- ES cells.  The decreased growth and increased apoptosis observed in   
CXXC1-/- ES cells were hypothesized to be a result of altered cytosine methylation and 
histone modifications leading to epigenomic stress.  Proper epigenomic regulation of 
gene expression is essential for the integrity of cell function, and it has been proposed 
that there is an epigenomic stress response mechanism to guard against aberrant 
cytosine methylation (Milutinovic 2003).  Knockdown of Dnmt1 by antisense 
oligonucleotide triggers an intra-S phase arrest of DNA replication that is proposed to 
protect the genome from extensive cytosine demethylation that could come about by 
DNA replication in the absence of Dnmt1 (Milutinovic 2003).  Genomic 
hypomethylation has multiple consequences, including chromosomal instability, 
aberrant activation of endogenous retroviral elements and oncogenes, and loss of 
genomic imprinting (Wilson 2007).  Therefore, it is possible that the increased 
apoptosis observed in CXXC1-/- ES cells is due to aberrant epigenetic regulation.  
However, CXXC1-/- ES cells expressing some Cfp1 mutations that rescue cytosine and 
histone methylation (e.g. Cfp1 1-481, 1-367, 103-481, and 103-367) still exhibit 
decreased growth and increased apoptosis.  In addition, DNMT1-/- ES cells exhibit a 
~90% reduction in global cytosine methylation, yet exhibit normal growth prior to in 
vitro differentiation (Lei 1996).  Consequently, the epigenetic alterations observed in 
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the absence of Cfp1 do not appear to account for the three-fold increase in apoptosis 
observed in CXXC1-/- ES cells.   
Cfp1 361-597 (containing the SID, coiled-coil, and PHD2 domain) is sufficient 
to rescue the decreased cell growth and increased apoptosis observed in CXXC1-/- ES 
cells.  In addition, ablation of Cfp1 361-656 interaction with the Setd1A and Setd1B 
complexes results in loss of rescue activity, indicating the importance of Cfp1 
interaction with Setd1A for appropriate ES cell growth.  In mammals, Setd1A is 
tethered to RNAP II by Wdr82, an integral component of the Setd1A complex, and is 
recruited to transcription start sites of actively transcribed genes (Lee 2008).  
Consequently, the decreased growth observed in CXXC1-/- ES cells may be due to 
aberrant transcriptional regulation.  Other groups have shown that cells from post-
gastrulation and differentiating cultures of DNMT1-/- embryos show stochastic apoptotic 
cell death, and DNMT1-/- primary MEFs undergo p53-dependent apoptosis and global 
induction of gene expression, and several of the genes involved in apoptosis were 
deregulated in DNMT1-/- MEF cells (Jackson-Grusby 2001).  Therefore, the increased 
apoptosis observed in CXXC1-/- ES cells may be due to aberrant expression of genes 
involved in the cellular stress response.  Microarray data is currently being analyzed to 
identify additional genes whose transcription is changed in the absence of Cfp1.   
Apoptosis is a natural biological process of development and is regulated by the 
intricate balance between cell-cycle proteins, tumor suppressor genes, and proto-
oncogenes (Okazawa 1996).  CXXC1-/- ES cells also exhibit decreased global translation 
(Butler 2009).  It remains possible that the decreased growth of CXXC1-/- ES cells may 
be due to aberrant global translation, leading to altered expression of pro-apoptotic 
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proteins (Bax, Bid, Bak, or Bad), anti-apoptotic proteins (BclXl and Bcl-2), or 
additional proteins involved in the cellular stress response.  However, additional 
experiments need to be carried out to determine the molecular mechanism leading to 
decreased cell growth and increased apoptosis observed in CXXC1-/- ES cells.      
In contrast to growth, it was determined that either half of Cfp1 (1-367; 
containing the PHD1, CXXC, acidic, and basic domains, or Cfp1 361-656; containing 
the SID, coiled-coil and PHD2 domains) is sufficient to rescue ES cell plating 
efficiency.  Thus, increased apoptosis does not account for decreased plating efficiency 
because certain Cfp1 mutations that exhibit increased apoptosis (e.g. 1-481, 1-367,  
103-481, 103-367) do not exhibit decreased plating efficiency.  Therefore, it seems 
likely that the epigenetic alterations observed in CXXC1-/- ES cells contribute to the 
decreased plating efficiency observed.    
 
2.  Cfp1 rescue activity for cytosine methylation and in vitro differentiation 
This section of the study investigated the functional properties of Cfp1 
necessary to rescue the decreased cytosine methylation due to decreased maintenance 
DNA methyltransferase activity and inability to achieve in vitro differentiation observed 
in CXXC1-/- ES cells.  CXXC1-/- ES cells expressing Cfp1 mutations that exhibit reduced 
global cytosine methylation and reduced cytosine methylation of IAP repetitive 
elements also demonstrate a significant (~50%) decrease in protein expression of 
Dnmt1 and fail to achieve in vitro differentiation.  However, DNMT1+/- ES cells express 
similarly reduced Dnmt1 protein but retain normal levels of cytosine methylation (Li 
1992; Chan 2001).  Therefore, it is unlikely that the decrease in Dnmt1 protein 
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expression observed in CXXC1-/- ES cells completely accounts for the decreased global 
cytosine methylation.  
The mammalian Dnmts are not sequence specific and little is known regarding 
their specific targeting within the genome (Bestor 2000).  Dnmt3a localizes with HP1, 
which binds to H3K9 methylated histones, and this association could be important for 
directing DNA methylation to chromatin (Burger 2002).  Dnmt1 binds retinoblastoma 
tumor suppressor protein (Rb), which is targeted to specific genes through its 
interaction with the sequence-specific DNA-binding factor E2F (Robertson 2000).  
Dnmt1 and Dnmt3a bind the oncogenic transcription factor PML-RAR, involved in 
acute promyelocytic leukemia, and are recruited by PML-RAR to hypermethylate the 
promoter and silence expression of RAR (Di Croce 2005).  In addition, Dnmt3a binds 
the sequence-specific DNA-binding transcriptional repressor, Rp58 (Fuks 2001).  
Therefore, Dnmts can be recruited to particular genomic loci through protein-protein 
interactions, such as their association with specific transcription factors (e.g. PML-
RAR, Rp58), methylated histone binding proteins (e.g. HP1), or co-repressors (e.g. Rb) 
(Burger 2002).  Regions in the N-terminal of Dnmt1 are believed to be responsible for 
targeting the enzyme to replication foci during S phase and maintaining methylation of 
the daughter strand, and Pcna is thought to bring Dnmt1 to the replication foci (Chuang 
1997).  Dnmt1 also interacts with HDACs (Fuks 2000) and with histone H3K9 
methyltransferases Suv39h1 (Rai 2006; Fuks 2003) and G9a (Esteve 2006) to mediate 
transcriptional silencing.  Therefore, it is likely that Dnmt1 interacts with additional 
chromatin-associated proteins to either open up chromatin structure to facilitate cytosine 
methylation or restore chromatin structure after DNA replication.  Dnmt1 and Cfp1 
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partially colocalize within ES cell nuclei and physically interact (Butler 2008; J.S. 
Butler, unpublished data).  There are three regions of Cfp1 sufficient for the interaction 
of Cfp1 with Dnmt1, Cfp1 1-123, 103-367, and 361-656 (Butler 2008).  Dnmt1 can also 
bind unmethylated CpG DNA through its CXXC domain and thus induce 
transcriptional gene silencing in a cytosine methylation-independent manner (Pradhan 
2008).  Cfp1 may play a similar role to Dnmt1 by binding unmethylated CpG motifs 
and recruiting Dnmt1 to initiate cytosine methylation and transcriptional silencing.  
Therefore, Cfp1 might participate in targeting Dnmt1 within the genome or regulating 
Dnmt1 methyltransferase activity.  
Dnmt enzymes are required for cellular differentiation during early embryonic 
development and regulate the systematic transcriptional inactivation of particular genes 
by promoter methylation (Gopalakrishnan 2008).  DNMT1-/- ES cells exhibit normal 
growth but undergo apoptosis when induced to differentiate (Bestor 2000).        
DNMT1-/- ES cells initiate differentiation in response to LIF withdrawal but fail to 
differentiate efficiently into terminally differentiated cardiomyocytes or hematopoietic 
cells (Jackson 2004).  During ES cell differentiation, increased heterochromatin 
formation is required for the specification of lineage-specific gene expression 
(Rassmussen 2000).  Therefore, CXXC1-/- ES cells expressing Cfp1 mutations that 
exhibit decreased Dnmt1 protein expression and fail to appropriately methylate the 
genome may consequently fail to achieve in vitro differentiation.  Therefore, inability to 
achieve differentiation may be due to decreased Dnmt1 maintenance methyltransferase 
activity.   
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The basic domain is essential for N-terminal Cfp1 rescue activity because Cfp1 
1-320 (containing the PHD1, CXXC, and acidic domains) fails to rescue plating 
efficiency, cytosine methylation, histone methylation, and differentiation.  Previous 
confocal immunofluorescence studies revealed that Cfp1 exhibits a speckled nuclear 
distribution, and biochemical subcellular fractionation revealed that Cfp1 is nearly 
exclusively associated with the nuclear matrix (Lee 2002).  The basic domain (amino 
acids 318-367) of Cfp1 is essential for directing a partially speckled nuclear distribution 
when linked to either the coiled-coil or acidic domains (Lee 2002).  Previous data also 
indicated that localization of Cfp1 to nuclear speckles and association with the nuclear 
matrix is required for transcriptional transactivation activity (Lee 2002).  In HEK-293 
cells, Cfp1 1-320 exhibits diffuse nuclear staining by confocal immunofluorescence, 
and biochemical fractionation revealed that the majority of Cfp1 1-320 is located in the 
soluble fraction and no localization in the nuclear matrix fraction was observed (Lee 
2002).  In addition, subcellular fractionation of CXXC1-/- ES cells expressing Cfp1       
1-320 revealed only partial localization of Cfp1 1-320 with the nuclear matrix and the 
majority located in the soluble fraction.  Therefore, lack of the basic domain in Cfp1    
1-320 may result in inappropriate subcellular localization of Cfp1 which may affect 
Cfp1 function in transcriptional transactivation and rescue activity.   
The minimum region of Cfp1 sufficient for cytosine methylation and in vitro 
differentiation is Cfp1 103-367 (containing the CXXC, acidic, and basic domains).  In 
contrast, Cfp1 103-367 fails to rescue plating efficiency, indicating that the PHD1 
domain of Cfp1 is dispensable for N-terminal Cfp1 function in cytosine methylation and 
in vitro differentiation but is essential for appropriate ES cell plating efficiency.  This 
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demonstrates that decreased plating efficiency does not contribute to decreased cytosine 
methylation or inability of CXXC1-/- ES cells to undergo in vitro differentiation.  The 
CXXC domain is the sole DNA-binding domain of Cfp1, which exhibits specificity for 
unmethylated CpG motifs (Lee 2000).  The acidic domain of Cfp1 is important for 
transcriptional transactivation activity (Fujino 2000).  The basic domain is essential for 
proper subnuclear localization of Cfp1 and has been suggested to be involved in 
dimerization of Cfp1 because a fragment of Cfp1 (amino acids 106-345) that contains a 
portion of the basic region formed an additional, lower-mobility EMSA complex when 
analyzed for DNA-binding activity (Voo 2000).  However, the basic domain is not 
required for DNA-binding activity of Cfp1 because Cfp1 106-287 lacks the basic 
domain but retains strong DNA-binding activity (Voo 2000).  Therefore, Cfp1 103-367 
retains DNA-binding activity, transcriptional transactivation activity, interaction with 
Dnmt1, proper subnuclear localization, and potentially dimerization which facilitate 
Cfp1 function in cytosine methylation and in vitro differentiation.    
DNA-binding activity of the N-terminal Cfp1 1-367 fragment is essential for 
Cfp1 function in ES cell cytosine methylation and differentiation because Cfp1 1-367 
C169A fails to rescue.  CXXC domains have been identified in a number of chromatin-
associated proteins including Dnmt1 (Pradhan 2008); methyl-DNA-binding protein 1 
(Mbd1), a protein that binds methylated DNA and recruits a histone H3K9 
methyltransferase (Cross 1997); Fbxl11, a histone demethylase specific for H3K36 
(Tsukada 2006); leukemia-associated protein Lcx, found in Mll1 fusion proteins 
associated with acute myeloid leukemia (Ono 2002); and Mll1, a histone H3K4 
methyltransferase (Birke 2002).  The MLL1 gene is a frequent target of chromosomal 
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aberrations that are associated with leukemia (Tkachuk 1992).  The cysteine-rich CXXC 
domain of Mll1 is essential for the transforming capacity of Mll1 fusion proteins (Birke 
2002).  Similarly, mutation of conserved cysteines within the CXXC domain of Dnmt1 
abolished DNA-binding activity and resulted in a significant reduction in Dnmt1 
catalytic activity and loss of genomic cytosine methylation (Pradhan 2008).  Likewise, 
ablation of DNA-binding activity of Cfp1 1-367 results in loss of rescue activity, 
indicating the importance of DNA-binding activity for N-terminal Cfp1 fragments.   
In contrast to the PHD1 domain, the PHD2 domain appears essential for Cfp1 
361-656 function in ES cell plating efficiency, cytosine methylation, and differentiation, 
because Cfp1 318-481 (containing the basic, coiled-coil, and SID domains) fails to 
rescue.  However, Cfp1 318-481 lacks the acidic domain which may lead to loss of 
rescue activity.  In addition, Cfp1 361-656 interaction with the Setd1 complexes is 
essential for rescue activity, indicating the importance of the SID domain for C-terminal 
Cfp1 function.  In mammals and yeast, the coiled-coil motif has been identified in a 
variety of proteins and plays important roles in the structure and function of proteins 
(Mason 2004).  Coiled-coil domains can serve as a rod, providing a spacer separating 
two functional domains (White 2006).  In addition, coiled-coil motifs are present in 
several DNA-binding proteins, such as leucine zipper factors, and can facilitate homo- 
or hetero-dimerization (Voo 2000).  However, the function of the coiled-coil domain 
within Cfp1 remains unknown.  It is possible that the coiled-coil domain serves as a 
spacer between the SID and PHD2 domains, facilitates dimerization of Cfp1, mediates 
interaction with additional proteins, or mediates appropriate structure of the C-terminal 
fragment of Cfp1.   
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PHD domains have significant sequence differences, and various activities have 
been assigned to PHD domains (Bienz 2006).  Many PHD-containing proteins associate 
with chromatin, play a role in chromatin-mediated transcriptional control (Bienz 2006; 
Schindler 1993), and recent studies have shown that the PHD domains are binding 
modules for unmodified and methylated H3K4 and methylated H3K36 (Martin 2001; 
Ruthenberg 2007; Li 2006; Pena 2006; Shi 2006; Shi 2007).  PHD finger domains link 
H3K4me3 recognition with gene activation, such as the PHD of the bromodomain PHD 
finger transcription factor, BPTF, which helps to recruit the Nurf nucleosome 
remodeling factor complex to target promoters modulating transcription initiation 
(Wysocka 2006; Li 2006).  The histone acetyltransferase Cbp contains a PHD domain 
that is integral to acetyltransferase activity and transcriptional activity of Cbp because 
mutation of the putative zinc-coordinating residues from cysteine to alanine result in 
partial to complete loss of histone acetyltransferase activity (Kalkhoven 2002).  
Alternatively, a PHD domain in Hbxap (hepatitis B virus x associated protein), the PHD 
and bromodomain of Krab-associated protein-1 (Kap-1), and PHD-like motif in Dnmt3a 
(via recruitment of HDAC1), repress transcription along with the PHD finger and 
bromodomain of NoRC, a chromatin-remodeling complex, that recruits HDAC1, 
Dnmt1, Dnmt3a, and SNF2h to establish rDNA silencing (Shamay 2002; Schultz 2001; 
Fuks 2001; Zhou 2005).  Therefore, PHD-containing proteins are involved in 
transcriptional activation and also transcriptional silencing via interaction with HDAC 
(Shamay 2002).   
The PHD1 domain of Spp1, the yeast homologue of Cfp1, binds methylated 
histone H3K4 (Shi 2007).  Histone H3K4me3 is associated with the transcription start 
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sites of actively transcribed genes (Li 2006).  Cfp1 binds unmethylated CpG motifs, 
interacts with the Setd1 histone H3K4 methyltransferase complexes, and is a 
transcriptional activator (Lee 2001; Fujino 2000).  In contrast, Cfp1 also interacts with 
Dnmt1 and plays an essential role in cytosine methylation, suggesting that Cfp1 may 
play opposing roles in transcriptional activation and/or repression.  While it seems 
contradictive to couple cytosine methylation and transcriptional repression to a histone 
methylation mark associated with elongating, actively transcribing RNAP II, actively 
transcribed genes require a mechanism to restore chromatin to the basal state (Lee 
2007).  Maintenance of histone acetylation/methylation levels is important for 
preventing spurious transcription within coding regions (Carozza 2005).  Global HATs 
and HDACs rapidly restore chromatin structure back to the ground state at the end of a 
transcriptional response (Vogelauer 2000; Katan-Khaykovich 2002).  In addition, 
maintenance methyltransferase activity of Dnmt1 is independent of its association with 
Pcna (Spada 2007), suggesting that additional mechanisms exist to target Dnmt1 to 
chromatin independently of protein interactions at the DNA replication fork (Butler 
2008).  Therefore, Cfp1 may play a role in recruiting Dnmt1, and subsequently, HDACs 
and histone H3K9 methyltransferases, to re-establish a repressive chromatin state after 
transcriptional activity concludes.   
The phenotype exhibited by ES cells lacking Cfp1 is similar to that of cells 
lacking Uhrf1, a ubiquitin-like protein (Bostick 2007).  Uhrf1 (ubiquitin-like containing 
PHD and RING finger domains 1), or Np95 (nuclear protein 95) in mouse are RING-
type E3 ubiquitin ligases that bind methylated DNA (Citterio 2004).  ES cells lacking 
Np95 display demethylated interspersed repeats and altered methylation at imprinted 
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loci and tandem repeats.  Np95 has a preference for binding hemi-methylated DNA and 
directly interacts and recruits Dnmt1 to hemi-methylated DNA (Bostick 2007; Sharif 
2007).  Np95 recruits HDAC and Dnmt1 to pericentromeric heterochromatin (PH) and 
deletion of Np95 impairs PH replication.  The PHD domain of Np95 is required to 
facilitate the access of a restriction enzyme to DNA packaged into nucleosome arrays, 
suggesting that the PHD domain might enhance Np95 chromatin-binding ability and 
favor the recruitment of chromatin modifiers (Papait 2008).  Therefore, the PHD 
domain of Np95 is thought to facilitate the large-scale PH reorganization during 
replication (Papait 2008).  Consequently, Cfp1 may play a similar role as Np95 to 
recruit Dnmt1 following transcription and increase accessibility of chromatin to HDACs 
and histone methyltransferases.   
 
3.  Cfp1 rescue activity for appropriate Setd1A protein expression and 
histone methylation  
This portion of the study investigated the functional properties of Cfp1 required 
to rescue Setd1A protein expression and elevated histone H3K4 methylation observed 
in  CXXC1-/- ES cells.  CXXC1-/- ES cells demonstrate a significant decrease in Setd1A 
protein expression, but appropriate levels of the other protein components of the Setd1A 
complex (Ash2, Rbbp5, Wdr5, Wdr82) and HCF-1 (Setd1A interacting protein).   
CXXC1-/- ES cells demonstrate a ~6-fold increase in Setd1A mRNA, suggesting that 
CXXC1-/- ES cells have a compensatory mechanism to make up for decreased protein 
expression of Setd1A.  Therefore, the decreased protein expression of Setd1A is not due 
to decreased transcriptional activation of the SETD1A gene.  Similarly, yeast cells 
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lacking Spp1, the Cfp1 homologue, also have reduced amounts of Set1 (Dehe 2006).  
Consequently, Spp1 is thought to stabilize Set1 (Dehe 2006).  Previous data indicates 
that exogenous expression of Setd1A fragments in HEK-293 cells competes with 
endogenous Setd1A binding with the Setd1A methyltransferase complex and results in 
decreased protein stability of endogenous Setd1A and Setd1B, suggesting that Setd1A 
and Setd1B are unstable when not bound to other components of the Setd1 complex 
(Lee 2007).  Similar to yeast cells lacking Spp1, the decreased Setd1A protein 
expression observed in ES cells lacking Cfp1 may be due to a decrease in Setd1A 
protein stability in the absence of Cfp1.  In contrast, protein expression of the other 
components of the Setd1A complex (Ash2, Rbbp5, Wdr5, Wdr82), and HCF-1 were not 
altered in CXXC1-/- ES cells, which may be explained by the fact that Ash2, Rbbp5, and 
Wdr5 are components of additional H3K4 methyltransferase complexes (Mll1, Mll2, 
and Mll3 complexes) (Lee 2008; Ansari 2007; Hughes 2004; Goo 2003; Nakamura 
2002; Wysocka 2003).  Upon removal of LIF from the media, CXXC1-/- ES cells exhibit 
elevated levels of H3K4me3 (~2-fold).  Therefore, Cfp1 presumably restricts the 
activity of the Setd1A histone H3K4 methyltransferase complex (Lee 2005).  
Consequently, the increased levels of H3K4me3 in the absence of Cfp1 may be caused 
by aberrant activation and/or targeting of histone H3K4 methyltransferase complexes.   
 
4.  Cfp1 contains redundant functional domains 
Unexpectedly, the data reported in this dissertation indicate that Cfp1 contains 
redundant functional domains for appropriate ES cell plating efficiency, cytosine 
methylation, histone methylation, and in vitro differentiation.  These studies emphasize 
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the significance of Cfp1 DNA-binding activity and Cfp1 interaction with the Setd1A 
and Setd1B histone H3K4 methyltransferase complexes for appropriate Cfp1 function in 
ES cells.  Cfp1 1-367 DNA-binding activity may facilitate Dnmt1 targeting or 
methyltransferase activity which would lead to appropriate cytosine methylation (Fig. 
56).  In addition, Cfp1 361-656 interaction with the Setd1 histone H3K4 
methyltransferase complexes may lead to appropriate modulation of histone 
methylation.  Cytosine methylation and histone modifications are intimately connected 
and have been shown to influence each other (Fuks 2000; Szyf 2005; Weissmann 2003; 
Tamaru 2001).  Dnmts are associated with many histone modifying enzymes, including 
HDACs, histone methyltransferases, and ATP-dependent chromatin remodeling 
enzymes (Paulsen 2001).  Deletion of Dnmt1 in a human colorectal cancer cell line 
results in a global change in chromatin structure; an increase in H3K9 acetylation and a 
decrease in H3K9 methylation (Espada 2004, Szyf 2005).  The Suv39h1 histone H3K9 
methyltransferase is required for recruiting Dnmt3b-dependent methylation to 
pericentromeric repeats (Gopalakrishnan. 2008), and murine ES cells lacking 
SUV39H1/2 display altered DNA methylation profiles at pericentromeric satellite 
repeats (Lehnertz 2003).  CXXC1-/- ES cells expressing Cfp1 mutations that exhibit 
appropriate cytosine methylation (1-656 C169A, 1-656 C375A, 1-481, 1-367, 302-656, 
and 361-656) also exhibit appropriate Setd1A protein expression and global levels of 
histone H3K9me2 and histone H3K4me3.  The finding of redundancy of Cfp1 
functional domains suggests a model in which cross-talk between epigenetic 
modifications permits ES cells to establish and maintain normal epigenetic function 
(Fig. 56).  Thus, restoration of appropriate cytosine methylation might provide critical  
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FIGURE 56.  Model for Cfp1 redundant function. 
Potential model for how two halves of Cfp1 when expressed in CXXC1-/- ES 
cells are sufficient for appropriate ES cell cytosine methylation and histone methylation.  
The N-terminal fragment of Cfp1 (amino acids 1-367) contains the CXXC DNA-
binding domain of Cfp1 and the C-terminal fragment (amino acids 361-656) contains 
the SID domain required for interaction with the Setd1 histone H3K4 methyltransferase 
complexes.  DNA-binding activity of Cfp1 may facilitate Dnmt1 targeting or 
methyltransferase activity.  Interaction of Cfp1 with the Setd1 complexes may promote 
appropriate modulation of histone methylation.  Cytosine methylation and histone 
modifications are intimately connected and mutually reinforcing.  Consequently, 
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correction of cytosine methylation may promote appropriate histone methylation or 
appropriate modulation of histone methylation may promote appropriate cytosine 
methylation due to epigenetic cross-talk.  Alternatively, Cfp1 361-656 interacts with 
Dnmt1 which may be required for Dnmt1 targeting or methyltransferase activity which 
may lead to appropriate cytosine methylation.   
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epigenetic marks to permit re-establishment and regulation of histone modifications, 
and restoration of appropriate regulation of histone H3K4 methylation might permit 
subsequent restoration of normal patterns of cytosine methylation due to epigenetic 
cross-talk (Fig. 56).   
Alternatively, Cfp1 361-656 can interact with Dnmt1 which may regulate 
Dnmt1 targeting or facilitate Dnmt1 methyltransferase activity independent of Cfp1 
DNA-binding activity (Fig. 56).  Importantly, the C375A point mutation in the SID 
domain that abolishes the interaction between Cfp1 and the Setd1A and Setd1B histone 
H3K4 methyltransferase complexes does not ablate the interaction between Cfp1     
361-656 and Dnmt1, indicating that Cfp1 interacts independently with the DNA 
methyltransferase and the histone methyltransferase complexes (Butler 2008).  
Therefore, Cfp1 361-656 C375A retains interaction with Dnmt1, but lacks interaction 
with the Setd1 histone H3K4 methyltransferase complexes and fails to rescue, 
highlighting the importance of Setd1 association within the C-terminal half of Cfp1.   
 
II.  Cfp1 DNA-Binding Activity and Setd1 Interaction is Required to Restrict the 
Setd1A Complex to Euchromatin  
This portion of the study investigated the subnuclear localization of Setd1A 
protein and histone H3K4me3.  Little is known about the targeting of histone H3K4 
methyltransferase complexes.  This study demonstrates that full-length Cfp1 is required 
to properly restrict Setd1A and histone H3K4me3 to euchromatic regions, indicating 
that Cfp1 DNA-binding activity and Cfp1 interaction with the Setd1A histone H3K4 
methyltransferase complex are required for proper subnuclear localization of the 
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Setd1A complex.  In addition, the full-length Cfp1 protein required to restrict Setd1A 
and histone H3K4me3 to euchromatin contains both PHD domains of Cfp1.  Therefore, 
the PHD domains of Cfp1 may be important for binding modified H3K4 and restricting 
the Cfp1/Setd1A complex to euchromatin.  Additional studies to determine whether 
Cfp1 PHD domains bind modified H3K4 would be important to provide additional 
insight into Cfp1 function.  It is possible that DNA-binding activity of Cfp1, interaction 
with the Setd1A complex, and histone H3K4 binding by the PHD domains are 
important for restricting subnuclear localization of the Setd1 complex to euchromatin.     
Interestingly, some Cfp1 mutations that rescue cytosine methylation and histone 
methylation (e.g. 1-656 C169A, 1-656 C375A, 1-367, and 361-656) exhibit subnuclear 
mis-localization of Setd1A and histone H3K4me3 with regions of heterochromatin.  
This suggests that subnuclear mis-localization of Setd1A does not affect the overall 
global levels of histone H3K4me3.  Therefore, mis-localization of Setd1A to DAPI-
bright heterochromatin may only affect histone H3K4 methylation at repetitive DNA 
(silenced heterochromatin).  Alternatively, regulation of the subnuclear localization of 
Setd1A and restriction of Setd1A complex activity may be independent functions of 
Cfp1.  This is supported by the fact that Cfp1 mutations that rescue Setd1A protein 
expression (e.g. 1-656 C169A, 1-656 C375A, 1-367, and 361-656) also rescue histone 
methylation.  Consequently, Setd1A protein stability or histone methyltransferase 
activity may influence global levels of histone methylation independent of subnuclear 
targeting.  In addition, Cfp1 also physically interacts with the Setd1B histone H3K4 
methyltransferase complex (Lee 2007).  It remains to be determined whether Cfp1 
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serves to restrict subnuclear localization or activity of the Setd1B histone H3K4 
methyltransferase complexes which would influence global histone methylation.   
 
III.  Cfp1 is Required for Appropriate DNA Damage Sensitivity and Ape1 Protein 
Expression and Endonuclease Activity  
This portion of the study investigated whether Cfp1 plays a role in the 
sensitivity of ES cells to DNA damaging agents.  It was determined that CXXC1-/- ES 
cells exhibit hypersensitivity to a variety of DNA damaging agents, including IR, H2O2, 
TMZ, MMS, cisplatin, and etoposide.  CXXC1-/- ES cells also exhibit a ~50% decrease 
in Ape1 protein expression and endonuclease activity.  In addition, CXXC1-/- ES cells 
accumulate more DNA damage based on increased platinum incorporation into DNA 
and increased H2AX-γ formation after treatment with cisplatin.  In contrast, despite a 
dramatic loss of cytosine methylation, DNMT1-/- ES cells are not hypersensitive to 
cisplatin, TMZ, and H2O2, and exhibit slightly elevated levels of Ape1 protein 
expression and endonuclease activity.   
Structure-function studies revealed that retention of either DNA-binding activity 
of Cfp1 or association with the Setd1 histone H3K4 methyltransferase complexes is 
required to rescue the hypersensitivity to DNA damaging agents and decreased Ape1 
protein expression.  Interestingly, this correlates with the rescue activity for plating 
efficiency, cytosine methylation, histone methylation, and in vitro differentiation.  This 
suggests that appropriate chromatin structure and appropriate protein expression of 
Ape1 play important roles in facilitating ES cell DNA damage susceptibility and/or 
DNA repair activity.   
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The structure of chromatin is a major factor determining radiosensitivity and 
repair in human cells (Karagiannis 2007).  CXXC1-/- ES cells demonstrate a 60-80% 
decrease in global cytosine methylation (Carlone 2005) and perturbations in global 
levels of histone methylation indicative of decreased amounts of heterochromatin (Lee 
2005).  Therefore, CXXC1-/- ES cells demonstrate an increased amount of euchromatin, 
or more open, accessible chromatin compared to CXXC1+/+ ES cells.  The hyper-
acetylation of histones induced by the HDAC inhibitor trichostatin A (TSA) increases 
chromatin accessibility (Gorisch 2005; Minucci 2006;Ozaki 2007).  TSA sensitized 
K562 cells to IR and is more efficient at suppressing DSB repair in euchromatic regions 
of the genome, whereas heterochromatin loci are resistant to HDAC inhibition and are 
highly resistant to DSBs (Karagiannis 2007).  HDAC inhibitors also sensitize tumor 
cells to the induction of cell death by IR, UV radiation, and several DNA-damaging 
drugs (Ozaki 2008; Kim 2005; Kim 2003; Piacentini 2006; Munshi 2005).  Therefore, 
the increased sensitivity to DNA damaging agents and increased damage accumulation 
observed in CXXC1-/- ES cells may be a consequence of epigenetic alterations resulting 
in increased euchromatin, or more accessible DNA.     
Increased sensitivity of CXXC1-/- ES cells to DNA damaging agents may also be 
due to a decrease in DNA repair activity.  CXXC1-/- ES cells exhibit ~50% decrease in 
Ape1 protein expression and endonuclease activity compared to CXXC1+/+ ES cells.  
Microarray data indicates that CXXC1-/- ES cells exhibit decreased mRNA expression of 
Ape1.  Cfp1 is a transcriptional activator that binds unmethylated CpG motifs.  
Therefore, it remains possible that Cfp1 binds the APE1 promoter and activates 
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transcription of APE1.  However, further experiments need to be carried out to 
determine the mechanism resulting in decreased protein expression of Ape1.   
Consistent with our findings, targeted reduction of Ape1 protein (~50-90% 
reduction) by specific anti-sense oligonucleotides or siRNA renders mammalian cells 
hypersensitive to a variety of laboratory and chemotherapeutic agents, including MMS, 
H2O2, bleomycin, TMZ, cisplatin, and gemcitabine (Ono 1994; Walker 2005; Bobola 
2005; Zang 2007; Lau 2004).  In addition, targeted reduction of Ape1 (~90% reduction) 
results in a decrease in proliferation, an increase in AP sites, and increased levels of 
apoptosis in human colon, breast cancer, and human lymphoblastoid cells (Fung 2005).   
Suppression of Ape1 in rat glioma cells increases sensitivity to MMS and H2O2 (Evans 
2000), and suppression of Ape1 in a human glioma line (~60% reduction in Ape1 
protein expression) and human medulloblastoma cell line (~90% reduction in Ape1 
protein expression) results in decreased AP endonuclease activity (~42% and ~75%, 
respectively), increased abasic site content, and increased sensitivity to 1,3-bis(2-
chloroethyl)-nitrosourea (BCNU), MMS, and TMZ (Bobola 2005; Silber 2004).  Ape1 
endonuclease activity was inversely correlated with time to tumor progression in grade 
II and grade III gliomas following radiation and alkylator therapy (Bobola 2004).  In 
addition, Ape1 endonuclease activity in human gliomas is positively correlated with 
tumor characteristics associated with greater malignancy and poor response (Bobola 
2001).  Conversely, protein upregulation of Ape1 is always associated with an increase 
in both redox and AP endonuclease activity, followed by an increase in cell resistance 
toward oxidative stress and DNA damaging agents (Grosch 1998; Ramana 1998; 
McNeill 2007; Mitra 2007; Bobola 2004).   
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Ape1 is essential for mammalian embryogenesis and cell viability.  Knockout of 
APE1 in mice causes post-implantation embryonic lethality on days E5 to E9 (Ludwig 
1998; Xanthoudakis 1996), and no viable cell lines have been isolated that are deficient 
of APE1 (Larsen 2007).  APE1+/- mice exhibit a 40-50% reduction in Ape1 mRNA, 
protein, and endonuclease activity in all tissues examined (Raffoul 2004; Meira 2001).  
In addition, APE1+/- mice display 35% reduced BER activity in nuclear extracts 
prepared from liver (Raffoul 2004) and 50% reduced BER activity in nuclear extracts 
prepared from spermatogenic cells or testis (Huamani 2005).  APE1+/- mice exhibit 
increased spontaneous mutation frequencies in somatic tissues and spermatogenic cells 
(Huamani 2004).  Therefore, haploinsufficiency or inactivation of Ape1 results in 
genomic instability.  APE1+/- mice also display hypersensitivity to oxidative stress in 
vivo, and APE1+/- MEFs exhibit diminished survival in response to oxidative DNA 
damaging agents (Meira 2001).  In addition, MEFs and specific cerebellar cells derived 
from APE1+/- mice exhibit significantly increased sensitivity to redox-cycling drugs 
(menadione and paraquat) in vitro (Meira 2001).  This suggests that the ~50% decrease 
in Ape1 protein expression and endonuclease activity in CXXC1-/- ES cells may 
contribute to the observed hypersensitivity to DNA damaging agents.   
In contrast, DNMT1-/- ES cells, which exhibit less global cytosine methylation 
than CXXC1-/- ES cells, do not exhibit hypersensitivity to TMZ, H2O2, or cisplatin, 
indicating that a global decrease in cytosine methylation cannot solely account for the 
hypersensitivity to DNA damaging agents.  CXXC1-/- ES cells exhibit altered histone 
methylation, whereas alterations in histone modifications are not well established in 
DNMT1-/- ES cells.  DNMT1-/- ES cells exhibit increased histone H3K9 acetylation and 
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decreased histone H3K9me2/3 (Espada 2004), while another group has shown 
appropriate levels of histone H4K5 acetylation (Jackson 2004).  In addition, in contrast 
to CXXC1-/- ES cells, DNMT1-/- ES cells exhibit an increase in Ape1 protein expression 
and endonuclease activity.  The protein expression of Ape1 is tightly linked to 
sensitivity of cells to DNA damaging agents.  Therefore, DNMT1-/- ES cells may not 
exhibit hypersensitivity to agents that cause DNA damage that is repaired by BER due 
to the high level of Ape1 protein expression and endonuclease activity.  In contrast, 
other studies have implicated a role for Dnmt1 in the DNA damage response.  Rat 
fibroblast cells genetically altered to overexpress Dnmt1 are resistant to the cytotoxicity 
of H2O2, etoposide, and cisplatin (Mishra 2008).  In addition, HCT116 (colon 
carcinoma) knockout cells that do not express either Dnmt1 or Dnmt3b are more 
sensitive to the cytotoxicity of H2O2, etoposide, and cisplatin (Mishra 2008).  However, 
these studies were carried out in an immortal cancer cell line that lacked Dnmt1 and 
Dnmt3b, and forced over-expression of Dnmt1 in fibroblasts, compared to our studies 
performed in pluripotent ES cells.   
Histone modifications and chromatin remodeling have been implicated to be 
important during BER.  In vitro data demonstrates that the ATP-dependent chromatin 
remodeler SWI/SNF stimulates the processing of 8-oxoG during BER (Menoni 2007).  
The HAT, Cbp/p300 interacts with the BER thymine DNA glycosylase (TDG) and 
retains its capacity to acetylate histones in mammalian cells (Tini 2002).  The Cbp-TDG 
complex can recognize mispairs, mediate excision, and acetylate histone tails 
supporting a model whereby Cbp/p300 coupled to TDG mediate local chromatin 
remodeling to facilitate further processing of the abasic site (Tini 2002).  However, the 
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precise roles of histone modifications during BER remain unclear.  Therefore, the 
hypersensitivity to DNA damaging agents and the increased accumulation of DNA 
damage observed in CXXC1-/- ES cells may be a consequence of aberrant histone 
modifications.   
In yeast, Set1, the sole histone H3K4 methyltransferase, is involved in the stress 
and DNA damage response.  The SET domain of the yeast protein Set1 interacts with 
the C-terminal region of Mec3p, a protein required for efficient DNA-damage 
dependent checkpoints at G1/S, intra-S, and G2/M, and has a role in DNA repair and 
telomere function (Corda 1999).  Deletion of Set1 in S. cerevisiae induces a response 
relayed by the signaling kinase Rad53p that leads to the Mec1/Tel1-independent hyper-
phosphorylation of replication protein A middle subunit (Rfa2p), which decreases the 
binding of Rfa2p to upstream repressing sequences of repair genes (Rad1, Rad2, Rad4, 
Rad10, Rad16), components of nucleotide excision repair; Rad51 (central component of 
recombinational repair); Ddr48 (stress protein induced by DNA damage); and Mag and 
Mgt1 (DNA alkylation repair genes), leading to their derepression (Schramke 2001).  It 
remains to be determined whether Setd1A plays a role in mammalian DNA repair.  
Therefore, the hypersensitivity to DNA damaging agents and the increased 
accumulation of DNA damage observed in the CXXC1-/- ES cells may be a consequence 
of aberrant regulation/targeting of the Setd1A and Setd1B histone H3K4 
methyltransferase complexes or aberrant histone modifications.   
Many chromatin-associated proteins are implicated in DNA repair, and it is well 
established that DNA becomes more accessible during DNA repair.  Nucleosomes are 
unpackaged allowing the DNA repair machinery to access the DNA lesion, followed by 
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reassembly of nucleosomes in newly replicated regions, as well as the restoration of the 
local epigenetic state of the chromatin (Ataian 2006; Smerdon 1978; Smerdon, 1991; 
Green 2003).  It remains to be determined whether Cfp1 plays a direct role in DNA 
repair possibly be re-establishing epigenetic states after DNA damage, or whether the 
DNA damage hypersensitivity is caused by aberrant chromatin structure observed in the 
absence of Cfp1, reduced DNA repair due to decreased Ape1 protein expression and 
endonuclease activity, or as an indirect consequence of aberrant transcriptional trans-
activation activity or aberrant translation of DNA repair proteins.  
 
IV.  Future Directions 
Since disruption of the CXXC1 gene in mice results in an embryonic lethal 
phenotype, it will be valuable to generate knock-in mice using targeting vectors that 
replace the endogenous CXXC1 gene with sequence encoding the various Cfp1 
mutations used in this study to determine the functional properties of Cfp1 necessary to 
rescue in vivo.  Conditional knockout of the CXXC1 gene in hematopoietic cells leads to 
hematopoietic defects and eventually death of the mice (11-12 days after poly IC 
injection).  CXXC1 conditional knockout mice exhibit decreased hematocrit, 
granulocytes, macrophages, red blood cells, and increased apoptosis of progenitor cells.   
Alternatively, bone marrow cells can be harvested from mice carrying the conditional 
knockout allele and retrovirally transduced ex vivo using vectors encoding the various 
Cfp1 mutations.  Then, cells stably expressing the Cfp1 mutations could be transplanted 
into lethally irradiated recipient mice and analyzed to determine whether the bone 
marrow cells expressing Cfp1 mutations can rescue hematopoiesis after poly IC 
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injection and deletion of the endogenous conditional CXXC1 allele.  Alternatively, 
CXXC1-/- ES cells expressing Cfp1 mutations could be injected into immune-deficient 
mice to analyze teratoma formation to assess differentiation potential in vivo by 
analyzing markers for the three germ layers: endoderm, ectoderm, and mesoderm.  It is 
expected that Cfp1 mutations that rescue plating efficiency, cytosine methylation, 
histone methylation, and differentiation defects observed in CXXC1-/- ES cells would 
generate mice in the knockout model, rescue hematopoiesis in the conditional knockout 
model, and maintain differentiation potential in the teratoma model.  In addition, it is 
expected that ES cells expressing certain Cfp1 mutations would generate mice that 
would exhibit a phenotype.  For example, Cfp1 103-367 rescues cytosine methylation, 
histone methylation, and differentiation, but fails to rescue growth, apoptosis, and 
subnuclear targeting of Setd1A and histone H3K4me3.  Therefore, aberrant apoptosis 
may lead to a variety of defects in the mouse and aberrant subnuclear localization of 
Setd1A may lead to alterations in transcriptional activity of Setd1A target genes.  
Analysis of the phenotype would allow a greater understanding into the functional 
significance of Cfp1 properties and protein domains in an in vivo system. 
In order to test if the decreased protein expression of Dnmt1 in CXXC1-/- ES 
cells is causally related to decreased cytosine methylation and an inability to achieve 
differentiation, transient or stable expression of Dnmt1 into CXXC1-/- ES cells could be 
achieved, followed by isolation of clones that exhibit Dnmt1 protein expression levels 
similar to CXXC1+/+ ES cells.  Then, ability of the clones to achieve in vitro 
differentiation would directly assess if the decreased Dnmt1 protein expression in 
CXXC1-/- ES cells results in the inability to achieve in vitro differentiation.  However, 
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expression of Dnmt1 is tightly regulated.  Overexpression of Dnmt1 is also detrimental, 
resulting in embryonic lethality with global hypermethylation and loss of imprinting 
(Biniszkiewicz 2002).  Therefore, isolation and analysis of multiple clones would be 
important to account for variations in Dnmt1 protein expression.   
The PHD1 domain of Cfp1 is important for Cfp1 function in ES cell plating 
efficiency, and the PHD2 domain appears essential for C-terminal Cfp1 fragment 361-
656 function in plating efficiency, cytosine methylation, histone methylation, and 
differentiation.  It will be important to determine whether the PHD domains of 
mammalian Cfp1 also bind to modified histone H3K4, and whether they function in 
transcriptional regulation.  In order to determine a direct interaction between the PHD 
domains and modified histone H3K4, GST pull-downs could be performed.  Purified 
GST-fused portions of Cfp1 that included the PHD domains could be incubated with 
biotinylated histone peptides (H3K4, H3K4me2/3), isolated and washed with 
streptavidin beads, and analyzed by Western blot analysis using anti-GST antibody.  If 
the PHD1 or PHD2 domains of Cfp1 bind modified histone H3K4, additional studies 
can be performed utilizing similar structure-function studies as reported here by making 
point mutations within the PHD1 or PHD2 domains of Cfp1 that abolish the interaction 
with modified H3K4 and analyzing the functional significance of the interaction.  
Mutation of conserved amino acids (D40A and W45A) to alanine within the PHD1 
domain of Spp1 resulted in ablation of PHD1 interaction with histone H3K4me2/3 (Shi 
2007).  Mutations of the corresponding amino acids were made within the PHD1 
domain of Cfp1 (D44A and W49A) in the context of the full-length Cfp1 protein and 
Cfp1 1-367.  These mutations did not affect Cfp1 rescue function in global cytosine 
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methylation and differentiation (data not shown).  However, the functional significance 
of the PHD1 (D44A and W49A) mutations remains unknown, and the rescue activity 
for plating efficiency, histone methylation, and Setd1A subnuclear localization was not 
examined.      
In order to gain more insight into Cfp1 function, it will be important to identify 
other proteins that interact with Cfp1.  If Cfp1 plays a role in transcriptional repression, 
it is expected that Cfp1 would also interact with HDACs or histone H3K9 
methyltransferase complexes.  Another group has reported that Cfp1 interacts with Mll1 
and Mll2 histone H3K4 methyltransferase complexes (Ansari 2007).  Upon knockdown 
of Cfp1, the recruitment of Mll1 and level of histone H3K4me3 were decreased at the 
HoxA7 promoter demonstrating an essential role for Cfp1 in the recruitment of Mll1 to 
the HoxA7 gene (Ansari 2007).  In addition, Cfp1 colocalizes with Mll1 within HEK-
293 nuclei (Lee 2001).  Therefore, it seems likely that Cfp1 may also function to restrict 
the Mll1, Mll2, and Setd1B complexes to specific genomic sites.  Similar to the 
confocal immunoflourescence studies reported in this dissertation, subnuclear 
localization of Mll1, Mll2, and Setd1B could be analyzed in CXXC1+/+ and         
CXXC1-/- ES cells to determine if mis-localization of Mll1, Mll2, or Setd1B occurs in 
the absence of Cfp1.  If so, similar structure-function studies using CXXC1-/- ES cells 
expressing Cfp1 mutations could be carried out to determine functional properties of 
Cfp1 required to restrict subnuclear localization of the histone H3K4 methyltransferase 
complexes.  Additional studies will be important to determine the molecular 
mechanisms regulating the recruitment and activity of the histone H3K4 
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methyltransferase complexes and would provide further insight into the regulation of 
gene expression.   
Setd1A and Setd1B exhibit distinct subnuclear distribution which is 
hypothesized to result from distinct target gene specificity (Lee 2007).  In mammals, 
there are approximately twelve histone H3K4 methyltransferases that provide non-
redundant functions.  Therefore, it is speculated that the histone H3K4 
methyltransferases have distinct target specificity, and it will be important to identify 
the distinct target genes.  The confocal immunofluorescense data presented in this study 
can be confirmed by higher resolution assessment using chromatin immunoprecipitation 
(ChIP).  ChIP is a method that can be used to determine the location of DNA-binding 
sites within the genome.  ChIP could be used to determine target genes for Setd1A and 
Setd1B occupancy in CXXC1+/+ ES cells.  ChIP analysis with CXXC1-/- ES cells would 
determine whether Setd1A and Setd1B are targeted to different regions of the genome 
in the absence of Cfp1.  Then, ChIP could be analyzed for CXXC1-/- ES cells expressing 
Cfp1 1-656 and the vector control to determine if reconstitution of Cfp1 rescues the 
mis-localization of Cfp1.  It is expected that appropriate targeting of Setd1A will be re-
established in CXXC1-/- ES cells expressing Cfp1 1-656 which would provide a way to 
assess structure-function relationships of Cfp1 by ChIP analysis of CXXC1-/- ES cells 
expressing Cfp1 mutations used for the studies reported here.   
For ChIP analysis, Setd1A and Setd1B proteins could be cross-linked to the 
DNA by formaldehyde treatment of the cells.  Following crosslinking, the cells could be 
lysed and the DNA broken into pieces by sonication.  Immunoprecipitation could be 
performed using antibodies specific to Setd1A and Setd1B resulting in the purification 
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of protein-DNA complexes.  The purified protein-DNA complexes could then be heated 
to reverse the formaldehyde cross-linking of the protein and DNA complexes, allowing 
the DNA to be separated from the proteins.  The DNA could be sent for 454 sequencing 
and the sequence results will be mapped to regions of the genome using BLAT software 
(Kent 2002).  Alternatively, if Setd1A and Setd1B target genes are known, the identity 
and quantity of the DNA fragments isolated by ChIP could be determined by PCR using 
primers specific for the known target genes.  Setd1A is localized near the transcription 
start sites of actively transcribed genes in HEK-293 cells, including PPIA 
(peptidylprolyl isomerase A), PABPC1 [poly(A) binding protein, cytoplasmic 1], and 
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (Lee 2007).  Therefore, analysis 
of Setd1A occupancy at these genes (or additional Set1A target genes identified in 
ChIP-on-chip analysis) in CXXC1+/+ and CXXC1-/- ES cells would demonstrate whether 
Setd1A is mis-localized in the absence of Cfp1 and structure-function studies would 
demonstrate the functional properties of Cfp1 necessary to target Setd1A.  ChIP-on-chip 
is a technique that combines chromatin immunoprecipitation (ChIP) with whole genome 
tiling microarray technology (chip).  The advantage of ChIP-on-chip would be the 
ability to identify binding sites on a genome-wide basis.   
The functional significance of the interaction of Cfp1 with Dnmt1 remains 
unknown.  Ablation of DNA-binding activity of Cfp1 103-367 does not ablate the 
interaction of Cfp1 with Dnmt1 but results in loss of cytosine methylation rescue 
activity.  Therefore, it is hypothesized that DNA-binding activity is important for 
targeting Dnmt1 or facilitating Dnmt1 methyltransferase activity.  In order to determine 
whether Cfp1 targets Dnmt1, in vivo targets of Cfp1 could be identified by ChIP-on-
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chip.  Then, target sites of interest could be examined for co-occupancy of Cfp1 and 
Dnmt1 by sequential ChIP or re-ChIP.  Sequential ChIP is performed by using two 
different antibodies for immunoprecipitation in order to analyze the simultaneous 
presence of two proteins at a specific target site.  If Dnmt1 and Cfp1 co-occupy specific 
genes in CXXC1+/+ ES cells, CXXC1-/- ES cells could be utilized to determine whether 
Dnmt1 recruitment to target genes identified in CXXC1+/+ ES cells is lost.  In addition, 
differences between the downstream effect of target gene expression between 
CXXC1+/+ and CXXC1-/- ES cells could be analyzed to determine the consequence of 
Cfp1 and Dnmt1 co-occupancy.    
Hypersensitivity to DNA damaging agents observed in CXXC1-/- ES cells may 
be a consequence of increased chromatin accessibility, decreased DNA repair, or a 
combination of both.  The hypothesis is that CXXC1-/- ES cells have decreased 
heterochromatin which leaves the DNA in a more open, accessible configuration to 
DNA damaging agents.  In order to directly test chromatin accessibility, CXXC1+/+, 
CXXC1-/-, DNMT1-/-, and CXXC1-/- ES cells expressing 1-656 and the vector could be 
subjected to micrococcal nuclease hypersensitivity assays.  Nuclei isolated from ES cell 
lines could be treated with miccrococcal nuclease for various amounts of time, and 
DNA isolated could be used as a template for PCR amplification of various genomic 
loci.  Real-time PCR could be performed to determine the relative amplification at each 
loci.  The amount of PCR product is inversely proportional to the accessibility of 
genomic sites to miccrococcal nuclease.  Therefore, the greater the degree of nuclease 
digestion, the less PCR product, and the more accessible the DNA.  It is expected that 
CXXC1-/- ES cells will have increased micrococcal nuclease cleavage.  In addition, 
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analysis of miccrococcal nuclease sensitivity in DNMT1-/- ES cells would indicate 
whether a decrease in cytosine methylation accounts for increased nuclease 
hypersensitivity.    
CXXC1-/- ES cell DNA exhibits increased incorporation of platinum directly 
after treatment with cisplatin and CXXC1-/- ES cells exhibit increased expression of 
H2AX-γ after treatment with TMZ and cisplatin.  Therefore, it is hypothesized that 
CXXC1-/- ES cells acquire more DNA damage upon drug treatments or have decreased 
repair activity.  Determination of platinum incorporation into DNMT1-/- ES cells using 
atomic absorption spectroscopy could allow a way to determine if the increased 
incorporation of platinum is a result of decreased global cytosine methylation.  An 
additional experiment to measure acquisition of DNA damage includes Comet assay to 
measure SSB and DSB after DNA damaging agent treatment in CXXC1+/+, CXXC1-/-, 
DNMT1-/-, and CXXC1-/- ES cells expressing Cfp1 1-656 and the vector control.  This 
experiment would provide additional insight into the degree of DNA damage 
acquisition in CXXC1-/- ES cells.     
In order to further access whether the hypersensitivity of CXXC1-/- ES cells to 
DNA damaging agents is due to DNA damage acquisition or a defect in DNA repair 
pathways, further experiments need to be carried out.  Some of the same experiments 
used to determine DNA damage acquisition can also be utilized to monitor repair of 
DNA damage.  Platinum incorporation into DNA by atomic absorption spectroscopy 
could be used to monitor the rate of platinum adduct repair over time.  If CXXC1-/- ES 
cells have decreased repair activity, they would be expected to have increased 
persistence of platinum.  CXXC1+/+ and CXXC1-/- ES cells would be treated with 
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cisplatin as previously described.  After cisplatin treatment, DNA from ES cells would 
be collected over a time course after treatment and sent for analysis of platinum 
incorporation.  Therefore, the degree of repair (decrease in platinum) over time can be 
monitored and compared between the cell lines.  Similarly, the rate of H2AX-γ 
accumulation and repair after treatment with TMZ and cisplatin in CXXC1+/+ and 
CXXC1-/- ES cells could be monitored over a longer time course than the studies 
reported here to compare the rate of DSB repair.     
CXXC1-/- ES cells exhibit hypersensitivity to many DNA damaging agents that 
cause a wide variety of DNA damage that can be repaired by different DNA repair 
pathways.  Microarray analysis demonstrates that mRNA expression of other genes 
involved in DNA repair pathways are altered in CXXC1-/- ES cells (data not shown).  
CXXC1-/- ES cells demonstrate decreased mRNA expression of some DNA glycosylases 
implicated in BER, including Ogg1, Mpg, and Mutyh.  In addition, decreased mRNA 
expression was observed for components of the BER pathway downstream of the DNA 
glycosylases including Ape1, Fen1, and Polβ.  In contrast, increased mRNA expression 
was observed for additional components in the BER pathway including Xrcc1 and Lig3 
(ligase 3).  Western blot analysis demonstrated a ~50% decrease in Ape1 protein 
expression and a ~40-50% decrease in Ape1 endonuclease activity in CXXC1-/- ES cells, 
suggesting a decreased BER capacity.  However, there was no difference in Xrcc1 
protein expression in CXXC1-/- ES cells.  Protein expression of other components of the 
BER pathway (DNA glycosylases, polymerase β, ligase 3, Parp) could be analyzed by 
Western blot analysis.  In addition, protein expression of components of other DNA 
repair pathways (NER, NHEJ, HR, MMR) might indicate if there are other repair 
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pathways affected in the absence of Cfp1 that may be contributing to the increased 
cytotoxicity after genotoxic damage.      
It is hypothesized that the decreased Ape1 protein expression and endonuclease 
activity observed in CXXC1-/- ES cells leads to reduced BER capacity which contributes 
to the observed DNA damaging agent hypersensitivity.  In order to directly assess BER 
activity, BER activity assays could be performed in CXXC1+/+ and CXXC1-/- ES cells.  
BER activity assays are similar to the Ape1 endonuclease activity assay reported here.  
A fluorescent labeled double-stranded oligonucleotide containing a G:U mismatch 
within a HpaII restriction site (recognizes CCGG sequence) could be incubated with 
nuclear extracts isolated from CXXC1+/+ and CXXC1-/- ES cells.  After cleavage of the 
reaction products with HpaII, analysis by electrophoresis would allow the separation of 
the repaired cleaved oligonucleotide and the unrepaired intact oligonucleotide which 
would allow the quantification of relative BER activity in CXXC1+/+ and CXXC1-/- ES 
cells.  In addition, to determine whether the increased DNA damage sensitivity in 
CXXC1-/- ES cells is caused by decreased Ape1 protein expression, rescue studies can 
be carried out by transiently or stably expressing Ape1 in CXXC1-/- ES cells back to 
CXXC1+/+ ES cell levels.  This could be achieved by utilizing the expression vector 
used in the studies reported here to insert Ape1 cDNA, then electroporating the 
expression vector into CXXC1-/- ES cells, isolating and expanding clones, then 
analyzing DNA damage sensitivity in CXXC1-/- ES cells expressing Ape1 levels 
equivalent to or above that of CXXC1+/+ ES cells.     
Ape1 is a multifunctional protein involved in AP endonuclease activity in BER, 
in proofreading exonuclease activity, and in modulating DNA-binding activity of 
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several transcription factors including nuclear factor-kB (Nf-kB), early growth response 
protein-1 (Egr-1), p53, Ap-1, Creb, hypoxia inducible factor-1α (Hif-α), cAMP 
response element binding protein (Creb), activator protein-1 (Ap-1), and members of 
the paired box-containing proteins (Pax) family (Merluzzi 2004; Tell 2009).  Analysis 
of various dominant-negative forms of Ape1 (endonuclease-deficient ED mutation and 
redox-deficient C65A mutant) demonstrate chemotherapeutic agent sensitization and 
emphasize the importance of both functions of Ape1 in both normal and tumor cells 
(Wang 2004; McNeill 2007; Vasko 2005).  Therefore, it is unclear whether the 
enhanced sensitivity to DNA damaging agents observed in CXXC1-/- ES cells is due to 
loss of Ape1 endonuclease activity, loss of Ape1 redox regulatory activity, or both.  
This can be explored by utilizing an Ape1 mutation that lacks endonuclease activity but 
retains redox function and an Ape1 mutation that retains endonuclease activity and 
lacks redox function (Vasko 2005).  Similar to the above studies, these Ape1 mutations 
can be transiently expressed in CXXC1-/- ES cells and evaluated for rescue of DNA 
damage sensitivity.  Alternatively, there is a small molecule redox inhibitor of Ape1, 
E3330, that does not affect DNA repair activity, or methoxyamine which blocks Ape1 
and Polβ DNA repair activity but does not affect Ape1 redox function that can be used 
in CXXC1+/+ ES cells to determine if blocking one of Ape1’s functions leads to 
hypersensitivity to DNA damaging agents similar to that observed in CXXC1-/- ES cells 
(Luo 2002).  These studies would provide further insight into the molecular 
mechanisms responsible for the DNA damaging agent hypersensitivity observed in 
CXXC1-/- ES cells.  In addition, these studies would provide insight into the relationship 
between the regulation of chromatin structure and DNA repair processes.  
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V.  Summary 
The experiments described in this dissertation describe novel roles for Cfp1 in 
regulating DNA damage sensitivity and for restricting subnuclear localization of the 
Setd1A histone H3K4 methyltransferase complex.  CXXC1-/- ES cells demonstrate 
hypersensitivity to a variety of DNA damaging agents and exhibit decreased (~50%) 
protein expression and endonuclease activity of Ape1, a dual function enzyme involved 
in DNA base excision repair and redox activation of transcription factors.  In addition, 
CXXC1-/- ES cells accumulate more DNA damage based on increased incorporation of 
platinum into DNA after treatment with cisplatin and increased expression of H2AX-γ 
after treatment with TMZ and cisplatin.  CXXC1-/- ES cells also exhibit reduced protein 
expression of Setd1A, a histone H3K4 methyltransferase, and subnuclear mis-
localization of Setd1A and histone H3K4me3 with regions of heterochromatin.    
This dissertation also describes the functional properties of Cfp1 required to 
rescue the defects observed in the absence of Cfp1.  These structure-function studies 
revealed that expression of the C-terminal fragments of Cfp1 (amino acids 361-656 or 
361-597) is sufficient to rescue the increased population doubling time and apoptosis 
observed in CXXC1-/- ES cells.  Surprisingly, either the amino half of Cfp1 (amino acids 
1-367) or carboxyl half of Cfp1 (amino acids 361-656) is sufficient to correct the DNA 
damaging agent hypersensitivity, plating efficiency, cytosine methylation, histone 
methylation, and differentiation defects observed in CXXC1-/- ES cells.  Additional 
studies revealed that a point mutation (C169A) that abolishes DNA-binding activity of 
Cfp1 ablates the rescue activity of the 1-367 Cfp1 fragment, and a point mutation 
(C375A) that abolishes the interaction of Cfp1 with the Setd1A and Setd1B histone 
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H3K4 methyltransferase complexes ablates the rescue activity of the 361-656 Cfp1 
fragment.  In addition, introduction of both point mutations (C169A and C375A) ablates 
the rescue activity of the full-length Cfp1 protein.  These results indicate that retention 
of either DNA-binding or Setd1 association of Cfp1 is required to rescue DNA 
damaging agent sensitivity, plating efficiency, cytosine methylation, histone 
methylation, and in vitro differentiation, and reveals that Cfp1 contains redundant 
functional domains.  In contrast, full-length Cfp1 is required to restrict subnuclear 
localization of Setd1A and histone H3K4me3 to euchromatic regions of the genome.  
The results reported here identify Cfp1 as a possible integrator of epigenetic 
modifications and possible mediator of DNA repair processes.  The results generated 
from this study also reveal insight into the biological importance of Cfp1 protein 
domains and functional properties and can be further exploited to gain insight into the in 
vivo relevance of Cfp1 functional properties and Cfp1 mutations.  In addition, ES cells 
lacking Cfp1 provide us with a unique system to investigate how chromatin 
configuration impacts the effectiveness of DNA-damaging or chemotherapeutic agents.  
Such insights may lead to more efficacious combinations of chemotherapy in cancer 
patients resulting in better overall patient outcomes.   
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